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ABSTRACT 
Schistosomes infect their hosts via a percutaneous route, during which they are likely to 
come into contact with numerous innate accessory cells, including those with potent antigen 
presenting cell (APQ function. In this thesis, innate interactions between skin-stage 
Schistosoma mansoni larvae and accessory cells were investigated in vitro. Molecules 
released by the parasite following transformation (0-3hRP) but not soluble preparations of 
whole larvae stimulated cytokine production by a variety of accessory cells independently 
of endotoxin. Furthermore, Interleukin (EL)-10 and IL-12p4O but not FL-6 production 
stimulated by O-ARP was partly dependent upon recognition by Toll-like receptor (TLR)4, 
whereas FcyRs had little clear effect upon the cytokine response. In addition, mannose 
receptor (MR) ligands were identified within O-ARP, suggesting numerous pattern 
recognition receptors (PRRs) are involved in schistosome recognition. 
Investigation of the effects of 0-3hRP upon maturation of 'professional' APC 
demonstrated that dendritic cells (DC) responded by increasing cytokine production, up- 
regulating MHC II, CD40, and CD86 expression (but not CD80 or OX40L), and exhibiting 
an increased capacity to prime proliferation of CD4+ cells in vitro. However, 0-3hRP 
induced an 'intermediate' state of maturation when compared to the microbial products 
LPS and Zymosan A. Further in vitro analysis demonstrated that DC matured with 0-3hRP 
primed CD4+ cells to secrete a Th2 profile of cytokines. Moreover, inoculation of mice 
with 0-3hRP-matured DC led to the development of polarised Th2-type responses in vivo. 
Finally, treatment with anti-CD40 antibody reversed the capacity of 0-3hRP-matured DC 
to prime for Th2 responses instead causing the induction of Th I -type responses. 
In conclusion, the innate immune system recognises schistosome material released upon 
infection, resulting in the stimulation of accessory cells. These putative schistosome 
'pathogen-associated molecular patterns' (PAMPs) act to promote induction of Th2 
acquired responses via their direct effect upon APC. 
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CHAPTER ONE 
INTRODUCTION 
INTRODUCTION OVERVIEW 
Schistosomiasis is a serious parasitic disease of humans and has been the focus of intense 
scientific study. Although much work has centred upon the immune responses following 
vaccination with radiation-attenuated cercariae and the immune-related pathology induced 
by schistosome eggs, little is known about the initial innate response to infectious cercanae. 
Recently, the role of innate responses in the generation of acquired immunity to pathogens 
has become clearer, providing valuable insights into the mechanisms that may be involved 
during infection with schistosomes. 
In this introduction, I will describe the evidence for innate and acquired immune responses 
during infection with Schistosoma mansoni, primarily in the murine model. This will cover; 
9 the induction of inflammatory and acquired responses generated by normal larvae 
dunng the initial stages of migration from the skin to the lungs, 
9 the induction of inflammatory and acquired / protective responses generated by 
radiation-attenuated larvae, 
o and finally, the immune responses elicited to adult worms and to schistosome eggs. 
I will then provide an overview of the current understanding of innate immune responses, 
focussing upon; 
e the induction of innate responses by infectious agents and disease, 
e the role of innate responses in the initiation of acquired immune responses, 
e the role of innate responses in the polarisation of acquired immune responses. 
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PART 1 Parasite / Host interactions during schistosomiasis 
1.1 Introduction to the disease 
Schistosomiasis is a debilitating parasitic disease of both humans and livestock. It is 
prevalent in parts of sub-Saharan Africa, south and central America, and eastern Asia. 
Recent estimates suggest that 200 million people are infected worldwide, with I million 
mortalities per year. The WHO places it second in importance only to malaria in terms of 
morbidity, suggesting that it contributes considerably to the economic deprivation of many 
developing countries. Thus, schistosomiasis is a global disease of huge social and 
economic importance. 
The disease is caused by infection with trematode helminth worms of the Schistosoma 
genus. There are three main species of schistosomes that infect man, S. mansoni, S. 
haematobium, and S. japonicum, although less frequently zoonoses can occur with a 
variety of other mammalian species. Of these species, most experimental work, including 
that presented in this thesis, has centred on S. mansoni. 
Infection of the mammalian host follows exposure to water containing free-swimming 
cercariae that are released from the intermediate host (freshwater snail). Infective cercariae 
penetrate the skin of the host and transform into skin-stage schistosomulae. These larvae 
undergo a complex migration from the skin by an intra-vascular or intra-lymphatic route to 
the lungs, before reaching the liver where they mature to adults (reviewed by Wilson, 
1987). The mature worms then form male and female pairs that migrate to either the 
hepatic portal / mesenteric veins (S. mansoni and S. japonicum), or the veins of the bladder 
(S. haematobium). Here, they take up a long-lived residency and female oviposition occurs 
approximately 5 weeks post-infection. The eggs cross into the lumen of the gut, or the 
bladder, from which they are excreted in faeces, or urine, respectively. The excreted egg-, 
hatch upon contact with fresh water, releasing miracidia which infect the intermediate 
molluscan host. 
Adult schistosomes live for an average of 5 to 10 years resulting in chronic infection of 
their hosts. The parasite has co-evolved with its human host to increase host / parasite 
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survival, thus increasing the chance of successfal transmission. In this respect, schistosome 
infection results in a spectrum of chronic disease that is graded according to severity. 
Whilst the majority of cases are associated with low-level morbidity, termed "intestinal 
schistosomiasis", approximately 4% - 12% develop "hepatosplenic disease" characterised 
by severe fibrosis of the liver. This pathology is mainly due to the immune response to the 
egg. Unfortunately for the host, not all eggs released by the female exit from the body. 
Using experimental models of primate infection, it has been estimated that 10% of eggs are 
washed by the hepatic portal blood-flow to the liver (Farah et al., 1997). Within the liver, 
eggs become trapped in the sinusoids and the host initiates the formation of inflammatory 
granulomas around them. These granulomas are associated with fibrotic scarring and 
destruction of the surrounding tissue. However, it should be noted that these granulomas 
appear to serve a protective role against hepatocytotoxicity induced by egg molecules, 
possibly by limiting or preventing toxin release (Dunne et al., 198 1; Doenhoff et al., 198 1; 
Dunne and Doenhoff, 1983; Murare et al., 1992). Ultimately, the cumulative effect of 
fibrosis can lead to an increased portal blood pressure due to blockage of blood-flow, 
resulting in the development of oesophageal varices and upper gastro-intestinal bleeding, 
and contributing to splenomegaly. Indeed, pathology directly correlates with egg burden 
(Cheever et al., 1977). In severe cases of chronic schistosomiasis these varices can rupture 
leading to death. 
Control of schistosomiasis via the use of anti-helminthics, molluscicides, education, and 
improved sanitation is either too expensive, or has inherent difficulties in effective 
execution. Therefore, the development of a vaccine is a major goal of much of the current 
research into schistosomes (reviewed by Bergquist et al., 2002). To be effective, a vaccine 
would have to limit infection, or limit infection-induced pathology. However, in designing 
vaccine strategies it is essential to understand the host immune responses that occur during 
normal infection, and those that may lead to protection. In this respect, study of innate 
immune responses to schistosomes during the initial stages of infection could provide 
valuable insights into early host / parasite interactions, and lead to a greater understanding 
of the events that culminate in the priming of the acquired immune response. 
The scope of the work that can be covered studying human infection is limited for ethical 
and practical reasons. Therefore, experimental models of infection in laboratory animals 
have been developed. Indeed, the initial host / parasite interaction has often long passed 
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once a person presents with clinical disease, necessitating the use of animal models in this 
area of research. S. mansoni can infect many animals, including rodents and primates, and 
therefore numerous models of infection have been developed. Of these, the mouse model 
has been the most intensely studied due to both its wide availability and because it is fully 
permissive to infection. Using mice has the added advantage that they are the most widely- 
studied animals in immunological research. For these reasons, the mouse model forms the 
focus of my work presented in this thesis. 
1.2 Parasite migration and development during infection. 
1.2.1 Parasite migration 
Cercariae need to successfully infect their mammalian host in order to develop into adults 
and continue the life-cycle. This requires the parasite to undergo a complex process of skin 
penetration and internal migration. Penetration is an active process achieved by both 
physical burrowing of the parasite and the release of proteolytic contents of the pre- and 
post-acetabular glands which digest a pathway through the stratum comeum and epidermis 
(reviewed by Salter and Mckerrow, 2002). During this period of penetration the cercariae 
transform into schistosomulae, lose their tails, and shed much (60%) of their surface 
glycocalyx (Samuelson and Caulfield, 1985). Within approximately 30 minutes, the larvae 
breach the stratum corneum and progress through to the basement membrane of the 
epidermis (Wilson and Lawson, 1980). 
The basement membrane appears to impede parasite migration, and after remaining there 
for between I and 3 days the schistosomulae cross into dermis (Wheater and Wilson, 
1979). The majority of larvae then exit the dermis via post-capillary venules but 
approximately 10% - 20% exit via lymph ducts (Wheater and Wilson, 1979; Mountford et 
al., 1988). Those larvae that exit the skin via the vasculature are carried to the lungs 
directly by the venous blood flow, whilst lymphatic migration first requires traversal of the 
local skin draining lymph node (sdLN). The length of time it takes for schistosomulae to 
migrate from the skin varies considerably, with some larvae detectable in the lungs or 
sdLN as early as 2 days post-infection. The TV2of parasite migration from the skin varies 
between reports, and ranges from approximately 4 days (Miller and Wilson, 1978; Georgi, 
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1982; Mangold and Dean, 1984), to 5.3 days (Wilson et al., 1986), and most likely reflects 
the technique used to assess migration. 
Schistosomulae eventually arrive in the lungs, with peak numbers of parasites detected at 
approximately day 6 (Miller and Wilson, 1980) to day 7 (Wheater and Wilson, 1979; 
Mangold and Dean, 1983; Mangold and Dean, 1984; Wilson et al., 1986). The lungs, with 
their complex narrow capillary network, represent a formidable obstacle to the parasite, 
apparent by the slow migration of the larvae through this organ (Wilson and Coulson, 
1986). Indeed, following arrival at the lungs, larvae undergo considerable elongation, 
which is thought to be necessary for successful migration through the pulmonary 
vasculature (Wilson et al., 1978). 
It is generally accepted that after leaving the lungs, the parasites travel in the direction of 
blood flow via the pulmonary vein to the left side of the heart. From here, they are 
distributed by the systemic blood flow. Those larvae arriving in the splanchic organs 
negotiate the capillaries and are carried to the liver by the portal blood flow. Most become 
trapped in the hepatic sinusoids and develop into blood feeding worms (Wilson and 
Coulson, 1986). Those larvae that arrive in other organs traverse the capillary networks 
and return to the pulmonary vasculature whereupon the cycle of migration is repeated. 
Hepatic accumulation of the larvae appears to be complete by day 21 post-infection 
(Wilson et al., 1986). Following arrival in the liver, larvae initiate blood-feeding and 
mature to adult worms. What causes maturation is not known. Upon pairing, adult worms 
migrate back up the veins of the hepatic portal system, where they take up residency in a 
state of permanent copulation. 
1.2.2 Parasite attrition during migration 
Parasite migration in naYve mice is associated with a large degree of attrition, with only 
about 40% - 50% reaching maturation (Mangold and Dean, 1983; Mangold et al., 1986). 
Autoradiographic tracking of larvae showed that more than 90% of the parasites had exited 
the skin and were present at other host sites 14 days post-infection, demonstrating that the 
skin is not the major site of parasite death (Wilson et al., 1986). Lymphatic migration also 
does not appear to affect parasite viability (Miller and Wilson, 1978; Mangold et al., 
1986). Since autoradiographic tracking demonstrates that the hepatic-portal worm 
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population is complete by day 21 post-infection, it is thought that migration of the 
remaining parasites must be halted and that their position indicates their place of death 
(Wilson et al., 1986). Based upon this supposition, the lungs appear to be the predominant 
site of parasite attrition. 
Death in the lungs has been indirectly associated with the entry of parasites into the 
alveoli (Crabtree and Wilson, 1986). Since, short-term residence in the alveoli does not 
affect parasite viability (Coulson and Wilson, 1988), it has been suggested that the 
mechanism of parasite death in the lungs is probably one of starvation through 
unsuccessful migration (Wilson, 1987). 
The fact that less than 50% of larvae reach maturation suggests migration through the host 
is inherently difficult. However, a role for the immune system in parasite attrition cannot 
be ruled out. Several studies assessing different immune components have demonstrated 
that the absence IL-12 (Anderson et al., 1998), IL-4 (King et al., 1996a), IFNy receptor 
(Wilson et al., 1996), and TNF receptor I (Street et al., 1999), do not affect the number of 
larvae reaching maturation. However, the absence of CD28 (King et al., 1996b), or IgE 
(King et al., 1997) does result in increased wonn burdens, suggesting that parasite attrition 
may represent 'innate resistance' to schistosome infection. 
Once larvae have matured to adults there is little evidence in the murine host that parasite 
attrition occurs. In addition, the longevity of adult survival during human infection also 
suggests there is little attrition of the parasites once they have reached this stage. 
1.3 Early inflammatory responses to normal infection: from penetration to lung stage 
migration 
Skin penetration and migration of larvae are highly invasive and relatively protracted 
events that involve the traversal of several immuno-competent organs. It would therefore 
seem likely that the onset of schistosome infection would trigger host innate / 
inflammatory immune responses. The evidence to support this hypothesis is described 
below. 
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1.3.1 Local inflammatory responses 
Infection of the skin is accompanied by acute inflammation. Both histological and 
physiological examination demonstrates that the skin-exposure site approximately doubles 
in thickness 2-3 days after infection, although increased tissue thickness has been 
reported as early as 6 hr post-infection (Mastin et al., 1983; Incani and McLaren, 1984). 
Inflammation is protracted, and although peaking 2-3 days post-infection (Mastin et al., 
1983) the skin stays significantly thickened up to day 14 (Mountford et al., 2001), 
considerably later than the point when most parasites have left the skin. This inflammation 
represents thickening of both the epidermal and dermal layers (Incani and McLaren, 1984). 
1.3.2 Local cellular responses 
Infection-induced inflammation is accompanied by changes in both epidermal and dermal 
cellular constituents and tissue ultrastructure. Histological studies provide evidence of 
neutrophilic / granulocytic infiltration in the epidermis, as early as 3 hr post-infection, 
which form micro-abscesses in the epidermal squames by 6 hr (Incani and McLaren, 1984; 
Ward and McLaren, 1988; Elsaghier and McLaren, 1989). Some of these neutrophils 
showed signs of degeneration, whereas others contained phagosomes possibly filled with 
debris and parasite gland secretions and could be observed adhering to the schistosomulae 
(Incani and McLaren, 1984). Resolution of abscesses occurred by day 4 post-infection 
(Incani and McLaren, 1984) by which point most larvae have left the epiderinis. This acute 
neutrophilia can be mimicked using an experimental model of parasite-induced 
chernotaxis, whereby intra-peritoneal injection of artificially-transformed schistosomulae 
results in the transient influx of neutrophils (2 - 12 hr) into the body cavity (Chao et al., 
1986). In addition, keratinocytes (which comprise the majority of the epidermal cells) in 
the vicinity of larvae show a considerable amount of hypertrophy (Incani and McLaren; 
1984). More recently, immuno-histochemical analysis has demonstrated that epidermal 
accessory cells, which may be Langerhans cells (LQ up-regulate surface expression of the 
activation markers MHC H and CD86 from I and 12 hr post-infection respectively (Angell 
et al., 2001 a). Although migration of these cells from the epidermis may be impaired 
during infection due to parasite-derived Prostaglandin D2 (PGD2; Angell et al., 2001 a), this 
data suggests that infection may stimulate local antigen presenting cells (APQ to capture 
and present parasitic antigen. 
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In the dermis, inflammatory responses can be observed by one to two days post-infection 
and are characterised by oedema, hyperkeratosis, leukocyte and erythrocyte infiltration, 
and considerable vasodilation (Miller and Wilson, 1978; Wheater and Wilson, 1979; 
Mastin et al., 1983; Incani and McLaren 1984; Ward and McLaren, 1988; Elsaghier and 
McLaren, 1989). This corresponds with the gross swelling of the skin described earlier. 
Specifically, dermal cellular infiltrate is initially diffuse, although some congregation 
below the basement membrane occurs. The infiltrate is comprised of both granulocytes, 
which are predominantly neutrophils (but include some mast cells), and mononuclear cells 
(Wilson and Wheater, 1979; hicani and McLaren, 1984; Ward and McLaren, 1988). 
Moreover, dermal MHC 11+ cells aggregate beneath epidermal larvae, again suggesting that 
local APC become activated (Riengrojpitak et al., 1998). By days 3-4, the inflammatory 
infiltrate was mainly mononuclear, and not granulocytic (Elsaghier and McLaren, 1989). 
Moreover, these cells were organised into distinct foci (Wheater and Wilson, 1979), which 
suggests chemotaxis towards parasites or tissues damaged / stimulated by their presence. 
Notably, mast cells appeared to undergo degranulation, and free granules were seen 
amongst the other cell types (Incani and McLaren, 1984). Importantly, this may be a direct 
consequence of interaction with parasite molecules in the skin, since material released by 
cercariae has recently been shown to cause deganulation of a rat basophil cell-line 
(Machado et al., 1996; Rao et al., 2002). It is unlikely that the inflammatory infiltrate is 
due to haemorrhage caused by physical trauma of the vasculature, since intra-dermal 
injection of guinea pigs with cercarial homogenate, or material released by cercaniae, 
resulted in rapid (30 min) oedema with an influx of neutrophils and eosinophils (Teixeira 
et al., 1993). Notably, some cells in the vicinity of schistosomulae were seen to undergo 
apoptosis in the skin of infected mice, and it has been suggested that the larvae may 
actively induce cell death as a method of immune evasion (Chen et al., 2002). 
In contrast to the skin, the appearance of schistosomes in the sdLN 2 to 7 days post- 
infection did not correspond with a visible host leukocyte response using histological 
techniques, although cellular damage to host leucocytes in the vicinity of the parasite was 
observed (Wheater and Wilson, 1979). Similarly, with the arrival of schistosomes in the 
lungs there is initially no recognisable host inflammatory tissue response detectable at the 
gross level (Wheater and Wilson, 1979; Mastin et al., 1983; von Lichtenberg et al., 1985). 
Although larvae can adhere to lung microvasculature endothelial cells in vitro (via active 
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cell remodelling), suggesting direct interactions may occur in vivo, these cells appear to 
take on an anti-inflammatory phenotype (Trottein et al., 1999a; 1999b). However, in vivo 
an inflammatory response develops by day 9 post-infection with increasing time post- 
infection (Menson and Wilson, 1990; Smythies et al., 1992a), and cellular foci can be 
observed within the vicinity of the lung schistosomulae (von Lichtenberg et al., 1985). In 
addition, alveolar macrophages increase their expression of MHC 11 and CR3 but decrease 
the expression of 174/80 (Menson and Wilson, 1990). It is possible that these inflammatory 
foci have a role in the parasite attrition that occurs in the lungs, potentially prohibiting the 
passage of larvae through the vasculature. In this respect, IL-6 -/- mice have greater 
numbers of leukocytes recruited to the alveoli in response to a secondary infection with 
schistosomes, and also a much greater level of parasite mortality in the lungs (Angeli et al., 
2001b). 
1.3.3 Local cytokine production 
Cytokines are the hormones of the immune system, allowing cells to communicate in 
paracrine, endocrine and autocrine fashion during responses to pathogens. The balance of 
regulatory and inflammatory cytokines is thought to play a key role in controlling immune 
responses to infection. Relatively few studies have addressed whether cytokines are 
produced in the skin in response to infection, and which cells are responsible for producing 
them. Wolowczuk et al. (1997) detected increased expression of EL-7 mRNA but not IL-2, 
IL-5 or IL- 10 in the skin infection site from day I post-infection. It is noteworthy that 
increased IL-6 mRNA expression in the skin was also detected but not restricted to the site 
of infection, suggesting that parasite infection may lead to a general heightened 
inflammatory status of the host. Transient expression of EFNy and IIL-4 was also detected 
on day 5 post-infection (Wolowczuk et al., 1997). In addition, Angeli et al. (2001 a) 
detected increased TNF(x, IL- I P, EL-4, EL- 10, and TNFR-H but not inhibitory EL- I Ra 
mRNA expression in the epidermis ftom I to 120 hr post-infection. More recently, a 
technique for culturing split pinnae has allowed detailed examination of cytokine 
production by the infection site as a whole organ (Hogg et al., 2003 a). Using this 
technique, increased EL- I P, EL-6, IL- 10, IL- I 2p4O, EL- 18, MEP- I (x, MIP I P, and eotaxin, 
can be detected in the culture supernatant from day I (earliest time-point examined) to day 
8 post-infection. Notably, production of EL- 1 2p4O and EL- 18 remained increased 
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(compared to naYve pinnae) up to day 14 post-infection, albeit at sub-peak quantities. In 
vitro work has demonstrated that schistosomulae and their products stimulate human and 
murine keratinocytes to produce IL- I Ra, EL- 10, and PGE2, which has been linked to 
parasite-derived PGE2 production (Ramaswamy et al., 1995a; 1995b; 2000). These host 
molecules have anti-inflammatory functions and may regulate the innate response during 
infection (Ramaswamy et al., 2000). In addition, human dermal microvasculature 
endothelial cells produce increased levels of IL-7 following in vitro culture with 
schistosomulae, and EL-7 mRNA expression could be detected in the vessels of human skin 
grafts 6 days post-infection (Roye et al., 1998). 
1.3.4 Inflammatory response upon re-infection 
Re-infection of mice previously exposed to cercariae results in increased dermal 
inflammation, characterised by more rapid and greater swelling and cellular influx 
compared to primary infection, indicative of an immediate hypersensitivity reaction 
(Incani and McLaren, 1984; Ramaswamy et al., 1997). Indeed, re-infection is also 
characterised by a much greater eosinophilic influx into the tissue and greater mast cell 
degranulation in re-infected tissue. Larvae can also be observed invested in a surface coat, 
with neutrophils and eosinophils attached (Incani and McLaren, 1984). This response may 
be mediated by parasite-specific IgE which is thought to be both induced and directed, in 
part, against the proteases released by the parasite (Verwaerde et al., 1986; 1988). Notably, 
skin from mice infected several times with the related schistosome Trichobilharzia regenti 
displays dramatic signs of type I hypersensitivity upon re-infection, with an abundant mast 
cell influx not seen in primary infection, and greatly increased levels of histamine, IL- I 
IL-4, EL-6 and IL- 10 production by in vitro-cultured pinnae (Kourilova et al., 2003). 
1.3.5 Human inflammatory responses 
The potent inflammatory responses generated in mice following exposure to schistosomes 
reflect the immediate hypersensitivity reaction observed in the skin (dermatitis) of some 
humans following infection (Farid et al., 1987). Some patients also develop acute 
pulmonary pneumonitis. These illnesses are caused by immediate hypersensitivity 
responses thought to be a consequence of mast cell and basophil activation by skin and 
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lung-stage schistosomulae (Hofstetter et al., 1982), although the pulmonary disease may 
also be caused by immune complexes between antibody and antigen from migrating lung 
schistosomulae (de Jesus et al., 2002). 
1.4 Acquired immune responses to normal infection: from penetration to lung-stage 
migration 
1.4.1 Lymphocyte activity 
Following infection with schistosomes, an acquired immune response is generated in both 
the sdLN and the mediastinal (lung-draining) LN (mLN). Cells from both sites are able to 
proliferate in vitro in response to re-stimulation with schistosome antigen, peaking on day 
7 post-infection in the sdLN but much later at day 15 in the mLN (Pemberton et al., 1991). 
Analysis of the cells within these organs demonstrates that both T-cell and B-cell numbers 
greatly increase in vivo following infection (Constant et al., 1990), corresponding with an 
increase in organ weight (Pemberton and Wilson, 1995). Again, peak cell number in the 
sdLN occurs 4-7 days post-infection, but not until approximately day 28 in the mLN 
(Constant et al., 1990; Pemberton et al., 1995). Notably, the kinetics of cell proliferation in 
vitro and cell numbers in vivo follows the pattern of parasite migration through the skin to 
the lungs, and probably reflects the levels of parasite antigen presented within these 
organs. 
A study using bronchoalveolar lavage (BAL) to analyse cellular events in lung alveoli 
demonstrated a transient influx of lymphocytes between days 14 and 21 post-infection 
(Smythies et al., 1992a). These cells produced cytokines upon in vitro culture with soluble 
schistosomulae antigen (SSP) suggestive of antigen-specific lymphocytes. These studies 
imply that differentiated effector T-cells migrate to the lung during the latter periods of 
larval migration through this organ. 
1.4.2 Cytokine production 
Detailed analyses of the antigen-specific cytokine production by cultured sdLN cells 
showed that there was production of EL-2, EL-3, IL-4, EL- 10, and IFN7 from day 4 post- 
24 
infection, suggestive of a mixed Thl / Th2 or ThO-type response (Pemberton et al., 1991; 
Hogg et al., 2003a). However, IFNy production peaked at day 4 post-infection whereas IL- 
4 production peaked at day 6, suggesting that Th I responses slightly precede Th2 
(Pemberton and Wilson, 1995). However, by day 14 post-infection both EFNy and IL-4 
production returned to near naYve levels (Pemberton and Wilson, 1995; Hogg et al., 
2003 a). In addition, increased levels of EL- 12p4O were produced by in vitro cultured sdLN 
cells from day 4 post-infection, which decreased but remained elevated above naYve levels 
by day 14 post-infection (Hogg et al., 2003a). This cytokine is of particular interest due to 
its ability to drive Thl polarisation. 
A similar profile of IL-4 and IFN7 production was also detected upon re-stimulation of 
mLN cells, although peak production did not occur until day 15 post-infectlon (Pemberton 
et al., 199 1). As with cell proliferation, the kinetics of T-cell cytokine production probably 
reflects the levels of parasite antigen being presented within these organs. 
Subsequent analysis of cytokine gene expression within the sdLN using semi-quantitative 
RT-PCR showed a similar cytokine profile to that produced in vitro, with Th 1 -associated 
EFNy, and Th2-associated EL-4 transcripts being detected at day 5 post-infection (Betts and 
Wilson, 1998). However, by days 10 and 15 transcripts of EFN7 had reduced to levels 
within naYve animals, but EL-4 remained high and a small increase in EL-5 was detected, 
possibly suggesting the cytokine profile was becoming more Th2 dominated (Betts and 
Wilson, 1998). 
Notably, infection with the related schistosome species T. regenti also results in a mixed 
Th I/ Th2 response, however, in multiply-infected mice re-infection results in an extremely 
Th2-polarised response, which is associated with Type I immediate hypersensitivity in the 
skin (Kourilova et al., 2003). Therefore, it is possible that local hypersensitivity reactions 
will help to drive Th_2 cytokine production. 
1.5 Inflammatory and acquired immune responses to y-irradiated cercariae 
Although the initial interactions between the normal parasite and the host's immune system 
have received little attention, responses to vaccination with radiation-attenuated larvae are 
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relatively well studied, since this regime induces a high level of protective immunity to 
challenge infection (reviewed by Dunne and Mountford, 2001). A brief review of this work 
provides greater evidence of host inflammatory responses upon exposure to larvae, and an 
understanding of events involved in priming for this protective acquired response. 
1.5.1 Inflammatory responses and APC stimulation in the skin 
The presence of attenuated larvae results in a pro-inflammatory response in the skin 
exposure site (as determined by pinnae thickness and in vitro cytokine production) similar 
to that seen in normal infection, although some inflammatory parameters appear more 
protracted (Mastin et al., 1983; Hogg et al., 2003a). Immunohistochernical analysis 
demonstrates an influx of 7/4+ neutrophils into the dermis by day 2 post-vaccination 
(Kumkate and Mountford, unpublished data). Increased CD II b+ populations were also 
detected, suggestive of them being macrophages (MO). Furthermore, IL- 1 2p4O+ cells were 
detected within the areas of greatest cellular influx (Hogg et al., 2003a). Analysis of cells 
detaching from the pinnae during culture shows a dramatic increase in number by day I 
post-vaccination, reaching a peak by day 4 (Mountford et al., 2001). Moreover, some of 
these cells were IIL- I 2p4O+ and expressed CD IIb, CD IIc, and F4/80, suggestive of them 
being myeloid dendritic cells (DQ and / or possibly MO (Hogg et al., 2003 a). These cells 
could be taken to be indicators of those contributing to dermal inflammation, but also 
indicate which types are capable of migrating to the sdLN to drive acquired responses. 
Further evidence of APC activation by irradiated parasites is provided by 
immunohistochernical studies. Larvae in the epidermis were shown to attract and interact 
with MHC II+ cells following migration into the dennis (Riengrojptak et al., 1998). There 
were also increased numbers of CD 11 c+ cells in the dermis, and as such may be dennal DC 
(Riengrojptak et al., 1998; Hogg et al., 2003a). Upon migration to the dermis, larvae 
become surrounded by CD 11 c+ cells, which could be detected up to 15 days post-exposure 
(Riengrojptak et al., 1998). In addition, Langerin+ LC decrease in number in the epidermis 
after vaccination, suggesting maturation and migration of these cells (Kumkate et al., 
2003). Indeed, LC have been detected in the dennis below penetrating larvae immediately 
following vaccination. The apparent emigration of LC corresponds with increased numbers 
of Langerin+ and MHC lI+ cells detectable in the sdLN (Kumkate et al., 2003). 
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Furthermore, accessory cells in the periphery of the sdLN interact with migrating larvae, 
and appear to contain endosomal vesicles comprised of cellular debris (Riengrojptak et al., 
1998). 
1.5.2 Acquired immune responses 
When compared to normal infection, exposure to irradiated larvae results in a markedly 
different acquired immune response. Firstly, antigen-specific responses are more 
protracted in the sdLN and mLN from vaccinated mice, as judged by proliferation and 
cytokine production of in vitro re-stimulated LN cells (Pemberton et al., 1991; Hogg et al., 
2003a). Moreover, cells from vaccinated mice produce greater levels of IFN7 but not IL-4. 
One interpretation of this data is that vaccination induces a more Thl response, however, it 
could equally be said that normal infection induces a more Th2 response. 
Several studies have attempted to determine what factors are involved in the induction of 
this protective acquired response. T-cell priming appears not to involve antibody or 
antigen-specific B-cells (Anderson et al., 1999; Jankovic et al., 1999). In contrast, T-cell 
IFNy production is highly dependent on EL-12 production, since sdLN cells from IL- 
12p4O-deficient mice produce greatly reduced levels of EFNy and greatly increased levels 
of EL-4 both at the protein and mRNA level (Anderson et al., 1998). Indeed, administration 
of recombinant IL-12 shortly after vaccination boosts EFNy production (Anderson et al., 
1998). However, in situations where EL-12p4O is elevated at the site of infection (e. g. IL- 
4R(x -- mice), production of IFNy by sdLN does not increase and IL-4 does not decrease, 
although levels of EL-5 and IL-13 are lower (Mountford et al., 2001). This suggests that IL- 
12p4O production at the site of infection may not increase Thl responses but could 
decrease Th2 responses, and that T-cell EL-4 production is not dependent upon EL-4 or IL- 
13 signalling (since these cytokine receptors share the IL-4R(x chain). In addition, IL-10 
appears to have a role in regulating the induction of protective pro-inflammatory 
responses, since EL- I O-deficient mice develop more highly polansed and more protective 
Thl responses, and exhibit greater inflammation at the skin site of exposure (Hoffman et 
al., 1999; Hogg et al., 2003b). 
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1.5.3 Challenge parasite death 
A great deal of controversy surrounds the mechanism of challenge parasite death in 
vaccinated animals. Following a single vaccination, the role of antibody in schistosome 
death is highly debatable. Results from several studies of B-cell-deficient mice disagree 
with each other, suggesting B-cell effector mechanisms either do, or do not, contribute to 
resistance (Jankovic et al., 1999; Anderson et al., 1999). Moreover, mice deficient in 
several Fc receptors show no defect in vaccine-induced immunity (Jankovic et al., 1999), 
but single vaccination of EL-4R(x-deficient mice results in impaired resistance associated 
with a lack of Th2-type antibodies (Mountford et al., 2001). In contrast, a Thl CD4' T- 
cell-mediated, EFN7-dependent, mechanism of challenge parasite death is largely 
undisputed (Smythies et al., 1992b; Wilson et al., 1996; Wynn 1996; Jankovic et al., 
1999), and protection can even be boosted by addition of rEL- 12 (Wynn et al., 1995; 1996; 
Anderson et al., 1998). In comparison to single exposure, there is clear evidence that 
antibodies play a role in the increased level of protection elicited by multiple vaccination 
(Caulada-Benedetti et al., 1991; Hoffinan et al., 1999). Thus, both hurnoral and cell- 
mediated mechanisms can operate in challenge parasite death. This prompted Wilson and 
Coulson (1999) to propose the 'Happy Valley Hypothesis' suggesting that schistosomes 
can survive if there is a relatively ineffective mixed Thl / Th2 response, but the 
environment becomes much more hostile if the response is strongly polarised to either pole 
(Wilson and Coulson, 1999). However, Wynn and Hoffman (2000) disagree, having 
recently demonstrated that high-level protective Thl and Th2 responses can develop 
simultaneously in multiply-vaccinated mice (Hoffinan et al., 1999), and suggest that 
greatest protection will be afforded by a vaccine that elicits both strong humoral and 
cellular responses. 
1.5.4 What is special about attenuated larvae? 
What causes the difference in cytokine profile between normal infection and vaccination is 
the subject of much debate. Radiation-attenuated parasites undergo retarded migration 
through the skin and the sdLN with delayed arrival in the lungs. Larvae fail to migrate 
further than the lungs in which most parasites die within the first 3 weeks post-vaccination 
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(Mastin et al., 1983; Mangold and Dean, 1984; Mountford et al., 1988). Harrop and 
Wilson (I 993a) observed that irradiated parasites had constrictions on their bodies 
indicative of contractions of circular muscle, and suggest that delayed migration may be 
due to a disruption in neuromuscular function. 
Alternatively, a recent report suggests that irradiated parasites may stimulate less anti- 
inflammatory IIL- 10 production by host keratinocytes (Ramaswamy et al., 2000). This 
could allow greater inflammatory responses to occur in the skin, which subsequently 
impair migration. However, Hogg et al. (2003a) demonstrate that there is little difference 
in pro-inflammatory cytokine production following vaccination compared to infection, 
although vaccination induces transiently lower levels of IL-10 production compared to 
infection, at early time-points. 
Delayed migration may allow for greater deposition of antigens and pathogen-associated 
molecular patterns (PAMP), and more time for parasite / accessory cell interaction 
(Mountford et al., 1988; Mountford et al., 1992). In this respect, more parasite-released 
material was found in the sdLN of vaccinated mice compared to normally infected mice 
(Mountford et al., 1988). However, it is possible that the process of attenuation causes the 
larvae to release more antigen material (Mountford et al., 1988). There could also be other 
differences between attenuated and normal larvae. Chen et al. (2002) state that irradiated 
parasites do not release a T-cell apoptotic factor and thus cause less cellular apoptosis 
during migration. Alternatively, it has been suggested that irradiation may induce abnormal 
antigens that make these parasites more immunogenic (Wales et al., 1992). However, a 
limitation of this theory is that, in order to be effective, a memory T-cell population would 
need to recognise unaltered parasite epitopes. In addition, the material contained within 
cercariae is pre-formed, with little de novo synthesis occurring until after 24 hr post- 
transformation (Harrop and Wilson, 1993b), therefore, it is likely that irradiated parasites 
have the same repertoire of molecules as normal cercariae. Moreover, there is not a great 
deal of difference in the initial (day I- 4) inflammatory immune response induced by 
vaccination compared to infection (Hogg et al., 2003a), suggesting that there is little 'bio- 
chemical' difference between these larvae at this early stage. Therefore, if normal larvae 
express parasite PAMPs, the irradiated larvae should have the same PAMP complement, 
and thus APC which are stimulated by exposure to irradiated parasites are also likely to be 
stimulated in a similar fashion / mechanism by exposure to normal larvae. 
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1.6 Inflammatory and acquired responses to normal infection: adult worms and eggs 
Many normal larvae successfully migrate through the lungs and proceed to mature in the 
liver. The onset of egg production leads to a dramatic increase in the levels of circulating 
antigen, with large quantities of soluble material released by the ova (Ashton et al., 2001). 
1.6.1 Acute infection 
The high levels of foreign antigen result in immune hyper-responsiveness, with increased 
levels of both IFNy and IL-4 detectable in infected mouse serum by 4 weeks-post infection 
(Wolowczuk et al., 1997). Prior to the onset of egg production (3 weeks post-infection), 
splenocytes re-stimulated in vitro with SSP, or soluble adult worm antigen (SWAP), 
produced high levels of EFNy and low levels of EL-5, and this is thought to be suggestive of 
a Th I response (Pearce et al., 1991; Grzych et al., 1991). Following the onset of egg 
production, a dramatic switch is seen in the profile of cytokines produced by splenocytes 
upon re-stimulation with parasite antigens. This is characterised by down-regulation of the 
Thl response in favour of a Th2-type cytokine profile (Pearce et al., 1991). The role of 
these Th2 cytokines may be to inhibit, or reduce, the pathogenic effect of inflammatory 
mediators (Brunet et al., 1997; Fallon et al., 2000). 
The ability of schistosome eggs to drive Th2 responses has been thoroughly investigated 
and the mechanisms leading to this switch are becoming more understood. Artificial 'egg 
only' infections (in which eggs are injected into recipients) are characterised by transient 
ThO followed by Th2 responses (Vella and Pearce, 1992). Moreover, SEA preferentially 
drives Th2-related responses after administration in vivo as judged by cytokine and IgE 
production, a characteristic dependent on its carbohydrate constituents (Okano, et al., 
1999). Specifically, the pentasaccharide lacto-N-fucopentose III (LNFP IH) appears to 
have Th. 2 adjuvant properties, driving acquired responses as well as polarising towards a 
Th2 phenotype (Okano et al., 2001), suggesting it has PAMP characteristics. One 
mechanism by which these carbohydrate moieties could induce Th2 responses is through 
the induction of EL- 10 production, and the expansion of EL- 10 producing B-cells 
(Velupillai and Ham, 1994; Velupillai et al., 1997), since this cytokine can inhibit pro- 
inflammatory Thl responses (Section 1.12.3). Egg-induced EL-6 production by LN cells 
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has also been implicated in EL- 10 production and Th2 polarisation (La Flarnme et al., 
1999; 2000). A glycoprotein from SEA can also stimulate M-4 production by human 
basophils in vitro, which might potentiate Th2 polarisation (Haisch et al., 2001). 
Alternatively, it was recently shown that SEA can preferentially induce Th2 polarisation 
through its direct effect upon DC (MacDonald et al., 2001). In this respect, the role of DC 
derived cytokines and co-stimulatory signals in this polarising function has been explored 
in several recent publications and will be discussed later in chapters 6 and 7. 
1.6.2 Chronic infection 
The down-regulation of host inflammatory Th I immune responses is critical for the 
progression to a chronic state of infection (Brunet et al., 1997; Fallon et al., 2000). The 
study of egg granulomas, which are mediated by egg-antigen specific CD4+ T-cells 
(Mathew and Boros, 1986), suggests that in addition to modulation of inflammatory 
responses, chronic infection is characterised by down-regulation of immune responses per 
se, leading to a state of immune hypo-responsiveness (reviewed by King, 2001; Sadler et 
al., 2003). 
One potential mechanism that could induce immune hypo-responsiveness is the inhibition 
of T-cell proliferation. In this respect, exposure to glycolipids contained within SEA causes 
DC to prime for regulatory T-cells that suppress T-cell proliferation through IL- 10 
production (van de Kleij et al., 2002). The LNFP III sugar from SEA also expands a subset 
of Mý (termed 'suppressors'), which can directly suppress T-cell proliferation and 
suppress Th I -type inflammatory cytokine production via contact-dependent and cytokine- 
dependent (IFNy & IL- 10) mechanisms (Atochina et al., 200 1; Terrazas et al., 200 1). 
Moreover, EL- 10 appears to be critical in the down-regulation of the granulomatous 
immune response during chronic schistosomiasis (Flores-Villanueva et al., 1996; Sadler et 
al., 2003). 
1.6.3 Human acute and chronic disease 
The regulation of acquired immune responses depicted in the mouse model reflects much 
that is known about pathology observed during human infection. A study of patients with 
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clinically acute disease showed their peripheral blood mononuclear cells (PBMC) 
produced numerous pro-inflammatory cytokines, and higher levels of EFNy but lower IIL-5 
when stimulated with SEA, or SWAP, compared to cells from patients with chronic 
schistosomiasis (de Jesus et al., 2002). Immune hypo-responsiveness is also characteristic 
of the majority of chronic infections in the human population, and has been linked to IIL- 10 
production (Malaquias et al., 1997; King, 2001). Most individuals with chronic but 
relatively asymptomatic intestinal disease appear to develop Th2 patterns of cytokine 
production (Williams et al., 1994; Araujo et al., 1996). In contrast, development of more 
severe hepatic disease in a minority of patients is associated with immune hyper- 
responsiveness (Dunne and Pearce, 1999), characterised by greater antigen-specific PMBC 
proliferation (Bahia-Oliveira et al., 1992), and elevated levels of the Thl cytokines IFNy 
and TNFcc (Mwatha et al., 1998; Henri et al., 2002). 
1.7 Summary 
The first section of this introduction has provided the reader with the current body of 
knowledge surrounding the inflammatory innate responses and acquired immune responses 
that follow infection with normal schistosomes. This has demonstrated that acute 
inflammatory responses characterise the immediate events in the skin following infection 
with schistosomes. It is highly possible that these responses are a result of direct parasite 
recognition by the innate immune system, although it is equally possible that tissue damage 
caused by parasite penetration and migration may also stimulate the inflammatory cascade. 
Following the innate response, a parasite- specific acquired response is generated in the 
local lymphoid tissues. This response may contribute to the considerable level of larval 
attrition that occurs during parasite migration, but may also lead to acute allergic 
hypersensitivity. However, compared to the relative wealth of information regarding the 
development and regulation of acquired responses to schistosomal egg antigens, it is not 
known what innate / inflammatory factors are important in the development of the acquired 
response during the early stages following infection. It is most likely that the initial 
inflammatory / innate reaction is critically important in this process. In this respect, the 
current body of knowledge surrounding the immune response following vaccination with 
radiation-attenuated larvae has been summansed. This provides a more in-depth 
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understanding of the orchestration of innate and acquired responses to larvae, and may 
indicate factors that are involved in the generation of acquired immune responses during 
nonnal infection. 
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Part 11 Innate immunity and its impact upon the induction of acquired 
immunity: innate recognition and T-cell polarisation 
The innate immune system is the first line of defence against infectious agents. Whilst 
minor pathogen insults may be dealt with without the requirement of further 'immune 
help', the outcome of many infections is usually determined by the induction of highly 
specific adaptive / acquired immune responses. This event involves the recognition of non- 
self antigen peptides by lymphocytes through diverse, and therefore, highly specific 
receptors in the form of T-cell receptors (TCR) and B-cell receptors (BCR or soluble 
antibody). Clonal expansion of the antigen-specific lymphocytes leads to the generation of 
acquired effector responses, under the direction of cytokines produced by CD4+ T-helper 
cells (Th). These effector responses can be divided into 'inflammatory' cell-mediated 
responses and humoral immune responses, and the generation of the correct type is thought 
to be key to the resolution or outcome of many infections. 
Although the basic model of adaptive immunity was proposed many years ago, only 
relatively recently has it been proposed that the initiation of acquired responses, and more 
specifically the type of effector mechanisms employed, is dependent upon the initial innate 
immune response to the pathogen (Fearon and Locksley, 1996; Medzhitov and Janeway, 
1997). In this respect, it has been suggested that the ftinctional outcome of the immune 
response to a pathogen is deten-nined by the innate response (Fearon and Locksley, 1996; 
Medzhitov and Janeway, 1997). 
Therefore, I will briefly introduce the current theories surrounding innate recognition 
during infection, and the downstream events that culminate in the generation of acquired 
T-cell help and the polarisation of the effector response. 
1.8 Current theories on innate recognition 
The innate immune system is thought to be evolutionarily ancient compared to the 
acquired system. Murine innate immunity also closely resembles what is known about 
human innate immunity, therefore, both the human and murine systems will be discussed 
together. 
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The innate immune system differs fundamentally from the acquired system in the manner 
in which it recognises potential infections. Whereas the latter can generate a seemingly 
infinite repertoire of receptors (approximately 1011 specificities) by genetic recombination 
of TCR and BCR genes, the innate immune system relies upon germline-encoded receptors 
which are limited in number by the size of the genome. In addition, while acquired 
immunity is primarily concerned with recognition of pathogens, innate recognition has 
been the subject of much debate. In this respect, innate recognition can be grouped into 2 
strategies: recognition of 'pathogen non-self (or 'pattern recognition'), and recognition of 
changes in host tissue associated with infection / disease, termed 'danger' or 'extended- 
self. 
1.8.1 Pathogen 'non-seýf' recognition orpattern recognition 
Janeway (1992) and Medzhitof and Janeway (1997) suggest that the innate immune system 
has evolved with the fundamental ability to discriminate between host molecules and 
pathogen molecules, enabling invading organisms to be destroyed without non-specific 
damage to the host. They propose that the innate immune system evolved a number of non- 
clonal receptors, tenned pattern recognition receptors (PRRs), which recognise molecular 
motifs, or patterns, that are common to many different pathogens, termed PAMPs. Several 
evolutionary pressures have determined the nature of these PAMPs. Firstly, genetic 
limitations on the number of possible innate receptors, means PAMPs must be shared by 
large groups of pathogens, hence the recognition of patterns or motifs rather than unique 
specific sequences. Second, the generally high rate of pathogen mutation has provided a 
great selection pressure to recognise only conserved PAMPs that are essential to pathogen 
survival, such that any mutation is lethal, or renders the organism non-pathogenic. Third, 
Medzhitof and Janeway suggest that PAMPs are absolutely distinct from self-antigens, 
thus allowing discrimination between self and non-self. 
Many PAMPs have so far been identified, the majority of which appear to have glycan or 
lipid components. These include bacterial cell-wall components, (LPS, lipo-teichoic acid, 
peptidoglycan), viral double-stranded RNA (dsRNA; Alexopoulou et al., 2001), yeast wall 
products (mannan, P-glucan), spirochete glycolipids (Schroder et al., 2000) and non- 
methylated CpG DNA motifs which are characteristic of bacterial but not mammalian 
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DNA (Sparwasser et al., 1998; Hemmi et al., 2000). In addition, putative protozoan 
PAMPs have also been identified from Leishmanial species (Borges et al., 2001; Hawn et 
al., 2002) and Trypanosomes (Camargo et al., 1997) including glycophosphoinsitol (GPI) 
anchors (Campos et al., 2001). The intense amount of study in this field has meant that the 
number and types of PAMPs so far identified is still rapidly growing. 
1.8.2 Danger theory of innate recognition 
Originally proposed by Matzinger (1994), the danger model of innate awareness describes 
how innate accessory cells can become activated by signs of tissue distress that occur 
during infection. In this respect, molecules produced by stressed cells, such as heat-shock 
proteins (HSPs), or molecules released by damaged tissues and necrotic cells, are normally 
not visible to innate accessory cells and therefore their appearance could signal for 
'danger'. Evidence supporting the existence of 'danger signals' is now starting to 
accumulate. Several groups have demonstrated that necrotic cells but not apoptotic cells 
stimulate DC (Gallucci et al., 1999; Sauter et al., 2000; Basu et al., 2000). In addition, 
certain human HSPs, such as HSP60, HSP70, HSP 90, and gp96, activate Mý and / or DC 
(Basu et al., 2000; Ohashi et al., 2000; Kol et al., 2000; reviewed by Wallin and 
Ljunggren, 2002), as do host molecules generated during tissue damage and inflammation 
(Okamura et al., 200 1; Smiley et al., 200 1; Termeer et al., 2002; Johnson et al., 2002), 
although this data may have been an artefact of endotoxin contaminants (Wallin and 
Ljunggren, 2002; Akira et al., 2003). Interestingly, many of these host danger signals are 
highly conserved between species, and related HSP from microbes also stimulate the 
innate immune system (Kol et al., 2000). Recognition of danger signals may occur through 
PRRs that also mediate recognition of PAMPs (Ohashi et al., 2000; Kol et al., 2000), 
indicating that innate discrimination between self- and non-self is not as rigid as current 
models suggest (Janeway and Medzhitov, 1997; Bendelac and Medzhitov, 2002). In this 
respect, Gallucci and Matzinger (2001) refer to PAMPs as 'exogenous danger signals'. 
Under the blanket term of the 'danger model' could be included the 'induced-self' and 
4missing-self' recognition of abnormal cells (reviewed by Diefenbach and Raulet, 2003). 
induced-self recognition relies on stressed cells up-regulating surface expression of cellular 
molecules that are associated with 'abnormal' cells, whereas 'missing-self recognition 
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describes the loss of inhibitory signals (supplied by the expression of certain surface 
molecules on normal cells) that may occur upon cellular damage. 
This is a rapidly changing area of immunology and it should be noted that there is still 
much debate on the finer theoretical points of innate recognition (Medzhitov, 2001; 
Gallucci and Matzinger, 2001; Johnson et al., 2003). However, for this thesis, the models 
discussed above represent adequate descriptions of the mechanisms of recognition. 
Innate recognition of both exogenous and endogenous 'danger signals' could occur dunng 
the initial stages of infection with schistosomes. in this respect, schistosomes may express 
molecules with PAMP-like activity. In addition, penetration and migration of larvae causes 
a high degree of cell lysis and necrosis, and might induce cellular stress or changes in 
surface expression of regulatory molecules. 
1.8.3 Pattern recognition receptors 
PRRs are either soluble plasma proteins, or are present on the surface of innate accessory 
cells. These receptors are highly diverse in their nature and function and six distinct 
families have been identified (Medzitof and Janeway, 1997). These include the C-type 
lectins, such as the homologues DEC-205 and the mannose receptor (MR), integrins, such 
as the complement receptor 3 complex (CR3), leucine-rich receptors, scavenger receptors, 
pentraxins such as Serum amyloid P and C-reactive protein, and lipid transferases, like 
LPS-binding protein (LBP). Notably, the family of leucine-rich receptors termed Toll-like 
receptors (TLRs), due to their homology with Drosophilia Toll-receptor, appear to play a 
central role in the recognition and signalling of pathogen products. These have been the 
focus of much research and so far, 10 mammalian TLRs have been identified. Each of 
these TLRs appear to be involved in the recognition of distinct ligands, although direct 
ligand-binding by many of them has not been formally demonstrated. 
Another property of some PRRs, is their ability to recognise several structurally related, or 
even unrelated ligands. This receptor promiscuity is not fully understood, but in the case of 
TLRs it may occur through the association with distinct accessory proteins / receptors. For 
example, TLR4 together with MD-2 and the PRRs CD14 and LBP, form the LPS receptor 
complex (reviewed by Underhill and Ozinsky, 2002). In addition, TLR2 dimerisation with 
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TLRI and TLR6 contributes to the diverse array of TLR2 PAMP ligands (Ozinsky et al., 
2000). Table 1.1 demonstrates some of the known self and non-self ligands for PRRs. 
Receptor Family Example Ligands 
C-type lectins MR Terminal Mannose 
DEC-205 Terminal Mannose 
Leucine-rich receptors TLR2 + (TLR6 or TLRX)* 
TLR3** 
TLR4 
TLR5 
TLR9 
Scavenger receptors 
Pentraxins 
Macrophage scavenger 
receptor 
C-reactive protein 
Lipid transferases 
Intergrins 
LBP 
CD11b, c: CD18 
Bactenal lipoproteins 
Peptidoglycan 
Zymosan 
GPI anchor 
Lipoarabinomannan 
dsRNA 
LPS 
HSP 60 (human and chlamydial) 
Fibronectin EDA 
F protein 
Flagellin 
CpG DNA 
Bacterial cell wall components 
Phosphatidyl choline 
LPS 
LPS 
LPS 
Table 1.1 Examples of pattern recognition receptors of the innate immune system and 
their ligands. Table adapted from Medzhitov and Janeway (1997) and Underhill and 
Ozinsky (2002). 
TLRX = TLRs 
** Alexopoulou et al., 2001. 
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PRRs are highly diverse in their function. Soluble receptors are mainly involved in 
opsonisation of pathogens and activation of the complement effector pathway (Sastry and 
Ezekowitz, 1993; Mold et al., 2001). In contrast, ligand binding of cellular PRRs can 
stimulate a variety of 'hard-wired' innate accessory cell functions, detailed below. 
Importantly, the type of response that is elicited is thought to be dependent upon the 
receptor (Akira et al., 2003). For example, intracellular signalling pathways utilized by 
TLR4 have functional distinctions compared to other TLRs, and will be discussed in more 
detail in Chapter 3. In addition, Underhill and Ozinsky (2002), emphasise that individual 
pathogens are likely to express a variety of different PAMPs that will be recognised 
simultaneously. Therefore, the response generated upon PAMP / 'danger' recognition is 
dependent on both the individual PRRs involved, and the interaction between multiple 
PRRs. This confers a certain amount of pathogen-specificity upon innate responses, which 
could be important in determining the types of acquire immune response that follows. 
A non-classical mechanism of pathogen (or self) lipid recognition that may also contribute 
to innate immunity occurs through CD I d-restricted receptors on a specialised T-cell subset 
terined natural killer T-cells (NKT). These receptors are TCRs but have an invariant TCR(x 
chain, and NKT cells have many properties unlike normal ap T-cells and more like innate 
cells, including a high natural frequency and the rapid production of ILL-4 and IFNy 
following stimulation (reviewed by Kronenberg and Gapin, 2002). 
1.9 Innate immune responses 
The innate immune system is comprised of numerous immuno-competent accessory cells 
that can act as sentinels in sites of potential infection, such as the skin. This tissue is 
populated by a vast array of accessory cells including epidermal LC, Mý, DC, natural killer 
(NK) cells, keratinocytes, and granulocytes, such as mast cells, eosinophils, and 
neutrophils (Williams and Kupper, 1996). Depending upon the cell type and the PRR 
engaged, PAMP recognition can cause a plethora of cellular responses, including 
intemalisation of pathogens / pathogen material (via phagocytosis, endocytosis, 
macropinocytosis), induction of cell cytotoxicity, the release of soluble immune mediators 
including cytokines and chemokines, and the maturation of APC. These responses may be 
directly, or indirectly, important in the development of innate immune responses and the 
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induction of acquired immunity. In addition, innate recognition by accessory cells also 
contributes to effector functions during acquired immune responses. 
1.9.1 Phagocytosis, endocytosis, and macropinocytosis 
Phagocytosis, endocytosis, and macropinocytosis are the mechanisms by which leukocytes 
ingest particulate and soluble pathogens / pathogen material. Numerous PRRs have been 
implicated in initiation of these mechanisms, such as MR (Sallusto et al., 1995), DEC-205 
(Jiang et al., 1995), and scavenger receptors (Peiser et al., 2002). In addition, opsonised 
material can be ingested via Fc and complement receptors (Mold et al., 2001). Cytokines, 
such as EL-4 and IL- 10, also effect the endocytic activity of MO, providing a mechanism 
for regulation of antigen uptake during inflammatory responses (Montaner et al., 1999). 
Interrialisation is involved in several accessory cell functions. Particularly important to the 
development of acquired responses is the processing and presentation of antigen by the 
specialised APC subset of accessory cells. Internalisation leads to the delivery of pathogen 
material to proteolytic endocytic, or phagocytic organelles, within which the antigens are 
catabolised, and become complexed with MHC II (reviewed by Harding et al., 2003). 
Although APC constitutively sample the environment by macropinocytosis (independently 
of PRR-ligation), receptor-mediated uptake dramatically enhances the efficiency of antigen 
capture and presentation (Jiang et al., 1995; Sallusto et al., 1995; Tan et al., 1997). 
In addition to antigen presentation, it has recently been demonstrated that internalisation 
can have an important role as a precursor event in TLR-mediated intracellular signalling by 
certain PAMPs. In this respect, TLR9 is restricted to endosomal intracellular compartments 
(Ahmad-Nej ad et al., 2002). In contrast, most TLRs appear to be expressed on the surface 
of accessory cells, although site-restricted expression within specialised subsets of 
accessory cells has been reported (Hornef et al., 2002). 
1.9.2 Production of cytokines, chemokines, and eicosanoids 
innate recognition also results in the production and release of important inflammatory 
mediators, such as chemokines, eicosanoids, and pro-inflammatory and regulatory 
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cytokines, including TNF(x, IL- 10, IL-6, EL- 10 and IIL- 12. These molecules act as soluble 
messengers with paracrine, endocrine, and autocrine functions, allowing the activation of 
further accessory cells. One consequence of this cross-talk is a series of complex events 
that results in inflammation, characterised by recruitment of further accessory cells into the 
site of infection. Another is the regulation of the local APC population in terms of 
composition and activity. A brief overview of these soluble molecules will be given. 
Cy! okines 
The control of inflammatory cytokine production is thought to be mediated through 
induction of NF-Yp signalling pathways. However, some accessory cells, such as 
neutrophils, contain preformed cytokines whose release does not require transcription 
(Bliss et al., 2000). TLRs are the major players in signal transduction for cytokine 
production utilising a pathway that shares much in common with EL- IR signalling due to 
the shared Toll / IIL- IR domains (TIR) they contain. Signalling through TIRs ultimately 
leads to the translocation of NF-rcp transcription factors to the nucleus through the 
recruitment of an adapter protein MyD88, and activation of IRAK serine / threonine 
kinases (reviewed by Underhill and Ozinsky, 2002). Alternative pathways that are specific 
to individual TLR have also recently been identified and will be discussed further in 
Chapter 3. This may explain the differences in cytokine gene expression induced by 
different TLR ligands (Re and Strominger, 2001). In addition, non-TLR PRRs, such as the 
MR and CDI lb, may also be involved in signalling for cytokine production (Yamamoto et 
al., 1997; Perera et al., 2001), possibly through a phagocytic mechanism (Shibata et al., 
1997). 
Key cytokines in the development and regulation of inflammatory responses are TNF(x, IL- 
I P, IL-6, and EL- 10, which are produced upon stimulation by numerous different accessory 
cells including Mý, neutrophils, and DC. Both TNFcc and IL- IP are potent pro- 
inflammatory cytokines sharing a similar spectrum of action that includes the activation of 
most accessory cells (reviewed by Mantovard, 1999 and Wallach et al., 1999). In addition, 
they stimulate APC maturation and emigration to local draining LN (Cumberbatch et al., 
1997a; 1997b). IL-12 is thought to mainly exert a pro-inflammatory effect by orchestrating 
EFNy production (Ma and Trinchieri, 2001), although it can also directly stimulate NF-KP 
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translocation in DC (Grohmann et al., 1998). Although the paracrine effect of IL-6 is the 
up-regulation of acute phase proteins (involved in anti-microbial defence) by the liver, its 
local effect during acute inflammation appears more regulatory (Xing et al., 1998). 
Concurring with this, EL-6 can reduce Mý and DC production of pro-inflammatory 
cytokines (Takenaka et al., 1997). IL-6 also stimulates differentiation of human monocyte 
precursors to Mý rather than DC, suggesting this cytokine will affect the constituent APC 
population (Chomarat et al., 2000). IL- 10 is a potent anti -inflammatory cytokine favouring 
the resolution of immune responses. Its effects include down-regulation of APC activity 
(Wang et al., 1999; Corinti et al., 2001), down-regulation of pro-inflammatory cytokine 
(e. g. TNFa and EL- 12) production and inhibition of cellular cytotoxicity by Mý (Kane and 
Mosser, 2001; Corinti et al., 2001). 
Chemokines 
The production of chemokines by tissue Mý and DC, and other accessory cells, is thought 
to play a major role in the initiation of inflammatory responses (Luster, 2002). Chemokine 
production is thought to be under control of a NF-Kp-dependent pathway, and thus 
principally the domain of TLRs. Chemokine genes expressed following TLR engagement 
include IL-8, MIP- I cc, and MIP- I P, although as for cytokines, these are differently 
regulated by separate TLRs (Re and Strominger, 2001). Briefly, IL-8 recruits neutrophils 
(Barker et al., 199 1; Kuijpers et al., 1992), whereas MIP- I cc and MIP- IP recruits Mý, 
immature DC (Dieu et al., 1998) and NK (Salazar-Mather et al., 2000). Chemokines may 
also be able to stimulate accessory cells to up-regulate cytokine production, since 
signalling through CCR5 by T gondii can result in EL-12 production (Aliberti et al., 2000). 
In this respect, it has been reported that MEP- 1 a, MIP- I P, and RANTES co-operate with 
IFNy to up-regulate CD40, EL- 12, and TNF(x expression by Mý (Dorner et al., 2002). 
Eicosanoids 
Eicosanoids are small lipid molecules with endocrine and autocrine activity, and most is 
known about the prostaglandin and leukotriene eicosanoids. Stimulation of accessory cells, 
such as Mý and DC, is thought to result in the phospholipase A2-dependent release of the 
membrane-bound progenitor arachidonic acid. This is then converted to different 
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prostaglandins, via constitutive cyclo-oxygenase (COX)- I and inflammation-inducible 
COX-2 enzymes, and various prostaglandin synthases (Harizi et al., 2002), or to 
leukotrienes by the lipoxygenase pathway. Prostaglandins and leukotrienes have profound 
effects on innate accessory cells. Of these, PGE2 stands out as the most studied, and is 
known to cause decreased production of EL-12, EL-6, and TNFCC by Mý (Zhong et al., 
1995), but increased IL-10 production (Shinomiya et al., 2001). PGE2 has also been 
implicated in the inhibition of DC activity, via the up-regulation of EL- 10 production 
(Harizi et al., 2002). 
1.10 Innate immune responses: induction of acquired immunity 
Effector CD4+ Th cells co-ordinate the acquired immune response. The single crucial event 
in the activation of naYve Th cells is ligation of their surface TCRs with peptide-MHC 11 
complexes. APC are a specialised subset of accessory cells that can capture exogenous 
antigen and present it to Th cells in complex with MHC H. In this respect, APCs are the 
cells that link innate and adaptive immunity. In addition, the initial activation of the innate 
immune system is critical to the induction of strong effector T-cell responses, including 
increased T-cell proliferation and the generation of long-lived memory (Reinhardt et al., 
2001). 
1.10.1 APCs 
Several types of accessory cell can express MHC 11 and can therefore act as APCs. 
However, DC, and to a lesser extent Mý, are the most potent activators of naYve Th cells, 
and in this respect they have become regarded as 'professional APC'. Their potency is 
emphasised by work using antigen-loaded DC as 'natural adjuvants' to elicit protective 
immune responses to pathogens (Flohe et al., 1998). DC can be divided into several 
subsets that are described in more detail in Chapter 5. 
The type of APC that will be involved in T-cell priming depends upon the site of antigen 
deposition and the inflammatory response that may accompany this. In infections where 
entry to the host is percutanous, such as schistosomiasis, APC within the skin may capture 
exogenous antigen and then migrate to local sdLN. The skin is known to contain several 
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types of APC: a specialised subset of DC tenned LC resides in the epiden-nis, while 
additional DC and MO also reside in the dermis. Moreover, the innate response that follows 
infection may critically change the repertoire of APC that are present (see above). 
1.10.2 Antigen uptake andprocessing 
As discussed earlier, APC can internalise antigen via a number of constitutive and PRR- 
mediated mechanisms. Antigen uptake can also be mediated by specific antibodies on B- 
cells (Rock et al., 1984), and through FcR and complement receptors on phagocytes such 
as Mý. Following degradation of antigen material in the endocytic compartment, peptides 
are loaded onto freshly synthesised MHC II molecules. The mechanisms of peptide loading 
are relatively well defined, and involve a sequence of proteolytic events to remove a 
protein (invariant chain) which blocks the MHC H peptide binding site, allowing antigen 
peptides to bind (Harding et al., 2003). 
1.10.3 Migration to T-cell areas 
Priming of naYve T-cells requires APC to be present in the T-cell areas of primary 
lymphoid tissues, such as spleen or local draining LN. This can occur in two ways: APC at 
the site of infection can capture antigens and then migrate to the lymphoid tissues. 
Alternatively, antigen may be carried directly to the LN, or spleen, in draining lymphatic 
fluid, or blood, where it can be processed by the resident APC. Moreover, migration of the 
pathogen may also take it through primary lymphoid tissue (as during schistosomiasis), 
where-upon antigen could be deposited directly. 
During percutaneous infections, skin-derived APC are likely to be important for antigen 
presentation. In this respect, stimulated resident tissue DC are known to down-regulate 
their expression of chemokine receptors CCRI, CCR5 and CCR6, whilst up-regulating 
expression of CCR7, allowing them to migrate from the tissue through the lymphatics 
towards the T-cell rich areas of the local LN (Sozzani et al., 1998; Dieu et al., 1998). 
Certain cytokines, including IL- 1P and TNF(x, are essential to the ability of LC to migrate 
from the skin, and can stimulate the cells to up-regulate expression of MHC 11 
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(Cumberbatch and Kimber, 1995; Wang et al., 1997; Cumberbatch et al., 1997a; 1997b). 
In fact, in the absence of these cytokines LC migration is greatly impaired (Cumberbatch 
and Kimber, 1995; Wang et al., 1997; Cumberbatch et al., 1997a). In contrast, IL-10 
inhibits LC migration, possibly by down-regulating IIL- IP and TNF(x production in the 
epidermis (Wang et al., 1999), and by maintaining the expression of CCR6 (Dieu-Nosjean 
et al., 2001). 
1.10.4 T-cellpriming 
In order to proliferate and generate effector cells, naYve CD4+ T-cells must receive co- 
stimulatory signals in addition to those signals received through the TCR. The most 
important co-stimulatory signal is thought to be received through CD28 but other signals 
also contribute to T-cell activation, including CD 154 and OX40, and will be discussed 
further in Chapter 6 and 7. These co-stimulatory signals are supplied by membrane surface 
molecules expressed on APC, such as CD80, CD86, CD40, and OX40L, and are thought to 
be essential for full activation of T-cells and prevention of T-cell death. In this manner, 
their absence can lead to reduced T-cell responses or T-cell anergy (unresponsiveness) 
(Boise et al., 1995; Van Gool et al., 1999). Indeed, T-cell responses to schistosome egg 
deposition are greatly reduced in CD28 -/- mice (King et al., 1996b). In addition, APC- 
derived cytokines may also contribute to the co-stimulatory signal (Holsti et al., 1994; 
Vella et al., 1997; Teague et al., 1997). Co-stimulatory signals act to enhance T-cell 
survival during proliferation by the induction of anti-apoptotic 'Intrinsic survival factors', 
such as Bcl-XL and Bcl-2 (Boise et al., 1995; Vella et al., 1997; Teague et al., 1997; 
Rogers et al., 2001). Upon activation, T-cells up-regulate their expression of a number of 
co-stimulatory receptors, such as CD 154, OX40, and 4-1 BB. Ligation of these molecules 
by their APC-expressed counterparts (CD40, OX40L and 4- 1 BBL, respectively), is 
thought to act as a series of check points in priming, delivering survival and maintenance 
signals to developing T-cells (Rogers et al., 2001; Cannons et al., 2001). 
Immature APC express low levels of co-stimulatory molecules and MHC II, and are 
inefficient in activating naYve T-cells. However, upon exposure to a variety of stimuli 
including many pathogens and PAMPs, such as LPS (Whelan et al., 2000), mycobacteria 
(Schnare et al., 2001), CpG DNA motifs (Sparwasser et al., 1998), yeast cells and hyphae 
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(d'Ostiani et al., 2000), 'danger signals' such as necrotic cells (Gallucci et al., 1999), and 
pro-inflammatory cytokines (Brunner et al., 2000; Schnare et al., 2001), DC undergo a 
maturation program that leads to increased expression of MHC II and co-stimulatory 
molecules, and an increased ability to prime T-cells. 
The mechanisms that control the up-regulation of these molecules are not fully understood. 
Similar to the control of cytokine production, PAMP-stimulated expression of co- 
stimulatory factors is also thought to mainly be controlled by signal transduction through 
the TLRs (reviewed by Medzhitov, 2001). However, the signalling pathways that lead to 
DC cytokine production can be different to pathways resulting in maturation and co- 
stimulatory factor expression. For example, DC from mice deficient in the adapter protein 
MyD88 fail to produce pro-inflammatory cytokines but still up-regulate MHC 11 and co- 
stimulatory factor expression upon exposure to LPS (Kaisho et al., 2001) or dsRNA 
(Alexopoulou et al., 2001). In contrast, both cytokine production and maturation 
stimulated by CpG motifs, or mycobacteria, rely on MyD88 (Schnare et al., 2000; 2001). 
Signalling could also be due, in part, to the induction and release of stimulatory autocrines, 
such as IL- IP and TNFa, the latter of which also signals through a MyD 88 -independent 
pathway (Schnare et al., 2001). The role of non-TLR PRRs in PAMP-driven DC 
maturation remains to be determined. 
1.11 Polarisation of acquired immune responses 
1. IL I Polarity of the acquired response: Th I and Th2 subsets 
CD4+ T-cells are responsible for both the type and the co-ordination of the acquired 
immune response. This is achieved through the repertoire of cytokines they produce upon 
activation. It has become widely accepted that murine effector CD4+ T-cells can be divided 
into two subsets based upon their profile of cytokine production (Mosmann et al., 1986). 
Thl cells produce EFNy and are potent drivers of cell-mediated 'Inflammatory' effector 
responses, characterised by delayed-type hypersensitivity (Cher and Mosmann, 1987). 
These cytokines can induce cellular cytotoxicity in Mý, and cause class-switching of 
antibody production to IgG2a- In contrast, Th2 cells produce IL-4, IL-5, EL-6, IL- 10 and IL- 
13, which drive antibody-associated humoral and allergic-type responses through enhanced 
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B-cell help, mast cell and eosinophil proliferation and activation, and switching to IgG, 
and IgE antibody production (Cherwinski, 1987; Fiorentino et al., 1989). A similar Thl 
and Th2 paradigm of cytokine production has been described in human effector T-cell 
responses (Del Prete et al., 1991). 
Recent advances in this field demonstrate that are there are a number of other CD4+ T-cell 
subsets which do not fit into this Th I/ Th2 model. First, ThO cells have been described 
which produce both Thl and Th2 cytokines (Firestein et al., 1989). These may represent an 
intermediate pluripotent phase of development prior to differentiation to polarised Thl or 
Th2 cells (Kamagowa et al., 1993). However, it is also possible that ThO cells form a stable 
subset of T helper cells (Miner and Croft, 1998). Second, resurgence in the field of T-cell 
mediated suppression has led to the identification of several 'suppressor' or 'regulatory' T 
cell populations (Teg). 'Naturally occurring' populations of Teg cells are present in un- 
manipulated mice and are enriched within CD4+ CD25+ cells (reviewed by Read and 
Powrie, 2001). In addition, a number of inducible Treg subsets have been described, 
including TO (Chen et al., 1994), Trl (McGuirk et al., 2002), and anergic T-cells (Chai et 
al., 1999). Again, similar cells types have been described in humans. The relationship 
between these different cells is unclear, but they appear to act through a diverse variety of 
cytokine (EL- 10 and TGFP) and cell-contact dependent mechanisms, in order to suppress 
both innate and T-helper cell responses (Chen et al., 1994; Chai et al., 1999; Read and 
Powne, 2001; McGuirk et al., 2002; Maloy et al., 2003). 
1. IL 2 Th I/ Th2 response in disease 
Infection can result in a broad spectrum of acquired Th cell responses, which is important 
in determining the course of disease. Some disease states are characterised by highly 
polarised responses, as demonstrated by; 
* the extensive work from R. Locksley's and P. Scott's laboratories on healing / non- 
healing Leishmania dependent on the induction of Thl and Th2 responses, respectively 
(Heinzel et al., 1989; Scott, 1991) 
the work done on Trichuris muris infection in which Th2 responses result in protection 
and Thl responses result in susceptibility (Else et al., 1993; Bancroft et al., 1998). 
47 
Alternatively, under the correct conditions mixed Th I/ Th. 2 responses can be highly 
protective, such as against challenge schistosome infection following vaccination of IL- 10 
-/- mice with irradiated larvae (discussed above; Hoffmann et al., 1999). Moreover, in 
malaria infection both Thl and Th2 responses can contribute to protection against the 
pathogen but at different stages of its life-cycle. These studies demonstrate that, depending 
upon the disease, immune responses need not be highly polarised in order to be protective. 
1.12 Innate immune responses: factors affecting T-cell polarisation 
Many factors have been linked to the development and regulation of Thl and Th2 subsets. 
Those derived from the innate immune system are thought to be critical for the initial 
progression towards a polar response (Fearon and Locksley, 1996). There is also thought to 
be a significant amount of cross-regulation between the Th subsets through the repertoires 
of cytokines they produce. However, exogenous innate signals may tip the balance of 
regulatory ones. 
1.12.1 PAMPs and PRRs 
A certain degree of specificity in innate responses is provided by differences in the 'hard- 
wired' responses to ligation of particular PRRs or PRR combinations, allowing the 
discrimination of diverse PAMPs or pathogens (Underhill and Ozinsky, 2002). Indeed, 
there is evidence that DC can directly interpret the information encoded in PAMPs, or 
'danger signals', and subsequently drive polarised Th responses (Whelan et al., 2000; 
MacDonald et al., 2001; de Jong et al., 2002; Manickasingliam et al., 2003), even to the 
extent of distinguishing between different cellular stages of the same organism (d'Ostiani 
et al., 2000). This will be discussed in further detail in chapters 6 and 7. 
The flexibility of innate accessory cells probably lies in the down-stream signalling effects 
of engagement of specific PRRs. The importance of TLR signalling in polarisation of T- 
cells has been investigated in a number of studies using mice deficient for the signalling 
adapter protein MyD88. These mice fail to mount Thl responses but develop Th2- 
associated responses when exposed to Toxoplasma gondii (Jankovic et al., 2002). They 
also fail to mount a Thl response when immunised with ovalbumin in complete Freunds 
adjuvant (Schnare et al., 2001), a mixture of mycobacterial PAMPs that signal through 
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TLR2 (Means et al., 1999; Underhill et al., 1999a). Although MyD88 is also important in 
the signalling pathways of the pro-inflammatory cytokines EL- IP and EL- 18 (Adachi et al., 
1998), mice deficient in bioactive IL- 1P and IL- 18 (i. e. caspase- I -/-) exhibited normal T- 
cell responses (Schnare et al., 2001). These studies have led to the hypothesis that TLR 
recognition and signalling pathways may only be relevant for the development of Th I and 
not Th2 responses (Schnare et al., 2001), although this requires further work to be verified. 
1.12.2 Antigen presentation, co-stimulatoryfactors, and APCs 
In addition to the crucial involvement in T-cell priming, co-stimulatory factors such as 
CD28, CD154, and OX40 may also have differential roles in Thl and Th2 development. In 
this respect, the role of CD80, CD86, CD40, and OX40L expressed upon APC has been 
the focus of intense study that has lead to contrasting observations, and will be discussed 
more thoroughly in Chapter 6 and 7. 
Many studies show that the certain types of APC preferentially stimulate either Th I or Th2 
responses. In this respect, DC infected with M tuberculosis drive Thl differentiation, 
whereas infected Mý do not (Hickman et al., 2002). The inherent difference in T-cell 
polarisation by APC is possibly due to the repertoire of cytokines or co-stimulatory factors 
that these cells express (Hickman et al., 2002). Different DC subsets have also been 
implicated in preferentially priming Thl or Th2 responses. However, despite these studies, 
it has been suggested that certain APCs, such as DC, are plunpotent in their T-cell 
polarising capacity, and currently this is an intensely studied area of research. 
1.12.3 Cytokines 
Of all the factors known to affect the development and polarisation of the Th populatIon, 
cytokines are thought to play the most critical role. They can act directly upon T-cells, or 
may affect polarisation indirectly by interfering with innate responses. Since the cytokines 
of the innate and acquired system overlap considerably, their possible roles as exogenous 
and endogenous factors will be discussed together. 
IL-12: This cytokine is produced by a variety of accessory cells and APC, such as Mý, DC 
and neutrophils, and it is a major link between innate and adaptive immunity (Trinchien, 
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2003). It has a direct and critical role in driving Thl polarisation, which has been 
extensively studied in vitro and in vivo (Hsieh et al., 1993). However, although APC- 
derived IL- 12 may be required for optimal IFNy production, it may not be a necessity for 
Thl induction (MacDonald and Pearce, 2002), suggesting that other mechanisms are also 
involved in this pathway. IL-12 may affect T-cell polarisation in a number of ways. 
Addition of EL-12 to T-cell cultures can result in induction of Thl responses when a 
normal Th2 response would prevail, while ablation of IL-12 leads to the inhibition of a 
normal Thl phenotype (Hsieh et al., 1993; Manetti et al., 1993; 1994). Moreover, EL- 
l2p40 -/- mice mount impaired Thl responses (Anderson et al., 1998; Jankovic et al., 
2002). One way in which IL-12 could enhance Th polarisation is by stimulating up- 
regulation of IL- 18 receptor a (IL- I 8Ra) expression, and EL- 12 receptor P2 (IL- I 2RP2) 
allowing cells to respond to these potent Thl inducing cytokines (Chang et al., 1999; 
Smeltz et al., 2002). In addition, EL- 12 may potentiate Th 1 responses by stimulating EFNy 
production by NK cells (Kobayashi et al., 1989) and y8 T-cells (Skeen and Ziegler, 1995). 
Expression of the IL-12 receptor may be critical in the control of T-cell polarisation, since 
exposure to IL-4 decreases expression of the IL- I 2RP2 subunit, leading to an increased 
likelihood of Th2 polarisation (Szabo et al., 1997). 
TNy: One of the most important cytokines produced by Thl cells, IFNy can also be 
produced by activated NK cells (Kobayashi et al., 1989), CD8+ T-cells, and y8 T-cells 
(Skeen and Ziegler, 1995). In addition, it has been found to be produced by APC such as 
DC (Ohteki et al., 1999). The involvement of EFNy in the direct induction of Thl 
differentiation remains unclear. It appears that IFNy is critical in the development and 
sustenance of Thl differentiation, but alone it may not be sufficient to drive polarisation 
down this route (Scott, 1991; Macatonia et al., 1993). Recently, it was observed that EFNy 
appears to limit the negative effects of EL-4 on EL- I 8Rct and EL- I 2RP2 expression 
(Nakamura et al., 1997; Smeltz et al., 2002), which could explain the positive feedback 
mechanism of this cytokine. EFNy may also indirectly induce Th I differentiation through 
the activation of APC, such as Mý, which then produce more pro-Th I IL- 12 and less 
inhibitory IL- 10, in response to PAMP recognition (see Chapter 3). 
IL- 18: This cytokine is produced by a number of accessory cells, including IFNy-activated 
Mý (Okamura et al., 1995). The observations that EL- 18 receptor is only expressed on Th I 
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cells (Xu et al., 1998) partly explains the effects EL- 18 has on T-cells. Firstly, it has little 
effect on Th cell IL-4 or EL- 10 production (Micallef et al., 1996; Robinson et al., 1997). 
Secondly, on its own, IL- 18 is relatively ineffective at driving Th 1 polarisation, although it 
acts in synergy with IL- 12 to augment T-cell IFN7 production (Micallef et al., 1996; 
Kohno et al., 1997; Robinson et al., 1997). Therefore, EL- 18 may not be an important 
cytokine in the initial event involved in polarisation but appears to function by enhancing 
and sustaining Thl responses (Okamura et al., 1998). 
Other potentially 'Thl -associated' cyjokines: 
IL-10 and TNF(x have been implicated in Thl polarisation (D'Andrea et al., 1993). 
These may act indirectly, as IL- 10 synergises with IL- 12 to stimulate IFNy production 
by NK cells and y8 T-cells (Hunter et al., 1995; Skeen and Ziegler, 1995), and both 
TNFcc and IL- IP stimulate accessory cells to exhibit a pro-inflammatory phenotypes 
and drive APC maturation. TNF(x also enhances T-cell expression of EL-12RP2 
(reviewed by Trinchieri, 2003). 
IFNoc can support Thl polarisation in the absence of IL-12 in response to certain 
PAMPs, such as dsRNA (Manetti et al., 1995). 
EL- 15 and IIL-21 were both recently shown to induce T-cell synthesis of EFNy, IIL- I 2RP2 
and EL- I 8R mRNA (Strengell et al., 2002), although the role of these cytokines in Th I 
development remains to be fully explored, and a recent report suggests IL-21 is a Th2 
cytokine (Wurster et al., 2002). 
EL-23 and IL-27, also have Thl polarising activity (Trinchieri, 2003), and both are 
produced by stimulated APCs (Oppmarm et al., 2000; Pflanz et al., 2002). The receptor 
for IL-23 shares the IL- 12RP I chain, and induces similar signalling as EL- 12 (Parham et 
al., 2002), which could explain why these molecules share similar functions. However, 
IL-23 appears to be less efficient than IL- 12 at driving EFNy production (Oppmann et 
al., 2000). IL-27 is also a strong inducer of EFNy production, acting in synergy with IL- 
12 and IL- 18 (Pflanz et al., 2002), and mice deficient for the EL-27 receptor chain 
TCCR (homologous to the EL-12RP2) have impaired Thl responses (Chen et al., 2000). 
IL-4: EL-4 is thought to be one of the major players in differentiation of Th2 cells. Gene 
deletion of IIL-4 significantly impairs the generation of Th2 responses (Kuhn et al., 1991; 
Kopf et al., 1993), while the addition of EL-4 increased the frequency of IL-4-producing 
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cells, but decreased that of IFNy-producing cells (Swain et al., 1990; Le Gros et al., 1990). 
IL-4 may drive Th2 polarisation in a number of ways. Firstly, it is thought to operate in a 
positive feedback loop since STAT6, an essential transcription factor for Th2 cytokines 
and Th2 development (Shimoda et al., 1996; Takeda et al., 1996), is activated through the 
IL-4 receptor (Hou et al., 1994). EL-4 can also act on APCs, such as Mý, to inhibit the 
production of IL- I 2p4O in response to PAMP stimuli (Major et al., 2002), with IL-4 
signalling thought to result in increased binding of a suppressor site in the p40 promoter 
(Becker et al., 2001). 
IL-4 can be produced by a wide array of cells, including T-cell subsets, and accessory cells 
such as mast cells and basophils (Machado et al., 1996; Haisch et al., 200 1; Rao et al., 
2002). IL-4 also acts with IL-3 to expand mast cells, which may result in a preferential 
environment for Th2 responses in the tissues. Recently DC have been shown to produce 
IL-4 in response to yeast hyphae, and subsequently drive Th2 polarisation (d'Ostiani et al., 
2000). However, DC from IL-4 -'- mice do not loose their ability to prime for Th2 
differentiation, although EL-4 production by responder T-cells is crucial (MacDonald and 
Pearce, 2002). This suggests that exogenous EL-4 is not essential for the induction of Th2 
responses, and that IL-4 may not be involved in the initial switch to Th2 cytokine 
production 
Perhaps surprisingly it has been shown that there could be a negative feedback mechanism 
to regulate IL-4 production and Th2 polarisation. Several studies demonstrate that IL-4 
stimulates human DC (Kalinski et al., 2000) and PBMC (D'Andrea et al., 1995) to produce 
increased levels of IL- I 2p7O. Moreover, culture of DC with Th2 cells leads to EL-4- 
dependent production of EL-12p7O and the reversal of the Th2 cells to a ThO / Th I 
phenotype (Kalinski et al., 2000). However, this is obviously controversial since it 
conflicts with the inhibitory effect of IL-4 on IL- 12 production, as discussed above. 
IL- 13: EL- 13 has many overlapping biological functions with EL-4 (de Waal Malefyt et al., 
1993), including the differentiation of Th2 cells (Bancroft et al., 1998; McKenzie et al., 
1998). The similarity between the function of these cytokines reflects the shared EL-4R(x 
chain used for signalling (Mohrs et al., 1999). Although EL- 13 is produced by ThO, Th 1, 
and Th2 activated T-cells (de Waal Malefyt et al., 1995), unlike IL-4 it only exerts its 
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action upon accessory cells, since T-cells do not express the IL- 13 receptor. In this respect, 
IL- 13 inhibits pro-inflammatory cytokine production, including EL- 12, by monocytes (de 
Waal Malefyt et al., 1993). Since IL- 13 is only expressed by activated T-cells it is not 
likely to be an early factor involved in Th2 polarisation, but may be a signal to augment it. 
IL-6: IL-6 is produced by both APCs, such as Mý, DC and B-cells, but also by Th2 cells, 
and has been documented to be involved in the induction of Th2 polarisation (Rincon et 
al., 1997; La Flamme et al., 2000). IL-6-deficient mice infected with Borrelia burgdorferi 
have greater incidence of inflammatory arthritis, and their splenocytes produce less IL-4 
upon re-stimulation in vitro (Anguita et al., 1998). IL-6 also drives naYve T-cell production 
of IL-4, although this is dependent upon endogenous EL-4 production (Rincon et al., 1997; 
Diehl et al., 2002). However, IL-6 can directly inhibit Thl differentiation through an IL-4- 
independent mechanism, by up-regulating suppressor of cytokine signalling (SOCS)- I 
expression, which interferes with EFN7 signalling (Diehl et al., 2000). In addition, IL-6 
may act by inducing IL- 10 production that could then inhibit Th I responses (La Flamme et 
al., 2000). Therefore, IL-6 may not be a primary stimulator of Th2 differentiation but can 
augment it upon IL-4 production. Moreover, IL-6 can inhibit Thl differentiation from an 
early stage, and therefore might be an important innate cytokine in driving Th2 responses. 
IL- 10: IL- 10 is an immunomodulatory cytokine. It is associated with Th2 polarisation, 
preferentially suppressing Thl responses, however, it also down-regulates acquired 
responses per se (de Waal Malefyt et al., 199 1; Taga and Tosata, 1992). This affect of IL- 
10 is thought to be an indirect result of its inhibitory actions upon pro-inflammatory Th I- 
promoting cytokine production by accessory cells and APC, and its down-regulatory effect 
on MHC II and co-stimulatory factor expression by APC (Fiorentino et al., 199 1 a; Hsieh et 
al., 1993; Corinti et al., 2001; Hickman et al., 2002). 
Chemokines: No direct effect of chemokines on T-cell polarisation has been described. 
However, since the type of APC may bias the outcome of priming, chemokines could 
indirectly influence polarisation by determining the cellular constituents of the APC 
population immigrating into a site of inflammation (discussed above), and emigrating to 
the draining LN. In addition, MIP- I ot, MIP- I P, and RANTES (produced by NK and Th I 
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cells and some accessory cells) have been implicated in Thl polarisation by driving pro- 
inflammatory cytokine production by rFN7-activated Mý (Dorner et al., 2002). 
Prostaglandins: PGE2 is an inducer of Th2 responses. It is thought to function through its 
mainly down-regulatory affects upon APC pro-inflammatory cytokine production (Kuroda 
et al., 2000; discussed above). In this respect, DC cultured with PGE2 drive potent Th2 
responses (Vieira et al., 2000; de Jong et al., 2002). 
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1.13 Aims of this study 
The overall aims of this project are to; 
4P determine how schistosomes interact with the innate immune system during the initial 
stages of infection; 
* establish what effect this interaction may have on the development of the acquired 
immune response to the parasite. 
Due to the complexities of immune interactions in vivo, this thesis focuses almost entirely 
on dissecting innate responses to schistosomes in vitro. To achieve the above aims, this 
thesis is structured around two key objectives, as follows. 
a) The first objective is to detennine if skin-stage schistosomes possess PAMP-like 
molecules that can directly stimulate innate accessory cells. 
Chapter 2 briefly deals with the production of parasite TAMP' preparations from 
schistosomes transformed and cultured in vitro to different developmental states. 
Chapter 3 concerns the screening of these schistosome preparations for their ability to 
stimulate murine Mý (as a representative of the innate immune system). 
The involvement of different cellular receptors in the recognition of parasite material is 
investigated in chapters 4&5, focussing upon the MR, and the FcyR. 
b) The second objective is to determine what effect putative parasitic PAMPs have on 
APCs. 
APCs fonn the bridge that links innate and acquired responses and are likely to be a 
critical factor affecting both the scale and the type of acquired immune response 
generated during infection. Therefore, in Chapter 6 the effect of schistosome PAMPs 
upon the maturation state of DC (the 'professional' APQ is examined in depth. In 
order to detennine the effect of parasite PAMPs upon the priming and polarisation of 
acquired immune responses, Chapter 7 deals with the outcome of Th cell priming by 
schistosome-activated DC, using both in vitro and in vivo methodologies for analysis. 
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CHAPTER 2 
PRODUCTION OF SCHISTOSOME PAMP PREPARATIONS FROM 
IN VITRO CULTURED LARVAE 
2.1 INTRODUCTION 
In order to determine whether S. mansoni larvae express PAMPs during the initial stages of 
infection, a number of different larval preparations will be screened for their ability to 
stimulate innate accessory cells. This parasite material must be, 1) representative of the 
molecules that come into contact with innate accessory cells during the different stages of 
skin penetration and migration; and 2) produced in large / sufficient quantities. 
Infective cercariae are easily obtainable in bulk from patent snails maintained at the 
University of York. However, ex vivo skin-stage schistosomulae are very difficult to obtain 
in large numbers, as they have to be extracted from the skin infection site, requiring 
significant numbers of infected mice. Coupled with this, molecules released by the parasite 
to facilitate penetration and migration will be lost within the host tissues. Therefore, a 
method for the high yield in vitro culture of artificially-transformed larvae was adopted to 
provide a viable source of large quantities of parasite material. Briefly, this method 
involves the mechanical-transformation of infective cercariae into schistosomulae, which 
can then be cultured in vitro to different developmental stages. This method also allows for 
the collection and analysis of the material released by cercariae during transformation and 
subsequent migration, such as the contents of the pre- and post-acetabular glands. As these 
released molecules are some of the first schistosome molecules to which innate accessory 
cells are exposed, they represent an important source of potentially stimulatory PAMPs. 
The aim of this short chapter is to describe the techniques used for the in vitro culture of 
schistosomulae, and to simply compare the different larval preparations that will be used in 
subsequent experimental chapters to study the effects of schistosome PAMPs upon innate 
accessory cells. 
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2.2 MATERIALS AND METHODS 
2.2.1 Parasites 
A Puerto Rican strain of Schistosoma mansoni was maintained by routine passage through 
out-bred NMR- I mice and albino Biomphalaria glabrata snails. 
2.2.1.1 Cercariae 
Schistosome cercariae were harvested from snails harbouring patent infections 
(approximately 260 snails from which 650,000 larvae are shed; pers. com. R. Curwen and 
A. Wilson). The parasites were induced to shed into clean 'aged tap-water' by exposure of 
infected snails to intense light (2 x 20OW bulbs) for 2 hr. Cercariae were then pooled, 
ensuring that snails and faeces were excluded, and concentrated by sedimentation on ice 
for I hr. In order to reduce naturally occurring microbial contaminants, cercariae were 
washed three times with sterile chilled 'aged tap-water'. Cercariae were frozen at -20 T 
prior to processing into soluble cercarial preparation (SCP; see section 2.2.1.4). 
Alternatively, cercariae were mechanically-transformed by vortexing for 90 sec in 2ml of 
sterile chilled RPMI 1640 containing 200 U/ml penicillin and 100 ýIg/ml streptomycin 
(Invitrogen, Paisley, UK) (RPMI-O). 
2.2.1.2 In vitro culture of schistosomulae 
Mechanically-transformed larvae were cultured in vitro in 25 ml RPMI-O for 3 hr at 37 T 
and 5% C02, in a T25 tissue-culture flask (Nalge Nunc International Corp., Naperville, 
USA). The absence of foetal calf serum (FCS) from this medium ensured that all protein 
present in the supernatant (SN) after culture would be parasite-derived. During this period, 
the now immobile cercarial heads (transformed to schistosomulae), and the cercarial tails, 
settled on the bottom of the culture flask. The top 20 ml of culture SN, was then removed, 
leaving 5 ml of larval sediment. A further 20 ml of RPMI-O was added to resuspend any 
particulate material released by larvae into the sediment. The heads and tails were allowed 
to sediment for 10 min, before the removal of the top 20 ml of SN. The pooled SN formed 
the basis of the 0-3 hr released molecule preparation (0-3hRP; Section 2.2.1.3). 
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Parasite heads, were isolated from tails by centrifugation (250 g for 12 min) on a 
discontinuous (45% / 70%) Percoll (Amersham Scientific, Amersham, UK) gradient, made 
up in RPMI-O (Lazdins et al., 1982). The denser larvae accumulated at the interface 
between the 45% and 70% layers, whereas the less dense tails remained in the upper region 
of the 40% layer, allowing the heads to be removed. Larvae were washed 7 times with 10 
ml RPMI-O to remove Percoll and the few remaining tails. They were then pelleted, frozen 
at -20 'C, and used to create the soluble 3 hr schistosomule preparation (3hSSP) (Section 
2.2.1.4). Alternatively, schistosomulae were cultured for longer periods of time to allow 
further development. Consequently, larvae were resuspended in 20 ml Medium 169 
(adapted from Basch, 198 1), containing 200 U/ml penicillin, 100 ýLg/ml streptomycin and 
5% heat-inactivated, low-endotoxin FCS (Harlan Seralab, Loughborough, UK) (M169-5). 
Medium 169 comprised BME (EAGLE) medium containing HEPES buffer (20 mM), 
Schneiders medium (5%, v/v; Invitrogen), lactalbumin hydrosolate (0.1%), glucose 
(0.1%), hypoxanthine (5 x 10-7 M), serotonin (1 x 10-6 M), hydrocortisone (1 x 10-6 M) 
triiodothyronine (2 X 10-7 M), and MEM vitamins (0.5%, v/v; Sigma-Aldrich, Poole, 
UK). Schistosomulae were then cultured in M169-5 (approximately 2000 - 3000 parasites 
ml) in 24-well plates (Nalge Nunc), and harvested 18 hr, 3 days, 5 days or 8 days later, 
depending on the stage of development required. The larvae were resuspended and pooled 
into 50 ml tubes and centrifuged at 45 g for 5 min. The SN was discarded and the larvae 
washed 4 times with RPMI-O, to remove any FCS components. The final larval pellet was 
frozen at -20 OC. These larvae were then used to create the 18 hr (I 8hSSP), 3 day QdSSP), 
5 day (5dSSP) or 8 day (8dSSP) soluble schistosomulurn preparations (Section 2.2.1.4). 
2.2.1.3 Preparation of soluble released larval molecules (0-3hRP) 
During the following procedure, parasite material was kept on ice at all times to ensure 
minimal enzymatic degradation. Pooled SN from the first 3 hr schistosomulae culture was 
centrifuged (120 g), 4 T, for 8 min to pellet any remaining heads and tails. This process 
was optimised in order to reduce any contaminating heads or tails, whilst increasing the 
amount of particulate released material remaining in suspension. The released parasite 
material within the SN was then concentrated 50-fold using Ultrafree-MC centriftigal filter 
units with 5 kDa cut-off membranes (Millipore, Watford), and used to produce 0-3hRP. As 
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a control, an equivalent volume of RPMI-O culture medium containing no parasite material 
was concentrated 50-fold using the same method. 
2.2.1.4 Production ofsoluble preparations ftom whole larvae and released molecules 
As above, parasite material was kept on ice at all times to minimise enzymatic degradation 
of the constituents. The suspensions were then sonicated (21 kHz at 6.5 ýim amplitude) for 
3 min. Each preparation was then centrifuged (100,000 g, for I hr) to separate soluble 
material within the supernatant ftorn the insoluble pellet. These were finally sterilised by 
irradiation with UV light for 30 min. The resulting soluble preparations are summarised in 
Table 2.1. 
Source of larvae Equivalent larval developmental Acronym 
stage in vivo 
Infective cercariae Infective cercariae SCP 
Artificial-transformation and in vitro 
culture ofschistosomulae 
Molecules released during first 3 hr Molecules released @ onset of O-ARP 
of in vitro culture infection (x50 conc. ) 
Medium control a N/A RPMIc 
3 hr in vitro larvae Epidermis 3hSSP 
18 hr 11 Epidermal / dermal interface l8hSSP 
3d 66 Dennis 3dSSP 
5d Lymph node / Lung 5dSSP 
8d Lung 8dSSP 
Table 2.1 Summary of the schistosome preparations analysed in this thesis and the 
source material used to produce them. 
a equivalent medium control to 0-3hRP. 
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2.2.2 Characterisation of soluble schistosome preparations 
2.2.2.1 Quantification of material within soluble preparations 
Protein concentration was used as the basis for quantitative comparison of the different 
soluble schistosome preparations. This was deten-nined using the Coomasie Plus-200 assay 
(Perbio Science UK Ltd, Tattenhall, UK). Samples were referenced against a bovine serum 
albumin (BSA; Sigma-Aldrich) standard curve. The preparations were tested neat, or at 
dilutions of 1: 2,1: 5, or 1: 10. The soluble preparations were then stored at -20 OC until 
ftirther use. 
2.2.2.2 SDS-PAGE analysis 
Samples (10 ýtg) of the schistosome preparations were denatured by boiling in LDS sample 
buffer and reducing agent for 5 min, before being separated on pre-cast 4% - 12% gradient 
acrylamide gels at 200 V for 40 min, in MES SDS running buffer containing 0.1 % 
antioxidant (all reagents from Invitrogen). Gels were stained with Brilliant Blue G- 
Colloidal Concentrate TM (BBGC; Sigma-Aldrich), a Coomasie based stain, according to 
manufacturer's instructions. Specifically, gels were fixed in 7% glacial acetic acid in 40% 
(v / v) methanol for I hr, and then stained in BBGC overnight. Gels were then de-stained 
with 10% acetic acid in 25% (v / v) methanol for 30 sec and then up to 24 hr in 25% 
methanol. 
2.2.2.3 Endotoxin content 
Endotoxin content of the preparations and of LPS from Escherichia coli strain 011 l: B4 
(Sigma-Aldrich) was determined using the Pyrogent Pluso Limulus Amoebocye Lysate 
(LAL) test kit (BioWhittaker, Wokingham, UK), according to manufacturer's instructions. 
Specifically, the presence of endotoxin in a sample was detected by the formation of a gel- 
clot after the lysate was incubated with the sample for 1 hr at 37 OC. The sensitivity of the 
lysate was first confirmed using an endotoxin standard of known potency. The endotoxin 
content of the preparations was then determined, in duplicate by performing a limiting 
dilution assay. 
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2.3 RESULTS 
2.3.1 Analysis of protein content of schistosome preparations 
Comparisons of total protein content of the preparations showed that the released larval 
molecules (0-3hRP) were less abundant (295 ± 39 ýtg / 650,000 parasites; n= 3) compared 
to the content of the equivalent 3hSSP preparations (1851 ± 460 [tg / 650,000 parasites) 
from whole larvae. SCP and the later stage schistosomulae preparations also contained 
higher levels of protein than 0-3hRP. 
Analysis by one-dimension (I -D) gel electrophoresis demonstrated that 0-3hRP differs 
considerably in protein content to SCP and larval SSPs (Figure 2.1). 0-3hRP contained 4 
dominant protein bands, at approximately 60,50,26 and 12 kDa, plus a large number of 
minor bands. 0-3hRP also contained a complex of large proteins (75 -> 250 kDa) that did 
not resolve clearly as discrete bands. 
SCP contained a larger array of discrete protein bands compared to 0-3hRP. This protein 
complement included all the components of 0-3hRP, except for the 75 -> 250 kDa 
complex and the 50 kDa band (Figure 2.1). Indeed, the protein complex appeared unique to 
0-3hR-P, and the 50 kDa protein was much more abundant in the released material 
compared to all of the soluble whole larval preparations (Figure 2.1 and Figure 2.2). 
The 60,26 and 12 kDa bands present in 0-3hRP were also present in, SCP, 3hSSP and 
18hSSP, but were less abundant (Figure 2.1). However, analysis of later stage preparations 
showed these bands to disappear, or be greatly reduced in concentration (Figure 2.2). 
Compared to each other, the preparations of whole larvae were more alike in content, with 
most bands expressed at similar levels within all preparations (Figure 2.1 and Figure 2.2). 
SCP contains two bands that were not detectable in other preparations, one at 
approximately 100 kDa and one at just under 50 kDa, whereas there was comparatively 
little difference in 3hSSP and l8hSSP (Figure 2.1). A greater variation in protein content 
was apparent when all the whole larval preparations (ASSP to 8dSSP) were compared 
(Figure 2-2). 
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2.3.2 Low levels of naturally occurring endotoxin are present in soluble preparations 
The gel-clot based LAL assay was used to detect and quantify the presence of endotoxin 
within the preparations. Data is presented as endotoxin in 50 [tg of schistosome 
preparation, because in subsequent chapters up to 50 ýtg / ml was used in cell stimulation 
assays. Of all the preparations tested, 0-3hRP contained the highest levels of endotoxin, 
ranging from 0.5 -2 Endotoxin Units (EU) per 50 ýtg of protein (Table 2.2). However, in 
subsequent screening of all batches of 0-3hRP, the average endotoxin content (n = 16) was 
6.17 ± 1.1 (mean ± SEM) EU per 50 [ig protein (data not shown). In contrast, a volume of 
RPMIc that was equivalent to 50 ýtg 0-3hRP contained less than 0.03 EU. 
Compared to 0-3hRP, soluble whole larval preparations contained very low levels of 
endotoxin (Table 2.2). Of these preparations, SCP had the highest endotoxin content level, 
containing between 0.06 - 0.2 EU / 50 ýLg protein, whereas 3hSSP, l8hSSP and 8dSSP all 
contained less than 0.02 EU / 50 ýtg protein. 
Analysis of the EU content of purified LPS from E. coli, demonstrated that it had an 
endotoxin activity of 4 EU / ng (data not shown). Therefore, an estimate of LPS levels 
within the preparations could be calculated (Table 2.2). 
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0-3hRP SCP 3hSSP 18hSSP 
IIIýIýII 
Figure 2.1 O-ARP differs in protein composition compared to whole 
larval SSPs. Soluble schistosome preparations (10 [ig / lane) were 
separated on a 4% - 12% gradient bis-tris acrylamide gel. Samples were 
denatured by boiling for 5 min in sample buffer, and run for 40 min at 
200 V. The gel was then stained with colloidal Coomasie overnight. 
Black arrows indicate the 4 dominant protein bands within 0-3hRP. The 
brace indicates a protein complex within 0-3hRP. Grey arrows indicate 
two protein bands which are visible only within SCP. 
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Figure 2.2 Soluble preparations of schistosomulae cultured in vitro to 
different developmental stages vary little in protein composition. 
Soluble schistosome preparations (10 ýtg / lane) were separated on a 4% - 
12% gradient bis-tris acrylamide gel. Samples were denatured by boiling 
for 5 min in sample buffer, and run for 40 min at 200 V. The gel was 
then stained with colloidal Coomasie overnight. Arrows indicate the 
positions of the 4 dominant Protein bands within 0-3hRP. The brace 
indicates the position of the protein complex within 0-3hRP. 
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Preparation Endotoxin (EU) 
per 50 pg 
preparation 
Equivalent LPS' 
(ng) per preparation 
(5 0 Pg) 
SCP i 0.06 0.015 
SCP ii 0.20 0.050 
0-3hRP i 0.50 0.125 
0-3hRP n 0.70 0.175 
0-3hRP iii 2.00 0.5 
R-PMIc i < 0.03 b < 0.007 
b 
3hSSP i 0.02 0.005 
18hSSP i 0.01 0.003 
8dSSP i 0.003 0.001 
Table Z2 Endotoxin content of schistosome preparations, as 
determined by the LAL assay. 
a Endotoxin content of LPS from E. coli strain 0111: 134. 
b RPMlc has no protein content, so value displayed represents amount of 
endotoxin in a volume equivalent to a 50 gg / ml aliquot of 0-3hRP. 
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2.4 DISCUSSION 
In this chapter, I demonstrate that soluble parasite preparations can be produced from 
schistosomulae cultured in vitro to different developmental stages. In addition, I -D gel 
electrophoresis reveals that the released molecule preparation, 0-3hRP, differs 
considerably in protein composition compared to the soluble preparations of whole 
parasites. In contrast, preparations of whole parasites show considerable similarity between 
different larval developmental stages. It is important to note that the goal of this chapter 
was not to provide a detailed analysis of specific proteins or components, but to simply 
identify whether there were major differences in the preparations, which will be used in 
subsequent experimental chapters for investigation of their immunological properties. 
Moreover, Rachel Curwen has undertaken an in-depth two-dimension (2-D) proteomic 
analysis of these skin-stage larval preparations (with the aim of identifying vaccine 
candidates) as part of her PhD studies under the supervision of Prof. R. A. Wilson. 
In this study, I used a method of mechanical-transformation of cercariae originally 
documented by Ramalho-Pinto et al. (1974). In vitro culture of larvae transformed using 
this technique results in schistosomulae that are viable, as reintroduction of both in vitro 
and ex vivo parasites results in similar levels of maturation (Harrop and Wilson, 1993b). In 
addition, several other methods of artificial-transformation have been documented. These 
can be grouped into 'penetration through skin membranes', using excised mouse or human 
skin, or 'chemical' transformation of cercariae, such as incubation with skin-derived 
products, like linoleate or linoleic acid. Although 'penetration of skin membranes' is the 
most natural method, it produces very low numbers of schistosomulae. Also, much of the 
material released during transformation is lost in the membrane, rendering this a poor 
method against the original criteria (Section 2.1). In a comparison of mechanical (vortex) 
versus chemical (linoleate) transfort-nation, both methods resulted in larvae with surface 
characteristics of schistosomulae (Salafsky et al., 1988). However, significant differences 
in the biochemical characteristics of these schistosomulae were observed, with chemical 
transformation resulting in dramatic increases in the detectable levels of eicosanoids, such 
as PGE2, in the larval culture SN. In an immunological context, eicosanoids can exert both 
stimulatory and inhibitory effects on a variety of innate accessory cells (Section 1.9.2). 
Moreover, fatty acids, such as linoelic acid, are potentially toxic and are known to have 
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effects on immune cell function, including inhibition of Mý cytokine production (Tappia et 
al., 1995). Therefore, the method of mechanical-transformation was chosen since it allows 
for the collection of material released by cultured schistosomulae that will lack potentially 
toxic / inhibitory fatty acids and contain only low levels of eicosanoids, allowing screening 
for stimulatory characteristics without interference from the presence of inhibitory 
prostaglandins. 
The parasite preparations used in my studies will be composed of protein, lipid, and 
carbohydrate moieties. All of these molecules are represented within the repertoire 
pathogen PAMPs that have been identified to date (Section 1.8.1 & 1.8.3). However, 
protein is likely to be the major constituent of my preparations, since others report that 
similar released preparations consist of protein and carbohydrate in ratios of 5: 1 - 7: 1 
(Vieira et al., 1986). Therefore, the quantitative and qualitative analysis of the different 
preparations in this study was based upon protein content. Moreover, methods for detection 
and quantification of protein are also far more reliable than for the other molecular species. 
My studies demonstrate that the mean (n = 3) amount of soluble material released by the 
parasite during the first 3 hr of culture (0-3hRP) represents approximately one sixth of the 
protein contained within the 3 hr soluble schistosomula preparation (3hSSP). This 
compares with values of one third (Harrop and Wilson, 1993b) and one twentieth 
(Ramaswamy et al., 1995b), reported in previous studies. The variation in these estimates 
is probably due to differences in either quantification techniques, or in the methods of 
production. Therefore, since 0-3hRP is less abundant than soluble material from whole 
larvae, the availability of 0-3hRP will be the limiting factor for use in subsequent cell- 
based stimulation assays. 
In addition to the material released during the first 3 hr post-transformation, migrating 
schistosomulae are also known to release material up to 14 days post-infection (Mountford 
et al., 1988). However, the amount of material released rapidly decreases with time post- 
infection. The profile of antigen release by schistosomulae in vivo is similar during in vitro 
culture, with three times as much material being released during the first 3 hr post- 
transformation, than released during the subsequent 24 hr of culture (Harrop and Wilson, 
1993b). Although the material released by the larvae from 3 hr to 8 days of culture may 
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contain parasite PAMPs, the low levels at which it is released make it impossible to collect 
enough for subsequent in vitro analysis of the stimulatory properties. 
I -D gel-electrophoresis showed the released molecule preparation, 0-3hRP, to have a more 
simple protein composition than the soluble whole larvae preparations. However, in-depth 
analysis of the 0-3hRP proteome using 2-D gel-electrophoresis has shown that it is 
comprised of over 100 components (pers. com. R. Curwen). As there is little protein 
synthesis by schistosomulae during the first 24 hr post-transforination (Harrop and Wilson, 
1993b), the molecules released by the larvae should be a constituent of the whole cercanae. 
Indeed, the majority of proteins within 0-3hRP were also present in SCP. However, most 
of these were less abundant, effectively diluted by the many additional protein species 
contained within SCP. Conversely, some of the shared components were more 
concentrated in SCP. This suggests that these represent largely non-secreted molecules, or 
somatic constituents. There are also bands within 0-3hRP that are not present in SCP. 
These may either represent the products of enzymatic degradation that could occur during 
the 3 hr period, or could be very dilute within SCP. 
Much work has been done to characterise the material that is released by cercariae as they 
undergo transformation. Up to 60% of the cercarial surface glycocalyx is shed into the 
culture SN during the first 3 hr post- in vitro transformation (Samuelson and Caulfield, 
1985; Samuelson and Caulfield, 1986; Marikovsky et al., 1986). The glycocalyx is highly 
glycosylated (Xu et al., 1994; Cummings and Nyame, 1999). For example, mucins are 
present within the cercarial glycocalyx and are secreted into the skin by the parasite and 
are thought to aid adherence and penetration of the host (Cummings and Nayame, 1999; 
Theodoropoulos et al., 2001). Much of this glycosylated material will be of high molecular 
weight, yet unlikely to resolve as a discrete protein bands under SDS-PAGE 
electrophoresis. Therefore, the complex of large proteins (75 -> 200 kDa) observed within 
0-3hRP, may potentially be comprised of the soluble fraction of these molecules. However, 
due to the membranous nature of the glycocalyx, the majority should be removed in the 
insoluble fraction of the concentrated SN, when centrifuged at 100,000 g for I hr. Indeed, 
analysis of crude non-centrifuged 0-3hRP shows it contains a much greater quantity of this 
high molecular weight protein complex (R. Curwen), suggesting that most glycocalyx 
material is absent in 0-3hRP, and consequently from SCP as well. 
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A large proportion of the material released by the parasite during transformation originates 
from the pre- and post-acetabular glands. This material is packaged into distinct vesicles, 
which are deposited as the parasite penetrates the host (Fishelson et al., 1992). Much 
controversy has surrounded the abundant protease component of this material, which is 
primarily thought to facilitate the degradation and penetration of host skin. Indeed, many 
skin structural molecules, such as elastin and collagen, are known to be substrates 
(Mckerrow et al., 1985a), and protease inhibitors can block cercarial penetration (Lim et 
al., 1999). Moreover, cercarial proteases have also been implicated in immune evasion 
(Pleass et al., 2000) and the shedding of the cercarial glycocalyx (Marikovsky et al., 
1988a). The main proteolytic component released is a serine-protease termed elastase. 
Historically, there have been 4 cercarial elastase genes registered (Salter et al., 2002), and 
numerous serine proteases of 25 kDa (Landsperger et al., 1982), 27 kDa (Darani et al., 
1997), 28 kDa (Marikovsky et al., 1988b), 30 kDa (McKerrow et al., 1985b), 47 kDa 
(Chavez-Olortegui et al., 1992) and 60 kDa (Marikovsky et al., 1988b) identified from 
cercariae. It has been suggested that some of these are products of the same gene, but with 
different post-translational modifications (McKerrow et al., 1991). However, a more 
simple picture of released cercarial proteases is emerging, with a single chyrno-trypsin 
serine protease composed of multiple 25 kDa iso-forms proposed to be solely responsible 
for the observed elastase activity. Elastase has also been identified on the surface 
membrane of transformed schistosomulae (Ghendler et al., 1996), and therefore, may be 
present in the S SPs used in my study. Indeed, in the I -D gel shown, the most dominant 
band observed within 0-3hRP, also present in the preparations of whole larvae up to 
3dSSP, was approximately 26 kDa. Other typsin-like proteases that had previously been 
identified in released cercarial material are thought to be contaminants derived from the 
intermediate snail host (Salter et al., 2000; Salter et al., 2002). With the method described 
in this chapter for the extensive washing of cercariae, snail protease contaminants should 
not be present in the schistosome preparations used in this thesis. Immuno-histochemical 
techniques have also identified cysteine-proteases, including cathespin-L, within the 
vesicles of the post-acetabular gland, suggesting these will be present in the released 
material (Dalton et al., 1997). Therefore, the proteases contained within the pre- and post- 
acetabular glands are likely to constitute a large proportion of 0-3hRP. 
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Other molecules known to be released during transformation include two 23 kDa proteins, 
Translationally Controlled Tumour Protein (TCTP; Rao et al., 2002) and S. mansoni- 
derived apoptosis inducing factor (SMAF; Chen et al., 2002). TCTP is also expressed in all 
other life-cycle stages, as a variety of differently sized but related molecules. Oddly, TCTP 
and SMAF were described by the same group, however appear to be the same molecule, as 
a BLAST search on the N-terminal sequence of SMAF perfectly matches part of TCTP, 
yet the authors make no mention of this (R. Curwen). The same group has also described a 
16.8 kDa protein with anti-inflammatory properties within the released material and 
soluble preparations of schistosomulae (Ramaswamy et al., 1995a; Rao and Ramaswamy, 
2000). 2D-gel separation followed by mass-spectrometry has confinned that Sm 16.8 is 
abundant within 0-3hRP (R. Curwen). Eicosanoids, such as PGE2, and leukotriene B4 
(LTBA are synthesised upon transformation (Fusco et al., 1985) but are only detected at 
low levels in the released material from mechanically transformed parasites (Salafsky et 
al., 1988). Moreover, the protein thought to control eicosanoid synthesis, a 28 kDa 
glutathione-s-transferase (GST 28; Herve et al., 2003) is known to be abundant in 0-3hRP, 
as well as SSPs (R. Curwen). Some of the pre- and post-acetabular gland contents are also 
glycosylated, binding to numerous different lectins (Linder, 1985). Indeed, glycans 
containing the Lewis X (Le') epitope, which is also carried by the immuno-regulatory 
pentasaccharide LNFP III from schistosome eggs (Section 1.6.1 - 1.6.2), are found within 
the released material (Koster and Strand, 1994), and are likely to be present in 0-3hRP. 
Therefore, the contents of 0-3hRP have been well characterised by others, demonstrating 
that it contains a complex mixture of potentially stimulatory molecules. 
In addition to molecules shared with 0-3hRP, the soluble schistosomulae preparations 
(SSPs) also contain many additional protein bands. Indeed, a 60 / 66 kDa doublet, 
potentially present on the surface of cercariae and schistosomulae, was recently described 
to stimulate neutrophil migration (Coelho-Castelo et al., 2002). However, as with the 
cercarial glycocalyx, the majority of the membrane-bound surface molecules are likely to 
have been removed from the preparations by centrifugation at 100,000 g. Therefore, the 
SSPs will largely represent somatic molecules, such as Heat Shock Proteins (HSPs), actin, 
and pararnyosin. 
A major consideration from the start of this project, has been the potential for exogenous 
endotoxin contamination within the schistosome preparations. The infective cercariae used 
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for the in vitro culture of schistosomulae originate from a non-sterile environment. 
Therefore, the method used to create the preparations was developed at the beginning of 
my PhD in order to greatly reduce the potential for contamination. This involved washing 
cercariae three times with sterile water prior to transformation, and the use of low 
endotoxin culture components and equipment. In addition, in all culture steps, the larvae 
were incubated with penicillin and streptomycin to inhibit bacterial growth. However, I 
identified that a limited amount of endotoxin is present in the different preparations (0.003 
- 6.17 EU per 50 ýtg / protein). It must be emphasised that these levels of endotoxin are 
classed as low (e. g. commercially available FCS marketed specifically as 'low endotoxin' 
[Invitrogen] is certified as containing not more than 10 EU / ml). 0-3hRP consistently 
contained higher levels of endotoxin than the whole larval preparations. This is most 
probably due to the process of concentrating culture SN 50-fold, effectively concentrating 
endotoxin as well. Moreover, the protein concentration of 0-3hRP is much lower than the 
other preparations, in effect increasing the relative protein to endotoxin ratio. 
The stimulatory effect of endotoxin has been well documented, and therefore, could 
potentially affect the stimulatory properties of the schistosome preparations. In this respect, 
the bacterial PAMP lipopolysaccharide (LPS) is the major active constituent of endotoxin. 
Several steps were taken in subsequent chapters to minimise the effect that this endotoxin 
contamination would have on the stimulatory properties of the schistosome preparations. 
The cyclic peptide polymyxin B (PMB) binds to the stimulatory lipid A region of LPS. 
Therefore, Detoxi-gelTM (Perbio Science UK Ltd), a PMB gel matrix, was used to remove 
the LPS. Unfortunately, much of the schistosome preparations were lost on these gel 
columns (data not shown), and therefore, this technique was abandoned. As an alternative, 
PMB is also known to inactivate the stimulatory properties of LPS when used directly in 
culture (Duff and Atkins, 1982). Indeed, it has become widely used to determine 
immunological properties of experimental agents, in the absence of endotoxin signalling 
(e. g. Yoshida and Koide, 1997). 
In summary, I have produced several soluble preparations of released and somatic 
molecules from in vitro cultured schistosomulae. These preparations have been produced 
in sufficient quantities for use in in vitro cell-based stimulation assays. The released 
molecule preparation (0-3hRP) is considerably different to the whole larvae preparations, 
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which on the other hand are broadly similar. Further to this, endotoxin contamination is 
detected at low levels in all preparations but is greatest in 0-3hRP. 
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CHAPTER 3 
Mý CYTOKINE PRODUCTION IN RESPONSE TO 
SCHISTOSOME PAMPS 
3.1 INTRODUCTION 
The schistosome preparations produced in Chapter 2 are likely to have stimulatory effects 
on innate accessory cells. Screening for these stimulatory properties requires an 
experimental in vitro cell-based assay using a defined source of cells, which should be 
available in large quantities and have measurable function as a readout of stimulation. 
The innate accessory cells present in the skin which may respond to invading schistosomes 
include epidermal LC, Mý, DC, granulocytes, NK, and keratinocytes (Williams and 
Kupper, 1996). In depth analysis of events following parasite penetration and migration 
through the skin, demonstrate acute local inflammation at the infection site, during which 
large numbers of mononuclear and granulocytic cells immigrate into the dermis and 
epidermis (Section 1.3.2). This cellular influx is likely to be caused by soluble factors, such 
as cytokines and chemokines, released by resident innate accessory cells stimulated by the 
presence of invading larvae. Recruited inflammatory accessory cells may respond in a 
similar way, and there is both in vivo and ex vivo evidence of pro-inflammatory and 
regulatory cytokine production at the site of infection (Section 1.3.3). Many of these innate 
accessory cells are rare or difficult to obtain ex vivo in sufficient quantities to screen the 
soluble schistosome preparations for their stimulatory properties. However, there are 
several techniques for the isolation of large numbers of Mý from murine tissues. Mý are 
also known to release large quantities of many pro-inflanu-natory and regulatory cytokines 
upon in vitro recognition of numerous pathogen PAMPs (Stein and Gordon, 1991; Moors 
et al., 2001; Nau et al., 2002) giving a quantifiable readout of stimulation. 
Mý, or their tissue-specific subsets, can be found in the majority of organs within the body 
and there are a variety of isolation techniques to enable their study in vitro. Mý may be 
resident within close cellular matrices, such as in the skin, but their isolation involves the 
use of traumatic enzymatic digestion techniques to dissociate them from connective 
tissues, and usually only a few cells are recovered. One alternative is to use Mý that exist 
in tissues lacking this close cellular restraint, such as the lung or the peritoneal cavity, from 
which they can be extracted by simple lavage. Using the peritoneal cavity as the Mý source 
has the additional benefit that relatively large quantities of cells are obtainable. For these 
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reasons, most in vitro studies on Mý have been performed using cells obtained from the 
peritoneal cavity. 
From a single mouse, approximately 2-3x 106 peritoneal exudate cells (PEC) can be 
obtained, of which 50% - 70% are "resident" Mý (reviewed by Fortier and Falk, 1994). 
However, injection of sterile inflammatory mediators 3 to 7 days prior to lavage causes the 
elicitation of "inflammatory" Mý (Mý) into the cavity, which dramatically increases the 
numbers of cells that can be harvested. A variety of different inflammatory irritants can be 
used, such as proteose peptone, thioglycollate, casein (Fortier and Falk, 1994), or Bio- 
gelTM polyacrylamide beads (Stein and Gordon, 1991). Of these, thioglycollate increases 
the number of peritoneal M+ to the greatest extent, resulting in approximately 6-fold more 
cells (Fortier and Falk, 1994). Therefore, this method was chosen to produce the large 
number of iM+ needed to screen the parasite preparations. 
Peritoneal lavage results in a mixed population of peritoneal exudate cells (PEC), which in 
addition to resident and Mý, includes neutrophils and B lymphocytes. There are several 
methods to purify Mý, based on cell size, density, or adherent function (reviewed by 
Gessani et al., 2000). Of these, the latter technique is the simplest and most widely used, 
relying upon the strongly adherent properties of Mý while less / non-adherent PEC (e. g. 
granulocytes and lymphocytes) are removed by washing. 
Mý can exist in a variety of maturation and activation states, resulting in a heterogeneous 
population within the tissues (Gordon et al., 1986; Rutherford et al., 1993). A two-step 
model of activation has been proposed, whereby Mý are 'primed' by cytokines but need a 
secondary signal, such as PAMPs, to 'trigger' or 'stimulate' a fully activated functional 
phenotype (Pace et al, 1985). Numerous cytokines are known to prime for Mý activation, 
such as EFN(x, EFNP (Pace et al., 1985), IIL-4 (Crawford et al., 1987) and GM-CSF (Reed 
et al., 1987). However, one of most potent and intensely studied is EFNy (Pace et al., 
1985), known to dramatically increase levels of some cytokines produced by Mý in 
response to stimulation with PAMPs, such as LPS (Rutherford et al., 1993) and 
glycoproteins from Typanosoma cruzi (Camargo et al., 1997). Thus, it may be necessary to 
prime the Mý with EFNy to achieve detectable cytokine production in response to the 
schistosome PAMP preparations. 
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In addition to primary cultures, MO cell-lines have been used to study the stimulatory 
properties of pathogen PAMPs (Kirikae et al., 1993; Yoshida and Koide, 1997). The use of 
cell-lines is beneficial because the population is completely homogeneous in maturation 
and activation status, and large numbers can be produced. There are a variety of murine 
MO-derived cell-lines that could offer an insight into the stimulatory properties of the 
parasite preparations. These include the BALB/c-derived J774 and RAW 264.7 lines. 
Furthermore, some clones have been created to lack certain PRRs, such as the CD14- 
deficient J3. DEF. 3 line (Kirikae et al., 1993). 
The aim of this chapter is to determine whether the schistosome preparations created in 
Chapter 2 are capable of stimulating the production of cytokines by primary Mý and 
IFNy-primed Mý (IFN7-Mý), and by Mý cell-lines. The profile of cytokine production in 
response to schistosome preparations will be compared to that of other well-documented 
PAMPs, such as LPS and Zymosan A. Finally, the response of Mý to live schistosomes 
will be examined. 
3.2 MATERIALS AND METHODS 
3.2.1 Mice 
All mice were maintained in open housing at the University of York animal unit. C57BL/6 
mice were bred in house, while C3H/HeN and C3H/HeJ mice were obtained from Harlan 
UK. Mice were age and / or sex matched in individual experiments. 
3.2.2 Production of inflammatory MO (iMO) 
Pentoneal exudate cells (PEC) were extracted from mice by pentoneal lavage 5 days post- 
injection with 0.5 ml sterile 0.09% thioglycollate medium FTG (Sigina-Aldrich). Where 
stated, in later experiments 0.5 ml 3% Brewers thioglycollate medium (Sigrna-Aldrich) 
was used as an alternative inflammatory agent. The medium used during collection and 
culture of Mý consisted of RPMI 1640, containing 200 U/ ml penicillin, 100 ýIg / ml 
streptomycin, 2mM L-glutamine (Invitrogen), and 10% heat-inactivated low-endotoxin 
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FCS (Harlan- S eralab; RPMI- 10). Due to the highly adherent nature of Mý, all medium and 
plastic-ware was kept chilled throughout the cell extraction procedure. Mice were killed by 
cervical dislocation, and chilled RPMI-10 (10 ml) plus air (I ml) was then injected into the 
peritoneal cavity using a 25 gauge needle. The cavity was then palpated before removal of 
the injected medium using a 23 gauge needle, attached to a 10 ml syringe. The PEC- 
containing medium was immediately decanted into a chilled 50 ml polypropylene tube 
(Falcon), and pooled from several mice if required. PEC were centriftiged at 350 g for 5 
min to remove remnants of thioglycollate and resuspended in fresh chilled medium (1 ml 
mouse). An aliquot of the cell suspension was diluted 1: 1 with diluting fluid (0.5 % 
Malachite green solution in 1.5 % acetic acid) and the cells counted using a 
haemocytometer. Cells were adjusted to IX 106 cells / ml, and plated out in either 24-well 
plates (I x 106 cells / well), or 96-well plates (2 x 105 cells / well; Nalge Nunc). 
Mý were purified from the PEC population by adherence to plastic. Specifically, after 
culture for 2 hours at 37 T, 5% C02, in a humidified incubator, the non-adherent cells 
were discarded from the adherent Mý monolayer. Semi-adherent cells were then removed 
and discarded by gently washing the monolayer 3 times with pre-warmed medium. 
3.2.3 Phenotypic characterisation of the Mý population 
PEC and adherent Mý populations were analysed for the expression of myeloid 
differentiation markers using flow cytometry. 
3.2.3.1 Preparation of cells for phenotyping 
To remove adherent Mý from the cell-culture wells, the culture media was discarded and 
the cell monolayer rinsed with phosphate buffered saline (PBS; pH 7.2; 137 mM NaCl, 1.5 
MM K-H2PO4,8 mM Na2HP04; 2.6 mM KCL). Following incubation with Trypsin-EDTA 
(0.25%, 1 mM, respectively; Invitrogen) for 10 min at 37 'C, to loosen attachment, the 
cells were then removed using the bung of aI ml pipette as a rubber policeman. RPMI- 10 
was immediately added to the cell suspension to quench the trypsin and limit the cleavage 
of cell surface markers. Cells were then washed with chilled medium and all subsequent 
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steps carried out on ice to minimise Mý adherence. Alternatively, the whole PEC 
population prior to adherence-selection was analysed. 
3.2.3.2 Staining of cells with specific antibodies 
PEC or Mý were re-suspended in cold phenobuffer (PB; PBS containing 0.01% CaC12. 
0.0 1% MgCl2 and 0.1 % BSA; Sigma-Aldrich) and all subsequent steps carried out on ice 
to minimise non-specific staining. Aliquots of cells (up to 5x 105) were incubated with 2 
ýil Rabbit IgG (Sigrna-Aldrich) for 10 min, to block Fcy receptors and any non-specific 
antibody binding sites. Cells were then incubated for 30 min with optimum concentrations 
(100 ýLl) of purified, biotin-conjugated, or fluorochrome-conjugated antibodies against 
specific surface markers. Fluorochromes used in this and subsequent chapters were; 
Fluorescein isothiocyanate (FITC), R-Phycoerythrin (PE), Quantum Red TM (QR TM) or Cy- 
Chrome TM . Antibodies against surface markers were as follows (clone; supplier): Gr- I 
(RB6-8C5; Caltag-MedSystems Ltd, Towcester, UK), F4/80 (CI: A3-1; Caltag), B220 
(RA3 -6B2; BD PharMingen, Oxford, UK), CD IIb (Mac- 1, M 1/70; BD PharMingen), or 
CD45 (30-FI 1; BD PharMingen). Alternatively, corresponding cell aliquots were 
incubated with isotype-matched antibodies of irrelevant specificity, in order to control for 
non-specific binding and to establish background levels of cellular auto- fluorescence. After 
staining, cells were washed in 1.5 ml PB. Cells stained with fluorochrome-conjugated 
antibodies were re-suspended in 100 ml PB and analysed. Cells stained with purified 
antibodies, were incubated for 30 min with optimal concentrations (100 ýtl) of FITC- 
conjugated antibody to rat IgG y-chain (STAR 69; Serotec, Kidlington, UK), whereas cells 
stained with biotinylated antibody were incubated with streptavidin-conjugated QR TM 
(Sigma-Aldrich). Cells were washed, as previously, and resuspended in 100 ýtl PB for 
analysis. 
3.2.3.3 Differentiation of livefrom dead cells 
To determine the percentage of dead cells, 10 ýtl of Propidium Iodide (PI; 200 mg / ml in 
PBS; BD PharMingen) was added to relevant cell aliquots and incubated for 20 sec before 
flow-cytometric analysis. Those cells staining positive for PI were considered dead. 
79 
3.2.3.4 Flow-cytometry 
Flow-cytometry was performed using an EPICS XL (Coulter) equipped with a 15 mW 
argon ion laser of 488nm wavelength. This machine contained three different filters, 
allowing for analysis of three different 'colour' flourochromes. FITC (green; 530 nin peak 
fluorescence) was measured using the FL- I detector, PE (orange; 575 nm) and PI were 
measured using the FL-2 detector, while QR (violet; 670 nm) and Cy-Chrome (violet; 670 
nm) were measured using the FL-3 detector. In addition, size and granularity of the cells 
was deten-nined using forward and side light scatter (900 to the laser source), respectively. 
3.2-3.5 Analysis of cellphenotype 
One-colour flow-cytometry was performed on the cells. On histograms depicting 
fluorescence intensity, a minimum- fluorescence cursor was set at an arbitrary value, 
typically on the 1% to 5% most fluorescent cells stained with the appropriate isotype 
control antibody. When cells stained with the specific antibody were analysed, the 
percentage of cells within this cursor was taken as the positive cell value, and the value 
adjusted to account for the arbitrary background staining. To determine the physical size 
and granularity of the positive or negative cells, this cursor was used to 'gate', or limit, 
analysis on the desired population. In addition, on the size versus granularity scatterplots, 
cregions' were set around particular cell populations. Using these regions, the population 
could then be excluded from, or focused upon, in subsequent analysis. Details of the 
'gates' and 'regions' used in analysis, are included in figure legends. In all experiments a 
'discriminator' was set on the forward light scatter parameter. Any events below this 
setting were subsequently excluded ftorn all analyses, thus ignoring very small events, 
such as cell debris. Equally, all oversized events (i. e. clumped cells) were removed from 
subsequent analysis using a cell 'region'. 
3.2.4 Mý stimulation assays 
Adherent Mý were used to determine the stimulatory properties of different pathogen 
PAMPs or parasite preparations. In addition, responses by EFN7-Mý were also analysed. 
This was achieved by co-culturing Mý with IFNy (5 U/ ml equivalent to 0.5 ng / ml; 
80 
purified from the culture supernatant of 211 A CHO cell-line) during stimulation assays. 
All assays were carried out within 96-well plates. 
3.2.4.1 Stimulation ofMý with parasite preparations andpathogen PAMPs 
The adherent monolayer of Mý was cultured for defined periods of time between 30 min - 
48 hr with soluble parasite preparations (10 - 200 [tg / ml; produced as described in 2.2.1), 
LPS (0.1 - 10 ng / ml; from E. coli, strain 011 I: B4; Sigma-Aldrich), or Zymosan A (0.2 -5 
[tg / ml; Sigma-Aldrich). Stimulation assays were carried out in the presence, or absence, 
of polymyxin B (PMB; 0.0 1- 100 ýtg / ml; Sigma-Aldrich). Culture supernatants were then 
removed and frozen at -20 'C, to await the detection of cytokines released by Mý, using 
ELISA. 
3.2.4.2 Stimulation of WO with live parasites, or neat parasite culture supernatant 
In order to determine the stimulatory properties of live parasites, Mý were cultured for 24 
hr with larvae (50 - 200 parasites / well) and PMB (3 [tg / ml). Three different parasite 
groups were analysed, and consisted of cercariae (CercN), mechanically-transforined 
cercariae (CercT; vortexed for 90 sec), or mechanically-transformed larvae that had been 
cultured in vitro for 3 hr followed by removal of the culture supernatant (3hSom). This 
culture supernatant, termed 0-3hSN, was also assayed for its stimulatory properties. Cell- 
culture supernatants were then removed and frozen at -20 OC, to await the detection of 
cytokines using ELISA. 
3.2.5 Culture of murine Mý cell-lines 
3.2.5.1 Maintenance of cell-lines 
The BALB/c derived Mý cell-line J774A. I was a gift from Dr. M. Taylor, University of 
Liverpool, and the J774A. I derived CD 14-deficient J7. DEF. 3 line was a gift from Dr. F. 
Kirikae, International Medical Centre of Japan. Both lines were grown as monolayer 
cultures in RPMI- 10 in the absence of penicillin and streptomycin. Cells were cultured in 
25 CM2 (10 ml media), or 75 cm 2 (50 ml media) tissue-culture flasks (Nalge Nunc). Cells 
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were sub-cultured when grown to confluence, typically every 2-3 days. To harvest, 
adherent cells were detached into the culture media using a cell scraper (Nalge Nunc). 
Cells were then seeded into new flasks at 1: 5-1: 10 split ratio. Both cell-lines tested 
negative for mycoplasma contamination using the Mycoplasma plUSTm PCR primer set 
(Stratagene, La Jolla, CA, USA). 
3.2.5.2 MO cell-line stimulation assays 
J774A. 1 or J7. DEF. 3 cells were harvested, transferred into fresh RPMI-10, and seeded into 
96-well plates at IX 105 cells / well. This quantity of cells was shown to be optimal for EL- 
6 and IL- 12p4O production in response to stimulation with LPS (data not shown). Cells 
were then cultured for 24 hr alone, in the presence of LPS (0.3 - 2000 ng / ml), or with 
different soluble schistosome preparations (50 ýtg / ml), and with or without the addition of 
PMB (10 ýtg / ml). In some experiments, an optimal concentration of EFN7 (I U/ ml) was 
used to prime the cells simultaneous to culture with pathogen stimuli. Cell-culture 
supernatants were then removed and frozen at -20 'C, to await the detection of cytokines 
using ELISA. 
3.2.6 Detection of Mý - released cytokines by ELISA. 
3.2.6.1 ELISA procedure 
Paired antibody capture ELISAs, utilising a biotinylated detection step, were used to detect 
and quantify the levels of cytokines within the Mý culture supernatants. At all stages, 
incubations were carried out in a total volume of 50 ýfl unless otherwise stated. Maxi- 
sorb TM 96-well plates (Nalge Nunc) were coated with an optimal concentration of capture 
antibody (see Section 3.2.6.2) diluted in PBS, and incubated in a humidified chamber 
overnight at 4 T. Plates were subsequently washed 3 times with 150 ýtl PBS, before 
blocking for 6 hr at room temperature (RT) with 150 ýtl of 10% FCS in PBS (block). 
Following removal of blocking agent, cell-culture supernatants were added to duplicate 
wells, either neat, or diluted in block at 1: 2,1: 5, or 1: 10. In addition, duplicate serial 
dilutions of known recombinant cytokine standards were performed. Plates were then 
incubated overnight at 4 OC, following which they were washed 5 times with 200 ýd of PBS 
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containing 0.5% Tween 20 (Sigma-Aldrich) (PBS-T). Wash was discarded and plates 
incubated with optimal dilutions of biotinylated detecting antibody (Section 3.2.6.2) in 
PBS-T, for 1.5 hr at RT. Plates were washed as before, and incubated with streptavidin- 
conjugated horseradish peroxidase (Amersham Scientific), at a dilution of 1: 5000 in PBS- 
T, for I hr at RT. Following a final wash, 50 [d of SureBlue TM tetra-methylbenzindine 
substrate (TMB; Kirkgaard and Perry Ltd., via Insight Biotechnologies Ltd., Wembly, UK) 
was added to each well and allowed to develop before reading at 63 0 nm, at 10 min 
intervals, using a MRX microplate reader (Dynex Technologies, Billingshurst, UK). 
Concentrations of cytokine within samples was determined against the recombinant 
standard curve. 
3.2.6.2 Antibodies and cytokine standards 
All antibodies were obtained from BD PharMingen, unless other wise stated. The presence 
of the following cytokines were analysed in the Mý culture supernatants (coating antibody 
clone; detection clone); EL-10 (30311; polyclonal; both from R&D Systems, Abingdon, 
UK), EL-6 (MP5-2OF3; MP5-32C 11), EL- 10 (JES5 2A5; SXC- 1), EL- I 2p4O (C 15-6; 
C17.8), and TNF-cc (G281-2626; MP6-XT3). Recombinant standards were as follows: IL- 
IP and IL- 10 (R&D Systems), EL-6 (BD PharMingen), IL- 12p4O (Dr S. Wolf, Genetics 
Institute, Cambridge, MA, USA), and TNF(x (Genzyme). 
3.3 RESULTS 
3.3.1 Purification and characterisation of peritoneal Mý. 
Injection of inflammatory mediators into the peritoneal cavity results in the immigration of 
numerous 'inflammatory' accessory cells. Purification of inflammatory macrophages 
(Mý) from these peritoneal exudate cells (PEC) was achieved by adherence of 1Mý to 
plastic, followed by removal of non-adherent cells. In order to confirm this technique, the 
PEC population both before and after adherence were analysed. 
The cellular composition of the PEC population was notably different to the population of 
adherent iMý (Figure 3.1 a). Moreover, within the PEC population, only 5 0% were positive 
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for the pan-leucocyte marker CD45, compared to 93 % of the adherent Mý (Figure 3.1 b). 
Analysis of the size and granularity of CD45+ cells within the PEC, demonstrated that 
there were 6 main cellular subsets (Figure 3.1 c). However, selection by adherence resulted 
in the dramatic decrease or complete removal of three of these subsets, leaving three major 
cell groups. Further analysis demonstrated that one of the adherent subsets was comprised 
of dead cells (Figure 3.1 c region B), leaving two major cell populations. However, in many 
repeats of this experiment, these two populations were shown to merge, with proportional 
loss of the smaller less granular population (Figure 3.2a). Subsequent analysis of the live 
adherent population (approximately 95% of all cells) showed that 98% were CD45+, 79% 
were F4/80+, and 90% were CD II b+ (Figure 3.2 b, c, d). The large granular population was 
shown to consist entirely of F4/80+ and CD II b+cells, whereas the small, less granular 
population was entirely F4/80-, and contained all the CID 11 b- cells (Figure 3.2c & d). 
3.3.2 Defining the optimum conditions for Mý stimulation by schistosome PAMPs. 
Cytokine production by Mý was used to determine the stimulatory properties of the 
different schistosome preparations. Prior to screening all of the preparations, the soluble 
cercarial antigen preparation (SCP) and the classic PAMP LPS were used to optimise the 
culture conditions for in vitro stimulation of Mý cytokine production. These studies were 
based upon the detection of EL-12p4O and EL-6 in the supernatant of the cultured cells, 
following overnight stimulation with SCP or LPS. 
3.3.2.1 MO concentration, schistosome PAMP concentration, and IFN7 concentration 
From initial studies, it was shown that the optimal Mý concentration was Ix 106 cells / ml 
for EL- I 2p4O production but 2x 106 cells / ml for IL-6 production (data not shown). Since 
limited numbers of cells were obtainable from a single mouse, 1X 106 cells / ml were used 
in further experiments. Titration of IFN7 demonstrated that 5U/ ml primed Mý for 
optimum IL- I 2p4O production in response to PAMP stimulation, and the optimal 
concentration of SCP using both Mý and IFN7-primed Mý (IFN7-Mý) was 50 [Ig / ml 
(data not shown). Therefore, these concentrations were used when comparing the 
stimulatory properties of the different schistosome preparations. 
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3.3.2.2 Kinetics of cytokine production in response to schistosome PAMPs 
Kinetics of cytokine production by both iMý and EFN7-Mý were studied in response to 
stimulation with the cercarial preparation, SCP, the released preparation, 0-3hRP, and the 
concentrated-media control for 0-3hRP (RPMlc). IL-12p4O was detectable in the 
supernatant of iMý as early as 3 hr post-stimulation with 0-3hRP, and 6 hr post-stimulation 
with SCP (Figure 3.3a). Moreover, the levels of EL-12p4O detected in iMý supernatants in 
response to stimulation with either parasite preparation appeared to reach a plateau by 6 hr. 
In contrast, EL- 1 2p4O production by IFN7-MO continued to increase with time up to the 
final time-point (Figure 3.3b). Dramatically greater levels of IL-12p4O were produced by 
IFN7-MO, than by iMO, in response to stimulation with SCP or 0-3hRP (Figure 3.3a & b; 
note difference in y-axis scale). 
EL-6 production by iMý showed a similar pattern to that of IIL- I 2p4O, reaching a plateau by 
6 hr post-stimulation (Figure 3.3c). However, an increase in EL-6 production over 
background levels was detectable by I hr post-stimulation. IFN7-priming of Mý had little 
effect on the kinetics of IL-6 production following stimulation with either parasite 
preparation (Figure 3.3d). Moreover, in contrast to EL-12p4O production, priming of iMý 
with IFN7 had a little effect on the levels of IL-6 produced. Indeed, when the responses of 
Mý from individual mice (n = 3) were compared, priming with EFN7 did not significantly 
(p > 0.05) effect the levels of EL-6, but significantly increased the levels of IL-l2p4O (P < 
0.05) produced in response to SCP (data not shown). 
IL- 10 was also detectable in the supernatants of Mý stimulated with 0-3hRP, although not 
in response to SCP (Figure 3.3 e). The production of EL- 10 was detectable by 3 hr post- 
stimulation, from which point the levels increased, reaching a plateau by 6 hr. In contrast 
to its effects upon Mý production of IL- I 2p4O, IFNy-priming abolished IL- 10 in response 
to 0-3hRP (Figure 3.3f). 
It is important to note that compared to the stimulatory properties of 0-3hRP, the 
concentrated medium control (RPMIc) had no stimulatory effect upon IL- 1 2p4O, EL-6, or 
EL- 10 production by Mý or IFN7-MO (Figure 3.3). 
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Analysis of later time points showed that detectable EL- I 2p4O from Mý stayed at a plateau 
up to 48 hr post-stimulation with either preparation (Figure 3.4a). In contrast, the levels of 
IL- I 2p4O detected in IFNy-Mý supernatants continued to rise with time, failing to reach a 
plateau by 48 hr post-stimulation (Figure 3.4b). The levels of EL-6 detected in response to 
either parasite preparation, in both Mý and IFNy-Mý supernatants, remained static 
between 6 to 48 hr post-stimulation (Figure 3.4c & d). Detectable EL- 10 in the supernatants 
of Mý stayed at a plateau until 24 hr, after which the level decreased (Figure 3.6e). The 
dramatic inhibitory effects of IFNy-priming upon IL- 10 production by Mý appeared to be 
transient, since 48 hr after stimulation with 0-3hRP, EL- 10 could be detected in the 
supernatants (Figure 3.4f). In addition, low levels of TNF(x from Mý stimulated with 0- 
3hRP only, could be detected at the earlier time points (6 and 12 hr) (data not shown). In 
contrast, IL- IP was only detectable at 24 hr and 48 hr post-stimulation with 0-3hRP (data 
not shown). IFNy-activation of Mý dramatically increased production of TNF(x in response 
to 0-3hRP, peaking later at 12 hr, but still detectable up to 48 hr, whereas EFN7 had little 
effect on EL- IP production (data not shown). Therefore, all subsequent analyses were 
confined to detection of cytokine production at 18 hr, and restricted to EL-12p4O, IIL-6 and 
IIL_ 10. 
3.3.3 Material released by schistosomes stimulates Mý cytokine production 
independently of naturally-occurring endotoxin 
Analysis of the kinetics of iMO and IFNy-MO cytokine production showed that for all 
cytokines tested, 0-3hRP consistently stimulated much higher levels of production than 
SCP (Figure 3.3 and 3.4). Analysis of these parasite preparations using the LAL assay 
showed that they contained low levels of naturally-occurring endotoxin (Section 2.3.2). In 
addition, there was considerably more endotoxin within 0-3hRP, than in SCP. Therefore, 
this leads to the hypothesis that the stimulatory properties of these preparations may be due 
to levels of endotoxin contained within them. Thus, two approaches to deten-nine the 
stimulatory effects of the parasite preparations independently of endotoxin were explored. 
Firstly, the major active component of endotoxin is lipopolysaccharide (LPS), the 
stimulatory properties of which are well known to be inhibited by the antibiotic Polymyxin 
B (PMB) (Haranaka et al., 1984; Iwagaki et al., 2000). Therefore, PMB was used to 
determine the stimulatory properties of the parasite preparations in the absence of LPS 
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signalling. Secondly, the most potent types / strains of LPS are known to stimulate innate 
cells through TLR4 (reviewed by Netea et al., 2002). Therefore, the stimulatory properties 
of the different parasite preparations were determined in the absence of signalling by 
endogenous LPS using Mý from C3H/HeJ mice that lack the functional TLR4 gene 
(Poltorak et al., 1998). 
3.3.3.1 PMB inhibits the stimulatory properties ofLPS in a dose-dependent manner, whilst 
not affecting cellfunction, or viability. 
Dose-response assays were performed in order to determine the most effective 
concentration of PMB to block the stimulatory properties of quantities of LPS similar to 
that within 0-3hRP. Using the LAL assay, it was determined that LPS from E. coli strain 
0 11 I: B4 had an activity of 4 EU / ng (Section 2.3.2). Thus, 0.1 and I ng / ml of LPS (0.4 
and 4 EU / ml, respectively), were used to test the effectiveness of PMB to block the 
stimulatory properties of endotoxin. 
LPS stimulated low levels and high levels of dose-dependent EL- 12p4O production by Mý 
and IFNy-primed Mý, respectively (Figure 3.5a & b). Addition of PMB inhibited the 
stimulatory properties of LPS, also in a dose-dependent manner. Indeed, 0.1 ýtg / ml and 
greater levels of PMB completely blocked EL- I 2p4O production stimulated by 0.1 ng / ml 
LPS, whereas I- 10 ýtg / ml PMB completely blocked IL- I 2p4O production stimulated by 
I ng / ml LPS. Addition of PMB had no effect on EL- 1 2p4O production by resting cells, 
with no cytokine detected at any of the PMB concentrations. 
A similar trend in IL-6 production by Mý and IFNy-Mý in response to LPS and PMB was 
observed (Figure 3.5c & d). Again, 0.1 ýtg / ml of PMB was enough to block cytokine 
production in response to the lowest concentration of LPS. However, 10 ýtg / ml was 
needed to completely block the higher concentration of LPS. From this data, it was decided 
that in all subsequent experiments PMB would be used at concentrations between I and 10 
ýtg / ml in order to block the stimulatory properties of endotoxin present within the 
schistosome preparations. 
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It has been shown that PMB can stimulate innate accessory cells, such as human 
monocytes (Hogasen and Abrahamsen, 1995), to produce cytokines. However, in my study 
this effect was not evident using Mý or 11`Ny-Mý cultured with 0.0 1- 10 ýig / ml of PMB 
(Figure 3.5a - d). In addition, low levels of PMB (0.2 - 20 [tg / ml) had no effect on cell 
viability (data not shown), demonstrating that the concentrations of PMB to be used in 
further assays (I - 10 ýig / ml) are not cytotoxic to Mý. 
It has also been shown that high levels of PMB can synergise with pro-inflammatory 
stimuli to further stimulate monocyte production of cytokines (Cavaillon and Haeffner- 
Cavaillon, 1986). Therefore, PMB could potentially synergise with schistosome PAMPs 
within the parasite preparations if PMB was used to block the stimulatory properties of the 
endogenous endotoxin. Therefore, it was important to determine if low levels of PMB 
interfere with the stimulatory properties of PAMPs other than LPS. In this respect, 
Zymosan A (a yeast PAMP preparation) stimulated dose-dependent IL- I 2p4O production 
by Wý, which remained unaffected by the presence of PMB (Figure 3.6). 
3.3.3.2 O-ARP retains its stimulatory properties in the presence of PMB. 
The two strategies to determine the stimulatory properties of schistosome preparations in 
the absence of endotoxin signalling were combined. Thus, cytokine production by Nlý 
from 'LP S -responsive' C3H/HeN mice was compared to that of Mý from 'LPS- 
unresponsive' C3H/HeJ mice, in response to stimulation with schistosome preparations in 
the presence of increasing concentrations of PMB. 
The stimulatory properties of 0-3hRP were compared to a concentration of LPS (I ng / ml) 
shown to have twice the quantity of endotoxin activity, as that calculated to be in 0-3hRP. 
Neither LPS, nor 0-3hRP, stimulated iMý from 'LPS-responsive' C3H/HeN mice to 
produce detectable levels of EL-12p4O (Figure 3.7a). Moreover, neither LPS, nor 0-3hRP 
stimulated IL- I 2p4O production by iMý 'LPS -unresponsive' C3H/HeJ (Figure 3.7b). In 
contrast, LPS stimulated high levels of EL-6 production by C3H/HeN iMý (Figure 3.7c). 
However, this was dramatically reduced by the addition of PMB, with I ýIg / ml PMB 
causing aI 0-fold decrease and 10 ýtg / ml causing a 90-fold decrease in the levels of IL-6 
detected. In comparison, 0-3hRP stimulated lower levels of EL-6 than LPS but these 
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properties were only slightly reduced (1.6 fold) by the addition of I ýtg / ml PMB. 
Moreover, a higher concentration of PMB (10 [tg / ml) had no ftirther effect on IL-6- 
inducing capacity of 0-3hRP. 
LPS stimulated I O-fold less IL-6 from C3H/HeJ Mý, compared to C3H/HeN Mý (Figure 
3.7d). This low level of IL-6 could be further reduced up to 5-fold by addition of PMB- In 
contrast, responses to 0-3hRP were only slightly reduced (1.5 fold) in Mý from C3H/HeJ 
compared to C3H/HeN, and subsequent addition of PMB had no effect upon these 
stimulatory properties (Figure 3.7d). It is important to note that in the presence of PMB, 0- 
3hRP appeared to stimulate the same amount of IL-6 from both C3H/HeN and C3H/HeJ 
iMO (Figure 3.7c & d). 
When IL-10 production from C3H/HeN iMý was analysed, the highest concentration of 
PMB completely inhibited the stimulatory properties of LPS, whereas 0-3hRP remained 
unaffected (Figure 3.7e). However, in contrast to IL-6 production, 0-3hRP stimulated 
higher levels of IL-10 than LPS, in the absence of PMB. Moreover, the production of IL- 
10 in response to 0-3hRP remained unaffected by addition of PMB. No EL-10 production 
by C3H/HeJ iM+ was detected in response to LPS, whereas 0-3hRP stimulated a low but 
detectable amount of IL- 10, which was not inhibited by the addition of PMB (Figure 3.7f). 
However, the levels of IL-10 production by C3H/HeJ iM+ in response to 0-3hRP were 
more than 4-fold less than that produced by C3H/HeN iM+ (Figure 3.7e & f). 
In a parallel experiment was performed using IFNy-MO from each mouse strain, elevated 
levels of IL- I 2p4O were detected after stimulation with LPS and 0-3hRP (Figure 3.8a & b). 
However, the stimulatory properties of LPS but not 0-3hRP, were ablated by addition of 
PMB (Figure 3.8a & b). The stimulatory properties of LPS were greater than that of 0- 
3hRP, when using IFNy-MO from C3H/HeN mice (Figure 3.8a). However, the response to 
LPS was dramatically lower (13-fold), using IFNy-MO from C3H/HeJ mice (Figure 3.8b). 
The response to 0-3hRP was also considerably reduced for IFNy-Mo from C3H/HeJ mice 
(5-fold), but the fold decrease was not as great as for LPS. 
The pattern of IL-6 production by IFNy-MO was very similar to that of iMO (Figures 3.7 c 
&d and 3.8c & d). However, the amount of EL-6 produced in response to 0-3hRP in the 
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presence of PMB was lower in C3H/HeJ cell-cultures compared to C3H/HeN cell-cultures, 
although this was less than a 2-fold reduction (Figure 3.8c & d). In addition, priming with 
EFNy had a different effect upon the levels of EL-6 produced in response to both 0-3hRP 
and LPS between the two cell types. In this respect, EFNy-Mý from C3H/HeN mice 
produced up to 4-fold more IL-6 than their iMO counterparts, whereas IFNy-Mý from 
C3H/HeJ mice produced only 2-fold more IL-6 than WO (Figures 3.7 c&d and 3.8c & d). 
In contrast to Mý, no detectable IL- 10 was produced by IFNy-Mý from either C3 H/HeN 
or C3H/HeJ mice in response to any stimuli (Figure 3.8e & f). 
Cytokine responses by Mý and IFNy-M+ from C57BI/6 mice followed a similar pattern to 
that produced by the respective C3H/HeN Nlý (Figure 3.9). 
3.3.4 Molecules released by schistosomes but not soluble preparations of whole 
larvae, are stimulatory for cytokine production by Mý. 
Having detennined the stimulatory properties of 0-3hRP in the absence of signalling by 
contaminating endotoxin, the stimulatory properties of all early skin-stage schistosome 
preparations were compared in a set of parallel experiments. 
None of the soluble schistosome preparations stimulated detectable production of IL-12p4O 
by iMý from either C3H/HeN or C3H/HeJ mice (Figure 3.1 Oa. & b). However, 0-3hRP 
stimulated much higher levels of IL-6 and IL-10 production by iMý from either mouse 
strain than any of the other schistosome preparations (Figure 3.1 Oc - f). Indeed, of all the 
soluble whole parasite preparations (SCP, 3hSSP, and 18hSSP), only the cercarial 
preparation SCP stimulated an increase in EL-6 production by C3H/HeN iMý, which was 
partially inhibited by addition of PMB (Figure 3.1 Oc). Moreover, SCP stimulated only very 
low levels of IL-6 production by C3H/HeJ (Figure 3.1 Od). None of the soluble whole 
parasite preparations stimulated any detectable IL- 10 production (Figure 3.1 Oe & f). 
The response of IFNy-Mý to the different preparations was similar to the response by IMý 
(Figure 3.11 a- f), with 0-3hRP being the only preparation to stimulate IL- I 2p4O and IL-6 
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production by cells from either mouse strain in the presence of PMB (Figure 3.11 a- d). No 
EL- 10 was detectable in any of the supernatants of the EFNy-Mý (Figure 3.11 e- f). 
This pattern of cytokine production was mimicked when Mý and IFNy-Mý from C57BI/6 
mice were used in this assay with 0-3hRP but not soluble whole parasite preparations 
stimulating high levels of IIL- I 2p4O, IL-6, and IIL- 10 in the presence of PMB (Figure 3.12). 
3.3.5 0-3hRP stimulates a different cytokine profile to other pathogen PAMPs 
From this point onwards, a different source of thioglycollate (Brewers Thioglycollate; 
Sigma-Aldrich; 3% final concentration), was used to elicit Wý into the peritoneal cavity. 
This resulted in greater numbers of PEC obtainable from individual mice (18 x 106 ± 2.1 x 
106 ;n= 3) compared to the original thioglycollate (7.1 X 106 + 0.4 x 106 ;n= 3). The 
adherent Mý elicited by 3% Brewers thioglycollate were slightly purer for the Mý markers 
F4/80 (87%) and CDI lb (92%; data not shown) when compared to the Mý elicited by the 
original thioglycollate (Figure 3.2). Functionally, these Mý produced lower levels of IL- 
10 and EL-6 in response to a range of stimuli (data not shown). 
0-3hRP is unique amongst the parasite preparations in its ability to stimulate Mý 
production of IL- 10, EL- 1 2p4O, and high levels of IIL-6. In order to more ftilly characterise 
the response to 0-3hRP, its stimulatory properties were compared to those of other 
pathogen PAMPs, representing bacteria (LPS), and yeast (Zymosan A). The two pathogen 
PAMPs were chosen due to their recognition by innate cells through different receptors, 
with LPS signalling largely through the TLR4 (Poltorak et al., 1998), and Zymosan A 
signalling through a TLR2-dependent pathway (Underhill et al., 1999b). 
Zymosan A appeared to stimulate production of the highest levels of EL- I 2p4O of all the 
PAMPs (Figure 3.13a). LPS also stimulated considerable amounts of EL-12p4O, whereas 0- 
3hRP + PMB stimulated only a little. In contrast, LPS stimulated the highest levels of EL-6 
(Figure 3.13b). 0-3hRP also stimulated high-level EL-6 production, which was much 
greater than the very low levels stimulated by Zymosan A. 
Similar to EL-6, LPS stimulated 
the highest levels of IL-10 (Figure 3.13c). 0-3hRP also stimulated IL-10, but this was low, 
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and like the production of IL-12p4O, it bordered on the lower limit of detection of the 
ELISA. In contrast, Zymosan A did not stimulate production of detectable IL- 10 
The batches of 0-3hRP tested here contained between 0.5 - 17.7 EU per 50 ýtg of protein, 
equivalent to 0.125 - 4.4 ng of LPS. To control for endotoxin, parallel cultures of Mý 
stimulated with LPS and PMB were performed. In all experiments, 1,3 and 10 ng / ml LPS 
stimulated higher levels of IL- I 2p4O, IIL-6 and IIL- 10 than 0-3hRP + PMB (data not 
shown). However, detectable cytokine production in response to all concentrations of LPS 
was completely inhibited by addition of PMB at 3 ptg / ml (data not shown). 
3.3.6 The J774A. 1 and J7. DEF. 3 Mý cell-lines do not respond to stimulation with 
schistosome PAMPs. 
The J774A. 1 Mý cell-line and the derivative J7. DEF. 3 line that lacks expression of surface 
CD14 were used to further study Mý responses to schistosome PAMPs and analyse the 
role of CD14 in parasite recognition. Since CD14 is a PRR known to be involved in the 
recognition of LPS (Perera et al., 2001), the response of these cell-lines to LPS was 
initially characterised. LPS (24 - 2000 ng / ml) stimulated dose-dependent production of 
IL- 12p4O by J774A. I cells (Figure 3.14a). However, at the lower levels of LPS (< 24 ng 
ml) production of IL-12p4O was not detected. A non-toxic and non-stimulatory quantity of 
PMB (10 ýtg / ml; data not shown) completely inhibited the production IL- I 2p4O by 
J774A. I cells in response to up to 74 ng / ml LPS, and considerably reduced the 
stimulatory properties of concentrations of LPS higher than this. J7. DEF. 3 cells also 
produced IL- 1 2p4O in an LPS dose-dependent manner (Figure 3.14a). However, in 
comparison to J774A. I cells, J7. DEF. 3 cells produced much less EL- 1 2p4O in response to 
74 - 666 ng / ml LPS, but similar quantities in response to 24 and 2000 ng / ml LPS. 
Moreover, in the presence of PMB, only the highest concentration of LPS (2000 ng / ml), 
could stimulate detectable production of EL-12p4O from J7. DEF. 3 cells compared to 222 
ng / ml LPS when using J774A. I cells. 
Similar to the pattern of IL- I 2p4O production, both J774A. I and J7. DEF. 3 cells produced 
IL-6 in a LPS dose-dependent manner (Figure 3.14b), although J7. DEF. 3 cells were less 
sensitive, producing lower levels of IL-6 than J774A. I cells, and only to ý! 74 ng / ml LPS 
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compared to ý! 24 ng / ml for J774A. I cells. Again, PMB inhibited production of EL-6 in 
response to up to 74 ng / ml LPS for J774A. I cells and 666 ng / ml LPS for J7. DEF. 3 cells, 
and reduced levels of IL-6 production in response to higher levels of LPS (Figure 3.14b). 
In comparison to LPS, none of the schistosome preparations, whether in the presence or 
absence of PMB, stimulated J774A. I cells to produce detectable levels of IL- I 2p4O or IL-6 
(Figure 3.14c & d). For this reason, the effect of schistosome preparations on J7. DEF. 3 
cells was not examined. 
iMý primed with IFNy produced greatly increased levels of IIL- I 2p4O when stimulated 
with schistosome PAMPs (Section 3.3.1 - 3.3.4). Therefore, an optimal concentration of 
EFN7 was used to prime J774A. I and J7. DEF. 3 cells during stimulation with LPS, or 
schistosome preparations. IIFNy-primed J774A. I cells were more sensitive to stimulation 
with LPS, producing detectable levels of EL-12p4O and IL-6 in response to as little as 0.9 
ng / ml LPS (Figure 3.15 a& b), when compared to non-primed cells (Figure 3.14a & b). 
Moreover, EFNy-primed J7. DEF. 3 cells were also more sensitive to stimulation with LPS, 
producing detectable EL-12p4O in response to as little as 0.9 ng / ml LPS (Figure 3.15a) 
and detectable EL-6 in response to as little as 2.7 ng / ml LPS (Figure 3.15b). Indeed, EFNy- 
primed J7. DEF. 3 cells produced more EL-12p4O in response to 0.9 - 2000 ng / ml LPS than 
the respective J774A. I cells, whereas in the presence of PMB the IL- I 2p4O production was 
similar for the different cell types across the range of LPS concentrations (Figure 3.15a). In 
contrast to IL- I 2p4O production, both cell types when primed with IFNy produced similar 
levels of IL-6 in response to a range of LPS concentrations, whereas in the presence of 
PMB, EFNy-primed J774A. I cells produced more IL-6 than the respective J7. DEF. 3 cells 
(Figure 3.15b). 
0-3hRP stimulated detectable production of EL- I 2p4O by IFNy-primed J774A. I cells, 
whereas the soluble whole larval preparations SCP, 3hSSP and l8hSSP remained non- 
stimulatory (Figure 3.15c). Similarly, 0-3hRP, but not the soluble whole larval 
preparations, stimulated detectable production of EL-12p4O by IFNy-primed J7. DEF. 3 cells 
(Figure 3.15c). Compared to IFNy-primed J774A. I cells, IFNy-primed J7. DEF. 3 produced 
more IL- I 2p4O in response to stimulation with 0-3hRP, as observed in response to LPS. 
However, in the presence of PMB, 0-3hRP failed to stimulate detectable production of IL- 
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12p4O by J774A. I or J7. DEF. I cells. It is important to note that the 0-3hR-P introduced 
approximately 0.5 ng / ml LPS into the cell culture, and in the absence of PMB 0-3hRP 
stimulated approximately the same amount of ELI 2p4O as 0.9 ng / ml LPS, by either 
J774A. I or J7. DEF. 3 cells (Figure 3.15a & c). 0-3hRP also stimulated PMB-sensitive IL-6 
production by IFNy-primed J774A. I cells, whereas the whole larval preparations remained 
non-stimulatory (Figure 3.15d). In contrast, none of the schistosome preparations 
stimulated detectable EL-6 production by IFNy-primed J7. DEF. 3 cells. Again, this pattern 
of cytokine production was similar to that seen in response to an equivalent concentration 
of LPS (0.9 ng / ml) to that contained within the 0-3hRP (Figure 3.15b & d). 
3.3.7 Live schistosomes stimulate Mý cytokine production 
As soluble preparations of cercariae and in vitro cultured schistosomulae do not stimulate 
high or detectable levels of cytokine production by Mo, this raises the question of whether 
live larvae can stimulate cellular responses, and if so, whether this is dependent upon the 
PAMPs released by the parasite. Infective cercariae (CercN) stimulated a dose-dependent 
increase in IL-6 production by iMO (Figure 3.16). Indeed, as few as 50 cercariae / well 
stimulated an increase in detectable EL-6 over background. However, cercariae that had 
been transfonned immediately prior to co-culture with the iMO (CercT) stimulated between 
1.3- and 2-fold more IL-6 compared to CercN (Figure 3.16). No IL-12p4O or EL-10 was 
detected in any of the wells (data not shown). 
The stimulatory properties of the transformed cercariae were then compared to those of its 
components parts (i. e. the material released by the parasite during the first 3 hr post- 
transformation [0-3hSN] and the 3 hr larval heads and tails, devoid of this released 
material, 3hSom). The 3hSom stimulated increased IIL-6 production over background, at 
100 and 200 but not 50 parasites / well (Figure 3.17). However, the levels of IL-6 produced 
were considerably less than detected in response to freshly transformed cercariae. In order 
to determine if the difference in stimulatory properties of 3hSom and CercT was due to the 
absence of the released molecules, 0-3hSN was assayed for its stimulatory capacity. 0- 
3hSN also stimulated an increase in detectable IL-6 over background levels at quantities 
equivalent to 100 or 200 but not 50 parasites / well (Figure 3.17). Again, these stiMulatory 
properties were less than that of transformed cercariae but similar to 3 hr larvae and tails. 
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Therefore, the amount of EL-6 production stimulated by both 0-3hSN combined with the 
3hSom, approximately equalled that stimulated by freshly transformed cercariae (CercT). 
Notably, the levels of IIL-6 produced in response to 0-3hSN were much lower than 
produced in response to the concentrated soluble preparation 0-3hRP (see Figure 3.13b). 
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Figure 3.1 PEC and adherent PEC populations differ in cellular composition. 
PEC were extracted from mice 5 days post-injection with 0.09% thioglycollate, and 
analysed as the whole population (i). Alternatively, PEC were incubated in tissue 
culture grade plastic for 2 hr, at 37 T. The non-adherent population was 
subsequently discarded and the 'adherent' population resuspended and analysed (11). 
Flow-cytometry was used to analyse the size and granularity of all cells (a). Cells 
were stained with CD45-specific Cy-Chrome'-"-conjugated antibody (red line) or an 
appropriate isotype control (blue line), and the percentage positive for CD45 
determined (b). Alternatively, the size and granularity of CD45- cells was determined 
(c). Analysis was based on 10,000 cells (b) or 10,000 CD45- cells (a & c). The 
population (B) was comprised of dead cells as determined by PI staining. 
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Figure 3.2 The adherent PEC population is highly enriched for Mý. 
PFC were cultured for 2 hr in 24-well culture plates (I x 101), after-which 
non-adherent cells were washed off and discarded. The remaining 
adherent population (A) was removed and the size and granularity ofthe 
cells determined (a). Alternatively, cells were stained with specific 
antibodies (red line) to CD45 (b), F4/80 (c) or CDI Ib (d), or with 
appropriate isotype control antibodies (blue line). The dead cell 
Population (13) was determined by PI staining, and gated-out of surface- 
inarkcr analysis (A-13). Data is representative of a minimum of 3 
experiments. 
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Figure 3.3 Kinetics of cytokine production by M+ stimulated with 
different schistosome PAMPs. iM+ (a, c, e), or IFNy-M+ (b, d, f), were 
cultured with SCP (M; 50 gg / ml), 0-3hRP (*; 50 gg / ml), RPMIc (x), or 
alone (*), for varying lengths of time (0 - 12 hr). Supernatants from 
triplicate wells of a 96-well plate were pooled and analysed by ELISA for 
production of IL- I 2p4O (a & b), IL-6 (c & d), or IL- 10 (e & f). Arrows 
indicate the lower detection limit of the ELISA. 
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Figure 3.4 Kinetics of cytokine production by Mý stimulated with 
different schistosome PAMPs. Mý (a, c, e), or IFN7-Mý (b, d, f), were 
cultured with SCP (M; 50 ýig / ml), 0-3hRP (0; 50 ýtg / ml), RPMlc (x), or 
alone (*), for varying lengths of time (6 - 48 hr). Supernatants from 
triplicate wells of a 96-well plate were pooled and analysed by ELISA for 
production of IL-12p4O (a & b), IL-6 (c & d), or IL-10 (e & f). Arrows 
indicate the lower detection limit of the ELISA. 
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Figure 3.5 PMB blocks the stimulatory properties of LPS. Mý (a & c), 
or IFNy-Mý (b & d), were cultured overnight with 0 (*), 0.1 (0), or 1 
(40), ng / ml LPS and the indicated concentrations of PMB (0 - 10 ýIg / 
ml). Supernatants from triplicate wells of a 96-well plate were pooled and 
analysed by ELISA for production of IL- I 2p4O (a & b), or IL-6 (c & d). 
Arrows denotes the lower detection limit of ELISA. 
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Figure 3.6 Effect of PMB on cytokine production by Mý after culture 
with Zymosan A. Mý were cultured overnight with different 
concentrations of Zymosan A (0 -5 Vtg / ml) with (clear bars), or without 
(solid bars), PMB (3 ýtg / ml). Supernatants from triplicate wells of a 96- 
well plate were pooled and analysed by ELISA for production of IL- 
12p4O. Dashed line denotes the lower detection limit of ELISA. Data is 
representative of 2 experiments. 
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Figure 3.7 Mutation in TLR-4, or co-culture with PMB, have different 
effects on iMý cytokine production when stimulation with schistosome 
PAM Ps is compared to LPS. 1Mý from C31 1/1 IcN 'ITS-responsi ve' (a, 
c, e), or C3H/HeJ 'LPS-unresponsive mice' (b, d, 1), were cultured 
overnight alone, or with LPS (I ng / ml), or 0-3hRI) (50 [ig / nil). in the 
presence of 0 (black bars), I (grey bars), or 10 (white bars), pg // ml I'M B. 
Endotoxin content of 0-3hRP :! ý endotoxin content of I ng // nil ITS, as 
judged by LAL assay. Supernatants from triplicate wells ol'a ()6-\, 'Vcll plaic 
were pooled and analysed by ELISA for production ot'l I, I 2p4O (a & b), 
IL-6 (c & d), and IL-10 (e & f). Data is representative oI'2 experiments. 
Arrows indicate the lower limit of detection of the ELISA. 
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Figure 3.8 Mutation in TLR-4, or co-culture with PMB, have different 
effects on IFNy-Mý cytokine production when stimulation with 
schistosome PAMPs is compared to LPS. ll`Ny-Mý froin (")11/1 IcN 
'ITS-responsive" (a, c, e), or C3H/IIeJ 'ITS-unresponsive micc' (h, (1,1), 
were cultured overnight alone, or with LPS (I ng / nil), or 0-31iRP (50 pg/ 
ml), in the presence of 0 (black bars), I (grey bars), or 10 (whitc bars), ýig 
/ ml PMB. Endotoxin content of 0-3hRP:! ý endotoxin content of I iig / iIII 
LPS, asjudged by LAL assay. Supernatants from triplicate "ells ofii 90- 
well plate were pooled and analysed by ELISA I'Or production oHL- 121140 
(a & b), IL-6 (c & d), or 11,10 (e & f). Data is representative of-1 
experiments. Arrows indicate the lower limit ofdctcctIon oftlic 
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Figure 3.9 PMB has different effects on Mý cytokine production when 
stimulation with schistosome PAMPs is compared to LPS. C57BI/6 
iMý, or IFNy-Mý, were cultured overnight alone, or with LPS (I ng / ml), 
or 0-3hRP (50 pg / ml), in the presence of 0 (black bars), I (grey bars), or 
10 (white bars), pg / ml PMB. Endotoxin content of 0-3 hRP :! ý endotoxin 
content of I ng / ml LPS. Supernatants from triplicate wells of a 96-well 
plate were pooled and analysed by ELISA for production of IL-12p4O (a 
& b), IL-6 (c & d), and IL- 10 (e & f). Arrows indicate the lower limit of 
detection of the ELISA. No bar means data point was not perfon-ned. 
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Figure 3.10 In the presence of PNIB, O-ARP but not other soluble 
schistosome preparations, stimulates cytokine production by Mý 
from both LPS-responsive and LPS-unresponsive mice. Peritoncid M(ý 
from C311/HeN (a, c, e), or C3[1/rleJ (b, d, e), were cultured overnight 
alone, or with the different parasite preparations indicated (50 pg /nil), and 
in the presence (clear bars), or absence (black bars) MAIM ( 10 ýtg / in I). 
Supernatants from triplicate wells of a 96-well plate were pooled ýInd 
analysed by ELISA for production of ll, - I 2p4O (a & b), IL-6 (c & d), and 
IL- 10 (e & f). Dashed line denotes the lower level ot'de1cction ofl ýH SA. 
Data is representative of 2 experiments. 
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Figure 3.11 In the Presence of PMB, 0-3hRl" but not other soluble 
schistosome preparations, stimulates cytokine production by I FNY-Mý 
from both LPS-responsive and LPS-un responsive mice. ll, 'Ny-M(O from 
C311/1-JeN (a, c, e), or C31111-IeJ (b, d, f). were cultured ovenilght alone. m- 
with the different parasite preparations indicated (50 pg /ml), ýind In the 
presence (clear bars), or absence (black bars) ofPM B( 10 ýtg // in 1). 
Supernatants from triplicate wells of a 96-well plate were pooled '111d 
analysed by FLISA for production oHlA -2p40 (a & 
b). IL-6 (c & d). or 
IL-10 (e & f). Dashed line denotes the lower level ot'delection ()I* 1-11"A. 
Data is representative of 2 experiments. 
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Figure 3.12 In the presence of PMB, 0-3hRP but not other soluble 
schistosome preparations, stimulates cytokine production by both Mý 
and IFN7-Mý from C57131/6 mice. Mý (a, c, e), or IFNy-Mý (b, d, f), 
were cultured overnight alone, or with the different parasite preparations 
indicated (50 ýtg / ml), in the presence (clear bars), or absence (black bars) 
of PMB (10 [tg / ml). Supernatants from triplicate wells of a 96-well plate 
were pooled and analysed by ELISA for production of IL- 12p4O (a & b), 
IL-6 (c & d), or IL-10 (e & f). Arrows denote the lower level of detection 
of ELISA. 
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Figure 3.13 0-3hRP stimulates a different profile of iMO cytokine 
production compared to other pathogen PAMPs. Mo from C57131/6 
mice were cultured overnight alone, or with 0-3hRP (50 [tg /ml) plus PMB 
(3 ýtg / ml) (n = 11), LPS (I ng / ml) (n = 3), or Zymosan A (1.6 ýtg / ml) 
(n = 2). Supernatants from triplicate wells of a 96-well plate were pooled 
and analysed by ELISA for production of IL- 12p4O (a), IL-6 (b), or IL- 10 
(c). Data is presented as mean ± SEM of three experiments, except for 
Zymosan A where n=2. Within each individual experiment up to 6 
batches of 0-3hRP were tested, and contribute to the mean. Dashed line 
denotes the lower limit of detection of ELISA. 
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Figure 3.14 LPS but not schistosome PAMPs, stimulates cytokine 
production by the J774 M+ cell-line, a property which is semi- 
dependent on expression of CD14. J774 cells ( 0, a&b; white bars, c& 
d), or the equivalent CD I 4-deficient J7. DEF. 3 cells (0, a&b; grey bars, c 
& d), were cultured overnight with LPS (0.1 - 2000 ng / ml), or different 
schistosome preparations (50 j_tg / ml), in the presence (dashed lines, a& 
b; hatched bars, c& d), or absence (solid lines, a&b; solid bars, c& d), 
of PMB (10 pg / ml). Supernatants from triplicate wells of a 96-well plate 
were pooled and analysed by ELISA for production of IL- I 2p4O (a & c), 
or IL-6 (b & d). Arrows denote the lower limit of detection of ELISA. 
Data is representative of up to 3 experiments. n. d. = not done. 
114 
0.1 1 10 100 1000 10000 
LPS ng 1 .1 
IL-12p4O b. IL-6 
1000 1000 
100 100 
10 lo 
1 1 
0.1 
01 0.01 -0001+ 011 10 100 1000 10000 
0.1 
LPS ng I ml 
10 100 1000 10000 
LPS ng I mi 
IL-12p4O d. IL-6 
1000 1000 
J774A. 1 
100 9 J774A. 1+ PM B 100 
lo Ej R. DEF. 3 10 
0 R. DEF. 3 + PMB 
1 
0.1 
0.01 
0,3hRP SCP 3hSSP 18hssp 
[-ý J774A, I 
0 J774A. 1+ PM B 
m R. DEF 3 
M J7 DEF 3+ PMB 
Oý3hRP SCP 3hSSP l8hSSP 
Figure 3.15 LPS but not schistosome PAMPs, stimulates cytokine 
production by IFNy-primed J774 Mý cell-line, a property which is not 
dependent on expression of CD14. J774 cells ( 0, a&b; white bars, c& 
d), or the equivalent CD14-deficient J7. DEF. 3 cells (0, a&b; grey bars, c 
& d), were cultured overnight with IFNy (I U/ ml), and LPS (0.1 - 2000 
ng / ml) or different schistosome preparations (50 Vtg / ml), in the presence 
(dashed lines, a&b; hatched bars c& d), or absence (solid lines, a&b; 
solid bars, c& d), of PMB (10 ýtg / ml). Supernatants from triplicate wells 
of a 96-well plate were pooled and analysed by ELISA for production of 
IL- I 2p4O (a & c), or IL-6 (b & d). Arrows denote the lower limit of 
detection of ELISA. Data is representative of up to 3 experiments. 
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Figure 3.16 Mechanically-transformed cereariae are more stimulatory 
than untransformed cercariae. iNlý from C57131/6 were cultured 
overnight alone, or with different concentrations (50 - 200 parasites / well) 
of cercariae (CercN; *), or mechanical ly-transformed cercariae (CercT; 
E). All iNlý were cultured in the presence of PMB (3 ýtg / ml) throughout. 
Supernatants from triplicate wells of a 96-well plate were pooled and 
analysed by ELISA for production of IL-6. Dashed line denotes the lower 
limit of detection of ELISA. Data is representative of 2 experiments. 
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Fig re 3.17 The stimulatory properties of artificially-transformed 
cereariae are shared between the products released by larvae and the 
larval bodies. Mý from C57BL/6 mice were cultured overnight alone, or 
with different concentrations (50 - 200 parasites / well) of mechanically- 
transformed cercariae (CercT; 0), mechanically-transfon-ned cercariae 
that had been previously cultured in vitro for 3 hr (3hSom; 0), or the SN 
from the 3hr in vitro cultured cercariae (0-3hSN; *). All iMO were 
cultured in the presence of PMB (3 ýtg / ml) throughout. Mý supernatants 
from triplicate wells of a 96-well plate were pooled and analysed by 
ELISA for production of IL-6. Dashed line denotes lower level of 
detection of ELISA. Data is representative of 2 experiments. 
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3.4 DISCUSSION 
In this chapter, I have demonstrated that the soluble material released by transforming 
schistosome cercariae (0-3hRP) is a potent stimulator of IL-6 and IL- 10 production by iMý 
from a variety of mouse strains. Moreover, when administered in parallel with IFNy, 
0-3hRP stimulates high levels of the Th I -associated pro-inflammatory cytokine EL- I 2p4O. 
3.4.1 The Mý-based assay 
At the start of this investigation, considerable time was spent to validate and optimise the 
iMý-based assay used to screen the stimulatory capacity of schistosome PAMP 
preparations. From heterogeneous inflammatory PECs, a highly enriched iMý population 
was generated using adherence-based selection. The vast majority were large, highly 
granular, and expressed the MO markers F4/80 and CD I lb. Since the expression of these 
markers varies greatly with MO activation and maturation states (McKnight and Gordon 
1998), these results suggest that this technique generates a heterogeneous adherent MO 
population. Furthermore, numerous parameters (including concentration of cells, EFN7, and 
schistosome PAMPs) were optimised for in vitro stimulation of iMO cytokine production. 
The kinetics of EL-6, IL- 10, and EL- 1 2p4O production by iMO were shown to be 
approximately similar, all reaching peak levels by 6 hr post- stimulation and remaining at a 
plateau until at least 24 hr post-stimulation. Therefore, for ease of experimental design, 
further analysis of cytokine production was restricted to 18 hr post-stimulation. 
Due to the limited numbers of Mý obtainable from individual mice, cells from several 
animals were often pooled. Consequently, it was generally not possible to look at variation 
in cytokine production between individual mice. In addition, due to the limited availability 
of schistosome PAMPs, it was impracticable to analyse variance between stimulation 
regimes, since assays were restricted to triplicate wells for each treatment, and the volume 
of supernatant required for multiple cytokine ELISA's meant these wells were pooled. 
However, experiments were repeated several times, giving greater confidence in the data. 
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3.4.2 Schistosome PAMPs are concentrated within larval released material 
The highly stimulatory properties of 0-3hRP suggest this preparation is rich in schistosome 
PAMPs. In contrast, the soluble preparations of in vitro-cultured schistosomulae (SSPs) 
were non-stimulatory causing little, if any, EL-6, EL- 10, or IL- I 2p4O production by 1Mý or 
IFNy-Mý. This suggests that these preparations contain few stimulatory components. The 
physiological context in which innate immune recognition of schistosomes evolved may 
reflect the difference in the stimulatory properties of these preparations (0-3hRP versus 
SSPs). The schistosome components most visible to innate accessory cells will be those 
released by the parasite during migration through the skin (such as 0-3hRP), and larval 
surface molecules. In contrast, since more than 90% of parasites exit the skin during 
infection (Wilson and Coulson, 1986), the host accessory cells are unlikely to be exposed 
to their somatic larval molecules (likely to be the abundant components of the SSPs). 
Alternatively, it could be argued that some somatic molecules within the SSPs should be 
stimulatory due to possible homology with host 'Danger Signals' and other pathogen 
PAMPs, for example highly conserved Heat Shock Proteins (HSPs), or DNA (Section 
1.8.1 & 1.8.2). Therefore, the SSPs may also contain inhibitory components that 
antagonise any stimulatory PAMPs, resulting in net stimulatory properties that are 
undetectable. In contrast to SSPs, the preparation of whole cercariae (SCP) was observed 
to have some stimulatory properties. However, compared to 0-3hRP, these properties were 
low, often verging upon the undetectable. It seems likely that SCP will contain some 
stimulatory 0-3hRP components but are greatly diluted by non-stimulatory / inhibitory 
somatic constituents (Section 2.4). 
In addition to schistosome PAMP preparations, live parasites stimulated dose-dependent 
IL-6 production. Cercariae that were mechanical transformed (CercT) were twice as 
stimulatory as their non-transformed counterparts (CercN). The only physical difference 
between these two groups is the active release of head gland material and shedding of the 
glycocalyx by CercT, whereas CercN remained intact in culture not shedding their tails 
(data not shown). Moreover, the stimulatory capacity of CercT was split approximately I 
I between the material released into the SN during the first 3 hours of culture (0-3hSN), 
and 3 hr schistosomulae from which the 0-3hSN was removed (3hSom). This provides 
clear evidence that components within the released material can stimulate Mý cytokine 
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production. Although 0-3hSN released by 100 to 200 cercariae stimulated less EL-6 
production than concentrated 0-3hRP, it demonstrates that physiological levels of these 
released PAMPs remain stimulatory for WO cytokine production. It is noteworthy that the 
stimulatory nature of 3hSorn contrasts with the non-stimulatory nature of the soluble 
preparation 3hSSP. The apparent increase in stimulatory capacity of the live larvae could 
be due to the presence of membrane bound surface material present on the schistosomulae 
(Section 2.4). Alternatively, the material that these larvae continue to release into the 
supernatant following the first 3 hours of culture could account for this. 
3.4.3 Schistosome preparations contain PAMPs of larval origin 
One concern of the work presented in this chapter is that the stimulatory nature of 0-3hRP 
may be due to the presence of naturally occuring endotoxin. However, it must be 
emphasised that the levels of endotoxin in 0-3hRP can be classed as 'low' (Section 2.4). 
Because low-levels of LPS endotoxin is detected within these preparations, contamination 
with other microbial endotoxins, such as bacterial lipoproteins and fungal glycans, cannot 
be discounted. However, since LPS is the most potent of these microbial stimulants, the 
contribution of other microbial PAMPs to the stimulatory properties of 0-3hRP, is likely to 
be much less important. Indeed, yeast-derived Zymosan A (Section 3.3.5) and Gram 
positive bacterial peptidoglycan and lipoteichoic acid (Takeuchi et al., 1999) are only 
stimulatory at microgram levels. Because LPS endotoxin was detected at low levels (pg to 
ng), any other microbial PAMPs present are likely to be at equally low levels, and thus of 
little significance. 
The results of this chapter strongly suggest that the stimulatory properties of 0-3hRP are 
predominantly due to schistosome PAMPs and not endotoxin. Definitive evidence of 
schistosome PAMPs in the released material is demonstrated by the fact that transforming- 
cercariae are almost twice as stimulatory as their non-transfon-ning counter-parts. In these 
experiments, both parasite groups were derived from exactly the same pool of larvae. 
Therefore, any microbial / endotoxin contaminants would be present in equal quantities in 
both cercarial suspensions. Thus, the increase in stimulatory capacity of transforming 
larvae must be due to the active release and shedding of larval PAMPs. Since 0-3hRP 
represents a considerably concentrated preparation of this released larval material, the 
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parasite PAMPs would be expected to account for most of its stimulatory properties. 
Preliminary studies also suggest that the stimulatory components of 0-3hRP are heat labile 
(data not shown). Since LPS endotoxin is thought to be heat stable (Smiley et al., 2001), 
this would demonstrate that the stimulatory properties of 0-3hRP are independent of LPS. 
In addition, 0-3hRP retained the majority of its potent EL-12p4O, EL-6, and EL-10 
stimulating properties in the presence of endotoxin-neutrali sing PMB. In contrast, PMB 
dramatically inhibited the stimulatory properties of LPS. PMB exerts this neutralising 
effect by high-affinity binding and subsequent blocking of the stimulatory Lipid A moiety 
of LPS. The control LPS used in this study was selected for its highly stimulatory 
properties from a range of sources by screening different preparations (data not shown) and 
reviewing the literature (Luchi and Morrison, 2000). Consequently, the potency of this 
control was probably much higher than the endotoxin contained within 0-3hRP. It has been 
reported that the stimulatory properties of LPS from some bacterial strains are less 
effectively blocked by PMB than others (Cavaillon and Haeffner-Cavaillon, 1985). 
However, at concentrations equivalent to the endotoxin contained in O-ARP, PMB still 
retained blocking capabilities against these 'PMB-resistant' LPS strains (Cavaillon and 
Haefffier-Cavaillon, 1985). From these results, I conclude that culture with endotoxin- 
neutralising PMB is a good method for further examination of the effects of 0-3hRP on the 
innate immune system. 
In this chapter I also show that LPS-stimulated cytokine production by Wý and EFNy-Mý 
was dependent on the presence of a functional TLR4 gene, as demonstrated using cells 
from LP S -unresponsive C3H/HeJ mice. In contrast, in the absence of TLR4 signalling, 0- 
3hRP still stimulated production of EL- 10 and EL- I 2p4O by iMý and EFNy-Mý respectively, 
albeit at a lower level than produced by cells from LPS-responsive C3H/HeN Mý. 
Moreover, both iMý and IFN7-Mý production of IL-6 was similar in the two strains of 
mice in response to 0-3hRP, in the presence of PMB. Since the adherent iMý populations 
from both C3H/HeJ and C3H/HeN mice were phenotypically and quantitatively similar 
(data not shown), it is unlikely that the difference in cytokine production was due to 
variations in cell population. However, it is conceivable that cells from C3H/HeN mice 
might be at a higher state of activation (due to endogenous priming by endotoxins within 
the peritoneal cavity), resulting in increased EL- I 2p4O or EL- 10 production. Nevertheless, 
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because IL-6 production is so similar between strains, this is unlikely. Therefore, my data 
strongly suggests that there are both TLR4-dependent and TLR4-independent stimulatory 
components within 0-3hRP. Although it has recently become apparent that LPS from some 
bacterial species signals through TLR2 (Hirschfeld et al., 2001; Werts et al., 2001), it is 
likely that both the TLR4-dependent and independent signalling pathways involved in 0- 
3hRP recognition are due to schistosome PAMPs and not endotoxin, as both were activated 
in the presence of PMB. This is quite probable as the complexity of 0-3hRP suggests it 
may contain numerous ligands for different PRRs. Moreover, TLR4 is a promiscuous 
receptor, sharing its signalling function with many different PAMPs (Section 1.8.3). One 
candidate PRR potentially involved is TLR2, since glycolipids from soluble schistosome 
egg antigen (SEA) that may be common to 0-3hRP, are recognised through this receptor 
(van de Kleij et al., 2002). Thus, the evidence suggests that 0-3hRP contains potent 
schistosome PAMPs that stimulate through a variety of different PRRs. Moreover, PMB is 
useful to examine the stimulatory properties of 0-3hRP in the absence of endotoxin 
signalling. 
3.4.4 Control of cytokine production by schistosome PAMPs 
In this chapter, I show that Mý can produce a variety of cytokines upon exposure to 
schistosome PAMPs. Indeed, Mý are regarded as a principle source of both pro- 
inflammatory (e. g. TNFcc, IL- I P, IL-6, & IL- 12) and regulatory cytokine production (e. g. 
IL- 10 & IL-6) during innate immune responses. As such, the mechanisms that control Mý 
cytokine production are the object of intense study. Furthermore, I show that the profile of 
Mý cytokine production differs both qualitatively and quantitatively in response to diverse 
pathogen stimuli, with LPS and 0-3hRP stimulating IL- 10, IL- I 2p4O, and high levels of 
IL-6, and Zymosan A stimulating little IL-6, no IL- 10, but higher levels of IL- I 2p4O. 
These observations support the hypothesis that Mý individually tailor responses to specific 
types of pathogen (Nau et al., 2002). 
The initial trigger for cytokine production by pathogens is thought to be the direct or 
indirect ligation of specific TLRs, or other PRRs, resulting in translocation of cytokine 
promoter-binding NF-icp transcription factors to the nucleus (Section 1.9.2). It has been 
proposed that the differences in macrophage cytokine production to diverse pathogen 
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products are due to signalling events mediated by the specific TLRs (Hirschfeld et al., 
200 1; Nau et al., 2002). Indeed, studies have shown that TLR4 agonists but not TLR2 
agonists preferentially induce expression of IL-6 (Hirschfeld et al., 2001; Schilling et al., 
2002). My work is partially consistent with these findings as TLR4-mediated LPS 
signalling resulted in high IL-6, whereas Zymosan A, thought to signal in part through a 
TLR2-dependent pathway (Underhill et al., 1999b), resulted in low IL-6 production. 
However, 0-3hRP poses an anomaly to this model, since it stimulated high levels of IL-6 in 
the absence of TLR4. This suggests there is a TLR4-independent pathway of high level IL- 
6 production through which 0-3hRP signals. 
The control of IL-6 production has been linked to the adapter proteins through which TLRs 
mediate signalling for transcription of cytokine genes. Specifically, all TLRs utilise the 
MyD88 pathway. However, TLR4 can signal via a MyD88-independent pathway. This 
alternative TLR4 signalling pathway utilises the MyD88 adaptor-like (MAL) adaptor 
protein (also known as Toll-IL- IR domain containing adapter protein [TIRAP]). Moreover, 
it is this TIRAP-dependent pathway which is thought to be required for maximal IL-6 
expression by MO (Schilling et al., 2002). Although the majority of work on Zymosan A 
suggests it signals through a TLR2 / MyD88 pathway, a MyD88-independent pathway has 
also recently been described (Edwards et al., 2002), which could explain the residual levels 
of IL-6 that were produced in response to this PAMP. However, responses to O-ARP 
appear to provide evidence of a TLR4 / TIRAP-independent alternative pathway for 
maximal IL-6 production by iMO. Moreover, my data appears to show redundancy in the 
IL-6 signalling pathway, since the majority of the IL- I 2p4O / IL- 10 stimulating capacity of 
0-3hRP was dependent on TLR4, yet IL-6 production was not, suggesting TLR4- 
dependent signalling can be replaced by the alternative pathway. In this case, the 
alternative pathway of IL-6 production signals weakly for IL- I 2p4O and IL- 10 production. 
Notably, other TLRs are now thought to utilise a TIRAP pathway (Horng et al., 2002), and 
it may be those through which 0-3hRP is co-recognised. Indeed, with very recent work it is 
becoming evident that other MyD88-independent signalling pathways exist in humans 
(Oshiumi et al., 2003), and thus probably exist in mice, through which PRRs may signal 
for maximal IL-6 production. With the intense amount of work taking place in this area, 
these other IL-6 transcription pathways may soon be described. 
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In addition to TLRs, it is also possible that components of 0-3hRP may signal for cytokine 
production through other PRRs. Although, there is limited evidence of direct signalling by 
non-TLR PRRs for cytokine production, the mannose receptor has been implicated in IL-6 
and IL- 12 production in response to a variety of PAMP ligands (Shibata et al., 1997; 
Yamamoto et al., 1997). Indeed, the J774A. I cell-line is reported to lack surface 
expression of the MR (Diment et al., 1987), which could explain the apparent lack of 
responsiveness by this and the related J7. DEF. 3 cell-line to stimulation with 0-3hRP and 
the other schistosome PAMP preparations. This proposition will be explored more fully in 
Chapter 4. Moreover, the J774A. I cell-line could also lack other PRRs whose functions 
may be important in schistosome PAMP recognition. Alternatively, this line may have a 
higher threshold of stimulation that must be reached before detectable cytokine production 
occurs since these cells were also less sensitive to stimulation with LPS than primary M+. 
The activity of the Mý was also critically important for the cytokine profile produced. 
Priming iMý with exogenous IFN7 dramatically increased the levels of IL- 12p4O whilst 
decreasing the level of IL- 10 produced in response to both 0-3hRP, SCP, and LPS. It is 
well documented that priming with IFN7 is required for iMý to produce high levels of IL- 
12p4O in response to stimulation with a variety of PAMPs (Chensue et al., 1995; Murphy 
et al., 1995; Skeen et al., 1996), and live pathogens (Flesch et al., 1995; Camargo et al., 
1997). IFN7 acts by enhancing the binding of PAMP-induced, NF-KP heterodimer, p50 / c- 
REL transcription factor complex to the IL- I 2p4O promoter (Murphy et al., 1995). This 
explains why IFN7 alone does not stimulate IL- I 2p4O production. The decrease in IL- 10 
production by IFN7-Mý compared to iMý, has previously been documented (Fiorentino et 
al., 1991b), but less is known about the intracellular mechanism involved. In contrast to 
IL- I 2p4O and IL- 10, IFN7 had inconsistent effects on the production of IL-6 stimulated by 
0-3hRP and SCP. Reviewing the literature, the capacity of IFN7 to effect IL-6 production 
remains controversial. Many groups have demonstrated that IFN7 enhances IL-6 
production in response to a variety of PAMP stimuli but the potency of this effect is 
limited and not as great as for IL- I 2p4O (Fiorentio et al., 1991 b; Goodridge et al., 200 1; 
Schilling et al., 2002). In contrast, other groups demonstrated that IFN7-priming had no 
effect on iMý production of IL-6 in response to LPS (Shnyra et al., 1998; Takeuchi et al., 
1999). Perhaps differences in the activity of the iMý used in my experiments, due to 
variables such as mouse age, or priming within the peritoneal cavity by endogenous 
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endotoxin, could account for this effect. This could also explain the considerable variation 
in overall levels of IL-12p4O produced by Mý between experiments (Figure 3.3 and 3.4). 
3.4.5 Stimulatory components within O-ARP 
0-3hRP is a complex mixture of components (Section 2.4) retaining stimulatory properties 
although it is thought to contain potentially anti-inflammatory factors (i. e. prostaglandins 
and Sm 16.8; Section 2-4). Many of the documented components of 0-3hRP have possible 
immunological properties, such as glycans containing the Lex epitope, and the abundant 
protease component. For example, some proteases including those released by cercariae 
can stimulate basophils to produce IL-4 and histamine (Machado et al., 1996), although the 
effect of schistosome proteases on Mý cytokine production is not known. Furthermore, the 
protease component complies with the PAMP-criterion of being essential for the survival / 
pathogenicity of an organism (Medzhitov and Janeway, 1997), since protease inhibitors are 
able to block parasite penetration (Lim et al., 1999). Alternatively, the schistosome may 
have evolved virulence factors, which sequester host pathways that result in cytokine 
production and inflammation (be that via PRRs or other surface receptors). This could be 
beneficial to the parasite as the inflammation and oedema produced by injection of 
cercarial homogenate actually enhances parasite infectivity (Fallon et al., 1996). In this 
respect, 0-3hRP probably contains several homologues of host proteins that may have 
stimulatory functions. For example, the homologue of TCTP can stimulate histamine 
production by mast cells (Rao et al., 2002). Thus, O-ARP most likely represents a mixture 
of potentially stimulatory PAMPs, potentially stimulatory host homologues, and as 
discussed above, potentially inhibitory factors. These may act on iMý directly, via 
recognition through PRRs, or by utilising other host signalling pathways, resulting in a 
profile of cytokines similar to LPS. 
In summary, the material released by S. mansoni cercariae upon transformation is highly 
enriched for putative parasite PAMPs. A soluble preparation of these PAMPs (0-3hRP) 
stimulates pro-inflammatory and regulatory cytokine production by MO. This cytokine 
profile is similar to that stimulated by the TLR4 agonist LPS but not the TLR2 agonist 
Zymosan A. Furthennore, the stimulatory properties of 0-3hRP are semi-dependent on 
signalling through TLR4, although 0-3hRP stimulates high levels of IL-6 via a TLR4- 
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independent pathway. This data provides a basis for further analysis of the effect of these 
putative parasite PAMPs on cells of the innate immune system, and on the priming of 
acquired immune responses. 
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CHAPTER 4 
SCREENING FOR MACROPHAGE MANNOSE RECEPTOR 
LIGANDS WITHIN THE SCHISTOSOME PAMP RFPERTOIRIE 
4.1 INTRODUCTION 
In Chapter 3,1 demonstrated that skin-stage schistosomes express PAMPs that stimulate 
cytokine production by murine Mo. These PAMPs were concentrated within the material 
released by cercariae during transformation, and their recognition involved both a TLR4- 
dependent and a TLR4-independent pathway. 
Many host PRR's are involved in the recognition of PAMPs by innate accessory cells, 
including members of the TLR family (leucine-rich proteins), intergrins, and C-type lectins 
(Medzhitov and Janeway, 1997). One such C-type lectin is the Mý mannose receptor 
(MR), which has been implicated in the recognition of viruses, bacteria, fungi and protozoa 
(reviewed by Linehan and Gordon, 2000). In addition to its well-defined role in microbe 
phagocytosis and endocytosis (e. g. Sallusto et al., 1995; Tan et al., 1997), the MR is also 
thought to be involved in the induction of cytokine production (including EL-6 and IL- 12), 
upon recognition of PAMP ligands (Garner et al., 1994; Yamamoto et al., 1997; Shibata et 
al., 1997). 
The MR is a complex receptor with 8 carbohydrate recognition domains (CRD), and an 
additional lectin activity mediated by its N-terminal cysteine-rich domain (MR-Cys). 
CRI)s are lectins with affinity for mannose, fucose and N-acetyl-glucosamine. Co- 
operative binding by multiple CRI)s generates the high affinity of the MR for multivalent 
oligosaccharides, such as certain glycans found upon the surface of microbial pathogens 
(Taylor and Drickamer, 1993). In this respect, the function of the MR in innate recognition 
of microbial PAMPs has been attributed to these domains (Taylor and Drickamer, 1993), 
although these regions also bind endogenous ligands, such as lysosomal enzymes and 
secretory glycoproteins (Linehan et al., 2001). Since schistosomes are known to synthesise 
many glycans, some with homology to host structures (Cummings and Nyame, 1999), it is 
a reasonable hypothesis that there may be MR ligands within this schistosome glycan 
repertoire. Indeed, molecules secreted by schistosome eggs have recently been shown to 
contain MR ligands (Linehan et al., manuscript submitted). Moreover, the material 
released by schistosomes during transformation is thought to be highly glycosylated (Veira 
et al., 1986), and it is possible that MR ligands may be concentrated within this highly 
stimulatory schistosome compartment. An additional indication that the MR may be 
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important in schistosome recognition came from observations that the J774A. I Mý cell- 
line, thought to be deficient in MR expression (Diment et al., 1987), was refractory to 
stimulation with schistosome PAMPs (Section 3.3.6). 
A naturally-occurring soluble form of the mannose receptor (sMR) has been used to 
identify MR ligands (Martinez-Pomares et al., 1998). However, sMR is only detectable at 
low levels in murine serum and Mý culture supernatant, making it difficult to obtain 
(Martinez-Pomares et al., 1998). A recombinant fusion protein containing MR CRDs 4 to 7 
fused to the Fc portion of human IgG, (CRD4-7Fc) has been produced and successfully 
used to probe for MR ligands within immobilised preparations of host tissue and host 
tissue-sections (Linehan et al., 2001), and schistosome egg secretions (Linehan et al., 
manuscript submitted). This MR probe has been shown to possess the same specificity as 
soluble MR (sMR) when tested with certain glycoconjugate ligands (Linehan et al., 2001). 
Moreover, a study of the recognition properties of segments of CRDs suggests that CRD4- 
7 are sufficient to mediate ftill affinity for high-mannose-type glycans (Taylor and 
Drickamer, 1993). 
The purpose of this short chapter is to study the expression of MR CRD ligands within the 
different schistosome preparations, using the CRD4-7Fc probe, in order to gain insight into 
the involvement of this PRR in schistosome PAMP recognition. 
4.2 MATEFJALS AND METHODS 
4.2.1 Lectin blotting 
The soluble MR probe (CRD4-7Fc) was a gift from Prof Siamon Gordon (University of 
Oxford). 
Soluble schistosome preparations (Section 2.2.1) were applied directly to pre-wetted (PBS; 
pH 7.2) Hybond TM PVDF membranes (Invitrogen) placed in a Bio-DotTm dot blot 
apparatus (Biorad Laboratories Ltd., Hemel Hempstead; UK) under suction. Alternatively, 
preparations were separated by I -D SDS-PAGE electrophoresis under denaturing 
conditions (previously described; Section 2.2.2.2), and then electrophoretically transferred 
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to PVDF membranes (hivitrogen) for 90 min at 30 V in blot transfer buffer (10% methanol 
and 1% NuPAGE Tm antioxidant in NuPAGEO transfer buffer; Invitrogen). Pre-stained 
molecular weight markers (Biorad Laboratories Ltd. ) were used for size comparison. To 
ensure separated material had transferred, the gels were stained with BBGC (Sigma- 
Aldrich), as described previously (Section 2.2.2.2). 
In some experiments, membranes were treated with sodium periodate prior to blotting. 
Specifically, membranes were equilibrated in sodium acetate solution (0.1 M; pH 4.5) 
solution for 30 min, then cut into strips and incubated with sodium meta-periodate (20 
mM; Sigma-Aldrich) in sodium acetate solution, or with sodium acetate solution alone, for 
I hr at room temperature (RT) with agitation. Strips were then washed twice with sodium 
acetate, and incubated with sodium borohydride (50 mM; Sigma-Aldrich) in PBS for 30 
min and then washed extensively in Tris buffered saline (TBS; pH 7.6; 137 mM NaCl, 20 
mM Tris) containing 0.1% (v / v) Tween 20 and 10 mM CaC12 (TBS-T). CaC12 was 
included in the buffer since MR binding is calcium dependent. 
In all subsequent washing and incubation steps, TBS-T was used except where specified. 
Membranes were blocked overnight at 4 'C in TBS-T plus 5% (w / v) non-fat milk and 
then rinsed twice before incubation with CRD4-7Fc (I ýtg / ml) for I hr at room 
temperature (RT) on an orbital shaker. In some experiments, membranes were incubated 
with CRD4-7Fc in the presence of 50 mM D-mannose (Sigma-Aldrich) in order to out- 
compete specific binding. The membrane was then extensively washed (rinsed twice, then 
washed once for 15 min followed by 3 washes for 5 min), and incubated with sheep HRP- 
conjugated anti-human IgG (1: 2000 dilution; Amersham Pharmacia Biotech UK Ltd., 
Little Chalfont, LTK) for I hr with orbital agitation. Finally, membranes were extensively 
washed as above before bound HRP was detected using chemiluminescence. Specifically, 
membranes were incubated with ECL plUSTm reagent for 5 min (Amersham Pharmacia), 
drained, and exposed to autoradiography film (Hyperfilm TM -ECL; Amersham Pharmacia). 
Exposure times were typically in the range 30 - 120 secs. Film was developed using an X- 
graph. 
130 
4.2.2 Phenotypic analysis of MR expression by iMý 
To determine if iM0 express the MR, inflammatory PEC were phenotyped using flow- 
cytometry. PECs from C57BI/6 mice were elicited using 3% Brewers thiogy1collate broth 
and harvested as previously described (Section 3.2.2). Red blood cells were lysed with 
ACK buffer (150 mM NH4Cl, 10 mM KIHCO3 and 0.1 mM Na2EDTA; Sigma Aldrich), 
and the remaining cells washed three times with RPMI- 10 (Section 3.2.2). Cells were 
stained with optimal concentrations of specific antibodies, or irrelevant isotype matched 
antibodies, using the method previously described (Section 3.2.3.2). Antibodies against 
various surface markers were as follows (clone; supplier): FITC-conjugated F4/80 (CI: A3- 
1; Caltag) and biotin-conjugated MR (5D3; gift from Prof Siamon Gordon, University of 
Oxford). Cells stained with biotinylated antibody were then incubated with streptavidin- 
conjugated QR TM (Sigma-Aldrich). Two-colour staining was used to analyse co-expression 
of F4/80 and MR. 
For two-colour flow-cytometry, the required amount of compensation was set using 
samples stained with specific antibody for one marker and the irrelevant isotype control for 
the second marker. Compensation is the use of electronic signal algorithms to prevent one 
colour's signal spilling over into another. 
4.3 RESULTS 
4.3.1 CRD4-7Fc recognises schistosome carbohydrates 
The recombinant fusion protein CRD4-7Fc was used to probe for ligands within the 
soluble schistosomal PAMP preparations, using a lectin blotting technique. CRD4-7Fc 
bound to dot-blots of 0-3hRP, SCP, and l8hSSP (Figure 4.1 a). In contrast, RPMlc did not 
contain ligands for the MR probe. The binding between the schistosome ligands and the 
MR probe was highly specific, being out-competed by the monomeric ligand mannose 
(Figure 4.1 b). 
To test whether CRD4-7Fc binding was dependent upon the glycan constituent of the 
schistosome preparations, membrane immobilised samples were first oxidised with sodium 
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periodate and then reduced with sodium borohydride, in order to structurally alter any 
carbohydrate components. To control for this procedure, an identical membrane underwent 
a similar procedure except that it was not exposed to sodium periodate. Treatment of the 
dot-blots with sodium periodate destroyed the ligands for CRD4-7Fc within 0-3hRP, SCP, 
and l8hSSP (Figure 4.2b), whereas control treatment did not affect the ability of the MR 
probe to bind to the sample (Figure 4.2a). Interestingly, CRD4-7Fc binding was 
consistently more intense for SCP and l8hSSP compared to 0-3hRP, even though equal 
amounts of these preparations were loaded onto the membrane (Figures 4.1 and 4.2). 
In order to determine if CRD4-7Fc was binding to similar ligands within the different 
preparations, samples were first separated by I -D SDS-PAGE and then probed. The 
soluble preparation of 3 hr in vitro-cultured schistosomulae was also included for 
reference. The most distinctive difference in the pattern of lectin binding was between the 
released schistosome molecules and the whole larval preparations. Specifically, the ligands 
within 0-3hRP did not resolve into distinct bands rather being associated with a 75 - 250 
kDa complex of macromolecules (Figure 4.3). In contrast, distinct ligand bands were 
visible within SCP, 3hSSP, and 18hSSP (Figure 4.3). Moreover, there were numerous 
different ligands within each of these preparations. One of the most striking features of 
these bands was their high molecular weight, ranging from approximately 75 to 250 kDa. 
Although several bands of equal size were shared between these whole larval preparations, 
SCP contained a band of approximately 100 kDa, which was detected only weakly in 
3hSSP and not in l8hSSP. Similarly, both schistosomulae preparations contained a distinct 
band of just under 150 kDa, which was not present in SCP. There was little difference 
between the ligand binding patterns of 3hSSP and 18hSSP. 
4.3.2 MR is expressed by a proportion of iMý 
Flow-cytometric analysis confirmed that iMý express the MR. F4/80+ cells comprised 60% 
of inflammatory PEC (Figure 4.4ia). Furthermore, 18% of PEC were MR+ although the 
levels of receptor expression by these cells was relatively low (Figure 4.4ib). Subsequent 
two-colour staining revealed that the MR+ PEC were F4/80+ (Figure 4.4iia & b), and that 
they represented approximately one third of the F4/80+ restricted group (Figure 4.4ia & b). 
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Figure 4.1 CRD4-7Fc binds to ligands within soluble schistosome 
preparations. Soluble schistosome preparations (4 jAg) were dotted onto 
PVDF membranes. In one experiment the membrane was probed with 
CRD4-7Fc (I pg / ml) (a). Alternatively the membrane was probed with 
CRD4-7Fc in the presence, or absence, of D-mannose (50 mM) (b). 
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Figure 4.2 CRD4-7Fc binds to glyeans within the soluble schistosome 
preparations. Soluble schistosome preparations (4 ýtg) were dotted onto 
PVDF membrane. The membrane was cut into strips which were treated 
with (b), or without (a), sodium meta-periodate. The membranes were 
then probed with CRD4-7Fc (I pg / ml). 
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Figure 4.3 CRD4-7Fc binds to distinct ligand bands within soluble 
whole larval preparations but not within 0-3hRP. Soluble 
schistosome preparations (10 ýtg / lane) were denatured and separated on 
a 4% - 12% gradient bis-tris acrylamide gel. The separated material was 
then transferred to a PVDF membrane and probed with CRD4-7Fc (I ýtg 
/ ml). The brace indicates a ligand complex within 0-3hRP. The grey 
arrow indicates a ligand band visible only with SCP, and the black 
arrows indicates a ligand band visible only within 3hSSP and l8hSSP. 
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Figure 4.4 The MR is expressed by a proportion of inflammatory macrophages. 
i) Thiog lyco I late-el 1 cited PEC were analysed for their surface expression of F4/80 (a) or 
MR (b). Cells were stained with antibodies specific for the surface marker (red line), or 
with matched isotype controls (blue line). The values represent the percentage of cells 
expressing the marker. For each marker, the population of positive cells was characterised 
upon size and granularity, and compared to the whole cell population. ii) Cells were 
double stained with antibodies specific for F4/80 and the MR (b) or appropriate isotype 
controls (a). Control antibody staining is represented by the quadrant boundaries, and 
values represent the percentage of cells in the garticular quadrant. 
13 
All cells 
4.4 DISCUSSION 
In order to determine if the skin-stage schistosomes express MR ligands, I employed a 
strategy of probing immobilised schistosome material with a recombinant fusion protein 
containing the fourth to the seventh CRDs of the murine MR. The MR CRDs incorporated 
into this probe confer recognition of high-mannose-type glycans and mediate recognition 
of a variety of microbial polysaccharides (Taylor and Drickamer, 1993). Moreover, this 
fusion protein has previously been used to successfully detect endogenous MR ligands 
(Linehan et al., 2001). In these assays, soluble mannose was used to out-compete binding 
to ensure that lectin / ligand interactions were specific. As an additional control, ligands 
were treated with sodium periodate to destroy glycan structures and demonstrate that 
binding was directed to the carbohydrate moieties. These controls were important since the 
CRD4-7Fc probe contained the Fc portion of human IgG which could potentially bind to 
Fc receptors that are known to be expressed by schistosomulae (Loukas et al., 2001). 
In this chapter, I have shown that soluble preparations of skin-stage schistosomes contain 
PAMPs recognised by CRDs of the MR. Therefore, I conclude that MR ligands are 
expressed in the soluble compartments of cercariae, schistosomulae and the material 
released by cercariae upon transformation. As might be expected, these ligands were all of 
high molecular weight, probably due to heavy oligosaccharide chains. The ligand species 
in the whole larval preparations (SCP, 3hSSP, 18hSSP) fon-ned distinct bands when 
separated by SDS-PAGE, that were not present in 0-3hR. P. This suggests that some ligands 
are exclusive to the somatic larval material. These ligand bands are most probably internal, 
or tegument components, since they are unlikely to represent cercarial glycocalyx material, 
which would also be present in 0-3hRP (Section 2.4). The detection of a schistosomulae 
specific band suggests that a new ligand could be synthesised upon transformation. 
However, it could be an enzymatic digest product of a one of the larger ligands contained 
within the whole larval preparations. Perhaps surprisingly, the ligand material contained 
within 0-3hRP did not resolve into discrete bands using SDS-PAGE. Since nearly all the 
proteins within 0-3hRP were below 75 kDa in size (Section 2.3.1), this suggests that the 
major protein components of 0-3hRP do not contain MR CRD ligands. The high molecular 
weight complex of ligands within 0-3hRP is probably the same high molecular weight 
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complex of proteins described in Section 2.3.1, and could well represent schistosome 
mucins (discussed in Section 2.4). 
Binding of carbohydrate ligands through the MR is thought to affect a range of Mo and 
accessory cell immune functions, such as phagocytosis and endocytosis of microbes, and 
the induction of cytokine production (Garner et al., 1994; Sallusto et al., 1995; Yamamoto 
et al., 1997; Shibata et al., 1997). Furthermore, MR activity may be important in adaptive 
immunity, through the uptake of antigens by DC and the delivery of these to MHC 11- 
loading compartments (Sallusto et al., 1995). In this respect MR-mediated up-take of 
antigen greatly enhances the efficiency of antigen presentation (e. g. Tan et al., 1997). 
Therefore, my data suggests that recognition through the MR may play a role in the innate 
and adaptive immune responses to schistosome infection. Indeed, approximately one third 
of F4/80+ PEC, thought to represent iM0, were shown to express the MR suggesting that 
culture of iMo with schistosome preparations (described in Chapter 3) would result in MR- 
mediated recognition of schistosome PAMPs. However, it is difficult to speculate what 
function MR recognition could have during infection and in the Mo responses observed in 
Chapter 3, since a recent review suggests that down-stream effects of MR ligation are not 
hard-wired, with many factors affecting MR-induced effector functions, such as the 
activation-state of the M0, the type of ligand, and co-operation with other lectins (Linehan 
et al., 2000). This is understandable for a receptor whose functions are though to include 
clearance of host secretory and circulatory glycoproteins, as well as microbial phagocytosis 
and immune signalling. This complex effector function could explain why the schistosome 
preparations containing the greatest quantity of MR ligands (SCP, 18hSSP) did not 
stimulate Mo cytokine production, whereas the preparation with the least quantity of 
ligands (0-3hRP) was a potent stimulator of cytokine production. One possible 
interpretation of these results is that schistosome MR ligation does not lead to cytokine 
production. Indeed, some reports suggest that MR ligands must be particulate in order to 
stimulate cytokine production (Shibata et al., 1997). This is controversial, since others 
suggest that soluble ligands are stimulatory (Garner et al., 1994), while a recent report 
suggests that MR ligation can actually have inhibitory functions on DC cytokine 
production (Nigou et al., 2001). Thus, a similar inhibitory effect on Mo cytokine 
production could be envisaged. In this respect, 0-3hRP could be most stimulatory for 
cytokine production because it contains lower levels of 'Inhibitory' MR ligands. In 
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addition, the MR ligands within 0-3hRP and the soluble whole larval preparations were 
quite different in character as deten-nined by SDS-PAGE separation, and therefore may 
actually have different effects upon receptor- ligation. It is yet unclear what controls these 
differences in MR ftinction, and further work is awaited in this area. 
It should be noted that the MR could also recognise schistosome PAMPs via its Cys-MR 
domain, which is not included in the CRD4-7Fc probe. Although only endogenous host 
ligands have been described for this region of the receptor, one of these, the Le x 
oligosaccharide (Martinez-Pomares et al., 1996; Leteux et al., 2000), is thought to be 
contained within 0-3hRP (Section 2.4), and could affect the outcome of MR-induced 
effector functions. In order to confirrn a role for the MR in innate immune responses to 
schistosome PAMPs, mice deficient for this receptor could be used in future studies. 
In this brief chapter, I have shown that soluble preparations of skin-stage schistosomes 
contain ligands of CRDs from the murine MR. However, MR ligands were more abundant 
in whole larval preparations than in the released products of schistosomulae, suggesting 
that MR recognition of somatic schistosome PAMPs may not be involved in signalling for 
cytokine production. In this respect, the repertoire of MR CRD ligands within the 
stimulatory 0-3hRP appear to be quite distinct to that of the whole larval preparations, 
possibly accounting for the difference in the stimulatory properties of these preparations. 
139 
CHAPTER 5 
THE ROLE OF Fcy RECEPTORS IN THE RECOGNTION OF 
RELEASED SCHISTOSOME PAMPS 
5.1 INTRODUCTION 
Fcy receptors (FcyR) are important phagocytic PRRs on accessory cells. These receptors 
recognise the Fc portion of antibodies of the IgG isotype but also mediate the recognition 
and phagocytosis of other soluble 'Innate' PRRs, such as the pentraxin family members 
Serum amyloid P and C-reactive protein, when in complex with pathogen PAMPs (Mold et 
al., 200 1; Bharadwaj et al., 200 1). Fc7R ligation by IgG-opsonised L. major amastigotes 
was recently shown to have a profound effect upon the regulatory function of Mý, acting in 
synergy with PAMPs to induce high-level IL-10 production (Kane and Mosser, 2001). This 
IL- 10 can inhibit pro-inflammatory cytokine production by additional Mý populations and 
enhance susceptibility of these cells to infection by amastigotes. Together with this, the 
observation that IL- 10 -/_ mice are able to control Leishmania infection has led to the 
proposal that amastigotes use host IgG as a virulence factor to exploit the inhibitory effects 
of signalling through FcyRs (Kane and Mosser, 2001). In this respect, Fc7R ligation is also 
known to directly suppress Mý production of EL-12 (Sutterwala et al., 1997; 1998; Grazia 
Cappiello et al., 2001; Gerber and Mosser, 2001). Indeed, Fc7R signalling via antibody, or 
pentraxins, can lead to the abrogation of IL- I 2p7O production concurrent with the 
induction of high levels of IL- 10 in response to many pro-inflammatory stimuli, including 
TLR-dependent PAMPs, danger signals, and CD40 ligation (Gerber and Mosser, 2001). 
Further studies have shown that these effects are mediated through the common FcR y- 
chain of the Fc7Rs (Sutterwala et al., 1997; 1998; Mold et al., 2002), an essential 
component in the signalling from FcyRI and FcyRIH (Takai et al., 1994). 
It is a reasonable hypothesis that production of parasite-specific antibody following 
infection with schistosomes could also promote the regulation of pro-inflammatory 
responses stimulated by parasite PAMPs released upon subsequent infections, or during the 
ensuing larval migration. In addition, opsonisation of parasite PAMPs by pentraxins could 
have a similar effect, but without requiring a preceding acquired (antibody) response. 
The availability in York of a small number of mice that lack the 7-chain of the FcRs (FcR 7 
-/-) allowed us to perform a short series of experiments to examine the potential role of 
FcyR-mediated regulation of inflammatory responses. A preliminary study by other 
researchers in the group demonstrated that infection of FcR y -/- mice resulted in reduced 
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IL- 10 production by skin biopsies on days 4 (prior to schistosome-specific antibody 
production) and 7 post-infection compared with those from wild-type (WT) mice (pers. 
com. K. Hogg and A. Mountford). However, there was more than 50% reduction in the 
production of IL-10 following re-infection of previously vaccinated FcR y -/- mice in which 
parasite-specific antibodies are abundant. 
Therefore, the aim of this study is to further investigate the role that Fc7Rs have in the 
recognition of released larval PAMPs, with respect to the resulting profile of IL- 10 and IL- 
12 production by Mý. The majority of work investigating FcyR signalling in PAMP- 
stimulated IL- 10 and IL- 12 production has been performed using in vitro Mý-stimulation 
assays. Since, I have already defined such an assay to study the effects of schistosome 
PAMPs on cytokine production (Chapter 3), a similar system incorporating inflammatory 
peritoneal Mý will be used in these studies. This chapter will follow three strategies. 
Firstly, the profile of IL- 10 and EL- I 2p4O production by Mý from FcR 7 -/- mice will be 
compared to that from WT mice upon culture with larval released material. This will 
determine whether signalling through the y-chain is essential to the 'Innate' profile of 
cytokine production stimulated by schistosome PAMPs. Secondly, cells from WT mice 
will be stimulated with released larval PAMPs in the presence or absence of anti-parasite 
polyclonal serum (antiserum), in order to determine whether Fc7R ligation by anti-parasite 
antibody / antigen complexes effects the profile IL- 10 and IL- I 2p4O produced by normal 
Mý. Released larval material will be used in these experiments since it should contain 
PAMPs that stimulate iMý directly through PRRs, and it provides the source of parasite 
antigens to forin complexes with the anti-parasite antibody. Finally, responses by FcR 7 
Mý will be compared to those of WT upon culture with larval released material, in the 
presence of antiser-um, to determine whether signalling through they-chain is essential for 
the profile of cytokines stimulated by schistosome PAMPs in the presence of parasite- 
specific antibody. 
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5.2 MATERIALS AND METHODS 
5.2.1 Animals 
All mice were maintained in open housing at the University of York animal unit until used. 
A breeding colony of FcR y -/- mice (Takai et al., 1994) were a gift from Prof. R. Grencis 
(University of Manchester), and together with wild-type (WT) 129 x C57 mice, were bred 
in-house. 
5.2.2 Preparation of crude released larval material 
Infective schistosome cercanae were obtained, concentrated, and transformed, as described 
in Section 2.2.1. These larvae were then cultured in vitro in RPMI 1640, containing 200 U 
/ ml penicillin, 100 [tg / ml streptomycin, and 2mM L-glutamine (UMI-00), at 37 T. The 
volume of medium used to culture the larvae depended on the amount of larval material 
required for the stimulation assays, typically 10 ml. After 3 hr, the culture supernatant was 
removed and centrifuged at 120 g, 4 OC, for 8 min to pellet the heads and tails, which were 
subsequently discarded. The remaining crude preparation, containing both the soluble and 
insoluble fractions of released material, was then sterilised by LTV-irradiation for 30 min 
and termed 0-3hRM. Because of the particulate nature of 0-3hRM it was not possible to 
accurately measure the protein content of the different batches used in these experiments. 
5.2.3 Production of anti-parasite polyclonal serum to larval released material 
Anti-parasite polyclonal serum (IRS) against larval released material was raised in a rabbit 
by subcutaneous immunisation with 0-3hRM in 'Complete Freunds adjuvant' and 
produced 'in house' by Harrop et al. (2000). Control rabbit serum was obtained from naYve 
animals (NRS). The IRS had previously been shown to contain abundant antibodies against 
0-3hRM, as judged by ELISA (Harrop et al., 2000). IRS and NRS were heat-inactivated 
for 30 min at 56 T, and then sterilised by UV-irradiation for a further 30 min. 
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5.2.4 Mý stimulation assay 
Inflammatory peritoneal MO (iMO) from WT or FcR y -/- mice were elicited, harvested, and 
adherence-puri fled in 96-well plates as described in Section 3.2.2, except that RPMI-00 
was used instead of medium containing FCS, and in one experiment (Experiment 2) cells 
were cultured at a concentration of 0.5 x 106 cells / ml rather than 1x 106 cells / ml (due to 
limited cell availability). 1MO were then cultured in a total volume of 200 ýd medium for 
24 hr with LPS (10 ng / ml), with a3: 1 dilution of 0-3hRM, or without any supplements. 
These stimulation assays were carried out in RPMI-00 containing 5% FCS, 5% NRS, or 
5% IRS. Supernatants were then harvested and analysed by ELISA for production of IL- 
10, or IL-12p4O, as described in Section 3.2.6. 
5.3 RESULTS 
5.3.1 IL-10 production stimulated by 0-3hRM is not effected by the absence of FcyR 
signalling through the common FcR -y-chain 
In order to determine the contribution of FcyRs to the recognition of released schistosome 
molecules, the response of 1Mý from FcR y -/_ mice to larval PAMPs was compared to that 
of cells from wild-type (WT) animals. Due to the limited availability of these mice, this 
study was restricted to 3 experimental repeats. 
Mý from the different mouse groups were cultured in media containing neutral FCS and 
either released larval material (0-3hRM), or LPS, in order to determine if they substantially 
differed in their ability to produce cytokines to these PAMP stimuli in the absence of 
specific antibody / antigen complexes. 1Mý from FcR 7 -/- mice produced marginally 
greater amounts (1.24-fold) of EL- 10 than their WT counterparts in response to 0-3hRM 
(Experiment 1; Figure 5.1 a). Similarly, the absence of this receptor had minimal effect on 
the level of IL- 10 produced in response to LPS. The same pattern was observed in two 
further experimental repeats (Experiment 2&3; Figure 5.1 b& c). In contrast, the profile 
of IL- I 2p4O produced by these two different Mý populations (in response to either 0- 
ARM or LPS) varied considerably between experiments, since a dramatic increase seen in 
the absence of Fc7R y-chain signalling in Experiment I (Figure 5.1 d) but a decrease was 
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observed in the repeat (Experiment 3; Figure 5.1 e). It is noteworthy that the high 
background levels of IL- 10 and IL- 12 production by cells cultured alone observed in 
Experiment 3 (Figure 5.1 c& e), were later confin-ned to be due to contaminating endotoxin 
in the batch of commercially available FCS used for that assay. However, for the purpose 
of my study, this further demonstrates that IL- 10 production did not differ greatly between 
the two Mý populations in response to stimulation with 0-3hRM in the absence of parasite- 
specific antibody/ antigen complexes. In addition, the overall levels of IL- 10 and IL- 
12p4O stimulated by 0-3hRM differed considerably between the experimental repeats, 
whereas LPS stimulated production of relatively consistent amounts of this cytokine. Since 
different batches of 0-3hRM (derived from separate cercarial sheds) were used in each 
experiment, the variation in IL- 10 production probably reflects the variation in the actual 
quantity of schistosome material to which the cells were exposed. In this respect, the batch 
of 0-3hRM used in Experiment 2, in which the least IL- 10 was detected, was thought to 
contain the lowest amount of parasite material. Furthermore, fewer cells (0.5 x 10 6 
compared to Ix 106 / MI) were used in this experiment. 
5.3.2 0-3hRM-specifc antibody has little effect on the production of IL-10 by Mý 
stimulated with released schistosome PAMPs 
To detennine if parasite-specific antibody alters the profile of cytokine production by IMý 
resulting from recognition of schistosome PAMPs, 1Mý were cultured with crude larval 
released material (0-3hRM) in the presence of anti-0-3hRM serum (IRS), or a neutral 
control serum (NRS). A crude preparation of the larval released material was used (rather 
than a soluble fraction centrifuged at 100,000 g) because it was deemed important to have 
both the soluble and insoluble components present. In this context, FcyR clustering that 
leads to the initiation of signalling pathways (following ligation by antigen / antibody 
complexes) may occur to a greater extent in the presence of particulate antigen. LPS was 
included as a stimulatory PAMP that should not cause antibody ligation of FcyR in the 
presence of anti-parasite polyclonal serum. The data from three experiments is presented in 
Figure 5.2, with the results of Experiment I and 2 corresponding to those presented in 
Figure 5.1. Experiment 4 represents an unrelated assay. 
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When cultured in neutral NRS, Mý produced high levels of IL- 10 upon stimulation with 
0-3hRM (Experiment 1; Figure 5.2a). Conversely, in the presence of anti-larval IRS, 1Mý 
produced dramatically lower levels of IL-10 (0.33-fold) when stimulated with 0-3hRM 
(Experiment 1; Figure 5.2a). In contrast, the levels of EL- 10 produced in response to 
stimulation with LPS did not differ when Nlý were cultured in IRS compared to NRS. 
However, in two further experimental repeats (Experiment 2& 3), IL-10 production 
stimulated by 0-3hRM did not decrease when the assays were carried out in IRS compared 
to NRS; in Experiment 3 the levels actually increased 1.2-fold (Figure 5.2b & c). Similarly, 
there was no clear difference in the levels of IL-12p4O stimulated by 0-3hRM following 
culture in either NRS, or IRS, when the results from two experiments were compared 
(Figure 5.2d & e). 
5.3.3 Maximal IL-1 0 production in the presence of anti-schistosome antibodies 
requires Fc7R signalling through the common FcR 7-chain 
As an alternative method to analyse the effect of schistosome-specific antibody / antigen 
complexes on stimulation by larval PAMPs, the cytokine response of iMý from FcR y 
mice to larval PAMPs was compared to that of cells from wild-type (WT) animals 
following culture in IRS. Again, the data from three experiments is presented (Figure 5.3), 
and directly correspond to those performed using FCS (Figure 5.1). 
Compared to culture with neutral FCS (Figure 5.1), the profile of IL- 10 production by FcR 
7 -/- and WT Mý stimulated in the presence of anti-0-3hRM serum displayed marked 
differences. Mý from FcR 7 -/- mice produced considerably lower levels of IL-10 in 
response to stimulation with either 0-3hRM (0.52-fold) or LPS (0.55-fold) when cultured 
with IRS, compared to the WT controls (Experiment 1; Figure 5.3a). This was repeatable 
in two further experiments (Experiment 2&3; Figure 5.3b & c), albeit less dramatically in 
Experiment 2. In contrast, the profile of IL- I 2p4O produced by the different cell 
populations was not consistent between experiments (Figure 5.3d & e). However, the 
relative increase in IL-12p4O production by FcR y -/- Mý upon stimulation with 0-3hRM, 
or LPS, observed in Experiment I (Figure 5.3d) mirrored that seen upon stimulation in the 
presence of FCS, in the same experiment (Figure 5.1 d). Similarly, the relative decrease in 
IL- I 2p4O production observed in the absence Of 7-chain signalling in Experiment 3 (Figure 
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5.3e) mirrored that in the equivalent experiment in the presence of FCS (Figure 5.1e). Itis 
also noteworthy that in experiments where there was overall high levels of EL- 10 there was 
little IL-12p4O production (Experiment 3; Figure 5.3c & e), whereas low levels of IL-10 
corresponded with higher levels of EL-12p4O production (Experiment 1; Figure 5.3 a& d). 
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Figure 5.1 Deficiency of FcR 7-chain-signalling has little effect on IL- 
10 production in the absence of specific antibody. 1Mý from WT (solid 
bars) or FcR y -'- mice (hatched bars) were cultured in medium containing 
FCS alone, with supernatant from in vitro-cultured transforming cercariae 
(0-3hRM), or with LPS, for 24 hr. Supernatants from duplicate, or 
triplicate wells of a 96-well plate were pooled and analysed by ELISA for 
production of IL- 10 (a, bc), or IL- 12 (d, e). Dashed lines indicate the 
lower detection limit of the ELISA. Data from three experiments are 
presented (Experiment I- 3). ND = not done. 
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Figure 5.2 Presence of 0-3hRM-specific antibody does not affect IL- 
10 production. Mý from WT mice were cultured alone, with supernatant 
from in vitro-cultured transforming cercariae (0-3hRM), or with LPS, for 
24 hr in medium containing either normal rabbit serum (open bars), or 
serum from a rabbit immunised with 0-3hRM (shaded bars). Supernatants 
from duplicate, or triplicate wells of a 96-well plate were pooled and 
analysed by ELISA for production of IL- 10 (a, b, c), or IL- 12 (d, e). 
Dashed lines indicate the lower detection limit of the ELISA. Data from 
three experiments are presented (Experiment 1,2, & 4). Experiments I 
and 2 correspond to those presented in Figure 5.1. 
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Figure 5.3 Deficiency of FcR y-chain-signalling causes reduction in 
IL-10 production in the presence of specific antibody. iklý from WT 
(solid bars) or FcR y -I- mice (hatched bars) were cultured alone, with 
supernatant from in vitro-cultured transforming cercariae (0-3hRM), or 
with LPS, for 24 hr in medium containing serum from a rabbit immunised 
with 0-3hRM (IRS). Supernatants from duplicate, or triplicate wells of a 
96-well plate were pooled and analysed by ELISA for production of IL- 
10 (a, b, c), or IL- 12 (d, e). Dashed lines indicate the lower detection limit 
of the ELISA. Data from three experiments are presented (Experiment I- 
3), and correspond to those presented in Figure 5.1. ND = not done. 
150 
CeUs Only 0-3hRM LPS 
C. ft 0.1y 0-3hRM LPS 
Cells Onry 0-3hRM LPS Cells Only 0-3hRM LPIS 
5.4 DISCUSSION 
The Fc7Rs may play an important role in the regulation of immune and inflammatory 
responses during disease. In this respect, these receptors can have a synergistic effect upon 
IL- 10 production and an inhibitory effect upon IL- I 2p4O production by murine Mý in 
response to a range of stimuli. In this study, I used several methods to investigate the 
effects of Fc7R-signalling upon the profile of regulatory and pro-inflammatory cytokine 
production stimulated by larval PAMPs, to determine if these receptors may function in 
regulation of the inflammatory responses following exposure to schistosomes. No clear 
role for these receptors was evident in innate responses to parasite PAMPs, since IL- 10 
production was not reduced by the absence of signalling through the FcR 7-chain when 
cultured in neutral serum. In contrast, FcR 7 -'- Mý produced reduced levels of IL- 10 
stimulated by released larval PAMPs in the presence of anti-parasite polyclonal serum 
(IRS), suggesting that Fc7R-ligation by parasite antigen / antibody complexes could 
promote IL- 10 production during the inflammatory responses initiated by schistosomes. 
However, no reliable difference was demonstrated between the levels of IL- 10 production 
by WT iMý following stimulation with 0-3hRM in the presence of IRS, or a neutral serum, 
NRS. Furthermore, no reliable differences in IL- 12p4O production between FcR 7 -/- and 
WT Mý, or culture in the presence, or absence, of anti-parasite antiserum were identified. 
FcyR signalling can be caused by the presence of pentraxin-opsonised pathogen PAMPs 
(Mold et al., 2002). The common 7-chain of the FcRs is an essential component of 
signalling through FcyRI and FcyRIH (Takai et al., 1994), and is required for the up- 
regulation of IL- 10 and inhibition of IL- I 2p4O production seen in response to pentraxin- 
opsonised pathogen PAMPs (Mold et al., 2002). In this respect, EL- 10 production by whole 
organ cultures of split pinnae is reduced in FcR 7 -/- mice compared to WT animals 4 days 
post-infection with schistosomes, which is prior to the onset of antibody production (pers. 
com. K. Hogg and A. Mountford). 
Therefore, to detennine if FcR y-chain-signalling contributes to the response of 1Mý to 
released schistosome PAMPs, Mý from mice lacking the FcR y-chain were analysed for 
their ability to produce IL- 10 and IL- 12p4O following stimulation with 0-3hRM in the 
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presence of a neutral serum that lacked parasite- specific antibody. Using this system, 0- 
3hRM stimulated slightly greater levels of IL-10 production by FcR y -/- compared to WT 
iMý, suggesting that FcR y-chain signalling does not contribute to IL- 10 production 
stimulated by larval released PAMPs. It is possible that the minimal increase in IL- 10 was 
due to a slightly higher activity of the FcR 7 -/- iMý compared to the WT. Similarly, LPS 
stimulated slightly greater levels of IL-10 in the absence of FcR y-chain signalling. Since 
pentraxin-opsonised LPS has been shown to augment IL-10 production by Mý (Mold et 
al., 2002), it would be expected that LPS-stimulated IL- 10 production by FcR y -/- Mý 
would be reduced compared to WT cells. Since this was not the case suggests that the FCS 
used in these experiments did not contain these opsonins in sufficient quantities to effect 
LP S-stimulated IL- 10 production, or that bovine pentraxins may not have a similar 
function to their murine counterparts. Therefore, it remains conceivable that schistosome 
PAMPs could be opsonised in vivo by murine pentraxins, and contribute to IL- 10 
production during the inflammatory responses in the skin via ligation of the FcyRs. 
FcyR-signalling is also caused by the presence of IgG-opsonised antigen, and binding of 
pathogen material opsonised with IgG, or polyclonal antisera, can result in the dramatic 
up-regulation of IL- 10 and inhibition of IL- I 2p4O produced in response to pathogen 
PAMPs (Sutterwala et al., 1997; 1998; Gerber and Mosser, 2001). Therefore, to determine 
whether opsonisation of parasite material by specific polyclonal antibody affects the 
stimulatory properties of schistosome PAMPs, Mý from WT mice were analysed for their 
ability to produce IL- 10 upon stimulation with 0-3hRM in the presence of anti-parasite 
polyclonal serum (IRS), or neutral serum (NRS). 
There was considerable variation in the production of IL- 10 between three experimental 
repeats, with stimulation by 0-3hRM in the presence of IRS resulting in increased, 
decreased, or the same levels compared to stimulation in the presence of NRS. However, 
the profile of IL- 10 produced in response to LPS in the presence of NRS, or fRS, did not 
differ between two repeats, suggesting that the variation observed in response to 0-3hRM 
could reflect differences in the schistosome material (such as concentration) used within 
each study. Therefore, it is impossible to say what overall effect anti-parasite antibody had 
upon IL- 10 production stimulated by 0-3hRM. However, it is clear that opsonisatlon by 
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anti-parasite antibody did not dramatically up-regulate the production of IL-10 stimulated 
by 0-3hRM. 
This obviously contrasts the many recent studies that conclusively demonstrate a dramatic 
synergistic effect of IgG-, or polyclonal antibody-, opsonisation upon EL- 10 production in 
response to a variety of different stimuli, including LPS, lipoteichoic acid, and hyaluronic 
acid (Sutterwala et al., 1997; 1998; Kane and Mosser, 2001; Gerber and Mosser, 2001). It 
is possible that antibodies within the polyclonal rabbit antiserurn used in my studies did not 
efficiently bind FcRs upon the murine Mý. However, this is doubtftil since LPS opsonised 
by polyclonal anti-LPS rabbit serum exhibited IL- 10 promoting activity (Gerber and 
Mosser, 2001). Moreover, the IRS used in this study conferred partial protection against 
schistosome infection to naYve mice, confirming a biological activity within this species 
(Harrop et al., 2000). 
Since the FcR y-chain is also required for the synergistic effect of antibody-opsonised 
material upon PAMP-stimulated IL- 10 production, Mý from FcR y -/-mice were used to 
fiirther investigate whether opsonised parasite material affects 0-3hRM-induced cytokine 
production. Using this system, 0-3hRM in the presence of IRS stimulated reduced levels of 
IL- 10 (between 0.5 - 0.8-fold) by FcR y -/- compared to WT Mý. This reduction was not 
due to a general lower activity of the FcR y -/- Mý, since cytokine production in the 
presence of neutral serum (FCS) was greater by these cells (discussed above). Therefore, 
this data indicates that opsonised parasite material could signal through the FcR y-chain to 
increase EL- 10 production by Mý stimulated with released schistosome PAMPs. Although 
the common y-chain is involved in signalling through a variety of other receptors, such as 
the high affinity IgE receptor, it seems likely the contribution to IIL- 10 production was 
made through the FcyRI, which has previously been shown to mediate such effects by IgG 
complexes (Sutterwala et al., 1998). 
It was expected that production of IL- 10 stimulated by LPS in the presence of anti- 
schistosome polyclonal serum, would not be affected by the absence of the FcR y-chain. 
Therefore, it is surprising that LPS also stimulated lower levels of IIL-10 production by 
FcR y -1- Mý than WT cells in the presence of IRS. The most feasible explanation for this 
observation is that IRS also contained antibodies against LPS. In hindsight this seems 
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logical, since the 0-3hRM used to generate this serum probably contained endotoxin to 
which the rabbit would have produced antibody. 
The observation that FcR y -1- Mý produce less IL- 10 than WT cells in response to 0- 
3hRM in the presence of IRS, suggests that parasite antibody / antigen complexes 
contribute to IL- 10 production. However, addition of IRS does not cause an increase in IL- 
10 production by WT Mý compared to culture in neutral NRS. It is possible that the IRS 
and NRS varied in content of a number of biological factors (in addition to antibody) that 
could have affected Mý cytokine production, such as regulatory cytokines (e. g. TGFP). 
Subsequent titration of both NRS and IRS demonstrated both to have inhibitory effects 
upon EL-10 and IL-12 production by Mý when used at high concentrations, such as used 
in these studies, which could have masked the effect of antibody complexes (data not 
shown). Similarly, differences between IRS and FCS could account for the considerable 
variation in IL-10 production by iMý cultured in these serums. 
Although this data appears to support a role for Fc7R signalling in IL- 10 production 
stimulated by opsonised 0-3hRM, the overall contribution of this to schistosome PAMP- 
stimulated cytokine production does not appear to be great. It is possible that the 
4regulatory' profile of cytokine production by Mý (when compared to EFN7-Mý; Section 
3.4) is not greatly affected by Fc7R signalling due to high levels of EL- 10 and low levels of 
EL- I 2p4O produced by these cells. Previous studies have focused upon responses by bone 
marrow-derived Mý, which produce a more 'pro-inflammatory' cytokine profile with high 
IL- 12 and low IL- 10, and which may be more sensitive to the consequences of Fc'YR 
signals. However, it is possible that the effects of opsonised 0-3hRM could be minimal due 
to cleavage of specific antibodies, or FcRs, by proteases contained within the released 
larval material. 
There was no reliable pattern in EL-12p4O production between two repeat experiments, 
when responses of WT and FcR y -'- 1Mý to 0-3hRM, or LPS, in the presence of FCS or 
IRS were compared. Similarly, there was no reliable pattern in IL- I 2p4O production by 
WT cells when comparing the effects of culture in NRS to culture in IRS. This variability 
may reflect a lack of sensitivity in these assays due to the relatively low overall levels of 
IL- 12 produced by Mý upon stimulation with 0-3hRM. Since FcR y-chain signalling 
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appeared to effect IL- 10 production in the presence of IRS, it is surprising that there was 
not a reciprocal effect upon IL- I 2p4O production. However, FcR 7-chain signalling could 
enhance IL- 10 production without inhibiting EL- 12 production. In this respect, the 
inhibitory effect of IgG-opsonised LPS upon Mý IL-12 production is independent of the 
IL- 10 production by these cells (Gerber and Mosser, 200 1 ). 
It is noteworthy that in experiments where there was overall high levels of EL- 10 there was 
little IL- I 2p4O production (Experiment 3; Figure 5.3 c& e), whereas low levels of IL- 10 
corresponded with higher levels of IL-12p4O production (Experiment 1; Figure 5.3a & d), 
suggesting that regulation of these two cytokines was tightly balanced. However, the 
factor that was primarily responsible for the predomination of either EL- 12, or IL- 10, was 
independent of PAMP stimulus (i. e. a similar profile was observed in response to both LPS 
and 0-3hRM), and appeared to be independent of the individual cell populations (i. e. the 
profiles were the same for both WT and FcR y -1- cells). 
In conclusion, it is unclear whether FcyRs, or other receptors utilising the common y-chain, 
contribute to the profile of Mý cytokine production stimulated by released schistosome 
PAMPs in the absence of schisto some- specific antibody. Furthennore, it is not clear from 
this study whether FcyR-ligation by antibody-opsonised PAMPs affect the Mý cytokine 
production stimulated by 0-3hRM, although this may potentially contribute to the 
production of IL-10. 
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CHAPTER 6 
INDUCTION OF DC MATURATION BY RELEASED 
SCHISTOSOME PAMPS 
6.1 INTRODUCTION 
DC are involved in the initiation of both innate and acquired immune responses during 
infection with pathogens. Immature DC reside in peripheral sites, such as the dermis, or 
epidermis, where they are optimally located to act as sentinels against potential pathogens 
(Steiriman, 1991). 
Early studies of DC showed that they have high levels of pathogen specific endocytosis, 
macropinocytosis and phagocytosis (Reis e Sousa et al., 1993; Sallusto et al., 1995). 
Further characterisation demonstrated that upon exposure / contact with pathogen stimuli, 
in vitro-cultured DC switch from a state of highly active environment sampling and 
antigen processing to a state of low environmental sampling (Cella et al., 1997). This 
change corresponded with dramatic up-regulation of MHC 11 expression and a switch from 
low to high T-cell stimulatory capacity, therefore allowing antigens captured at the site of 
infection / stimulation to be presented to T-cells (Cella et al., 1997). These two cellular 
states have been classified as 'immature', charactensed as expressing low levels of MHC 
11, and 'mature', charactensed as expressing high levels of MHC 11 (Pierre et al., 1997; 
Banchereau and Steinman, 1998; Sparwasser et al., 1998). 
DC have a unique ability to prime CD4+ T-cells (Steinman, 1991). This ability is due 
partly to their efficient capture and presentation of antigens, and partly to their capacity to 
migrate to, or their location in, T-cell areas of the local lymphoid tissue (Jenkins et al., 
2001). 
Studies of both human and murine DC demonstrate that they mature upon contact with a 
variety of different pathogens, or pathogen products, such as LPS (Cella et al., 1997; Lutz 
et al., 1999), CpG DNA (Sparwasser et al., 1998), dsRNA (Cella et al., 1999), Zymosan A 
(Reis e Sousa et al., 1993), and bacterial lipopeptide (Horng et al., 2002). However, it is 
becoming more fully understood that host molecules may play an important role in the 
maturation status of DC. Tissue factors, such as prostaglandins (PGE2) can drive human 
DC maturation, as can inflammatory cytokines such as TNF(x (Rieser et al., 1997; Cella et 
al., 1997). Indeed, inflammatory cytokines may be critical to the maturation of certain DC 
subsets (Cumberbatcb and Kimber, 1995; Wang et al., 1997; Cumberbatch et al., 1997a). 
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Moreover, contact with necrotic cells, danger signals, or physical trauma, can result in DC 
maturation (Gallucci et al., 1999; Johnson et al., 2002, Ten-neer et al., 2002). 
In addition to pathogen and host tissue factors, signals from effector T-cells, such as 
CD40L, can directly stimulate human and murine DC in vitro (Cella et al., 1996; Kelsall et 
al., 1996) and enhance DC maturation in vivo (Schulz et al., 2000). This provides evidence 
that feedback received by DC from T-cells during antigen presentation, could ultimately 
affect the outcome of priming. Indeed, it appears that ligation of CD40 can act as an 
amplification signal, enhancing the maturation phenotype of DC following stimulation 
with PAMPs and allowing the full display of maturation-associated factors (Schulz et al., 
2000; Edwards et al., 2002). 
Upon maturation, both human and murine DC up-regulate a variety of different cytokines, 
such as IL- 12, IL-6, and IL- 10, and membrane bound co-stimulatory factors, such as 
CD40, CD80, CD86, and OX40L. Further studies will undoubtedly continue to identify 
additional factors that can define the mature DC phenotype. However, it is only recently 
that the plasticity of the DC response to different stimuli has been fully appreciated. 
Several elegant studies have demonstrated that depending upon the source of stimuli, DC 
mature to different phenotypic states (d'Ostiam et al., 2000; Whelan et al., 2000; Huang et 
al., 200 1; MacDonald et al., 200 1; de Jong et al., 2002). These host factor / pathogen 
programmed responses are so specific that the DC can discriminate between different 
cellular states of the same pathogen (d'Ostiani et al., 2000). Moreover, the difference in 
maturation state leads directly to selective polarisation of the Th cell population during 
priming (d'Ostiani et al., 2000; Whelan et al., 2000; MacDonald et al., 2001; de Jong et 
al., 2002; McGuirk et al., 2002). Thus, depending upon the DC maturation signal, DC are 
instructed to mature to different states capable of priming for Thl, Th2, or 'Treg' 
polarisation. 
In the context of schistosome infection, there is evidence of epiderinal APC maturation, 
corresponding with up-regulated MHC 11 and CD86 expression (Angeli et al., 2001 a). 
Moreover, MHC Il+ cells accumulate in the dermis directly below schistosome larvae 
following infection (Riengrojpitak et al., 1998), and data emerging from our laboratory 
suggests that LC are stimulated to migrate from the epidennis, and IL-12-producing 
'myeloid' DC spontaneously migrate from the skin following vaccination with irradiated 
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cercariae (Kumkate et al., 2003; Hogg et al., 2003a). However, it is still not known if 
schistosome PAMPs directly stimulate these cells, or if tissue-derived inflammatory / 
'danger' signals produced during infection result in LC or DC maturation. Moreover, the 
maturation phenotype of DC exposed to schistosome PAMPs is not known. Since PAMPs 
released by transfon-ning cercanae are potent stimulators of iMý cytokine production, it is 
a reasonable hypothesis that these PAMPs will also drive DC maturation. However, in 
order to test this hypothesis, and to assess the maturation state that is induced, an in vitro 
stimulation assay is required. 
DC are rare within both lymphoid and non-lymphoid tissues, making it difficult to isolate 
sufficient numbers for the in vitro analysis of cell function. Several methods have been 
developed to increase the number of DC in vivo, enabling their subsequent recovery ex 
vivo. Injection of mice with 1710 ligand increases the numbers of DC found within a variety 
of organs, including LN and bone marrow (Maraskovsky et al., 1996). In addition, mice 
over-expressing GM-CSF had 3-fold more DC in their LN, than wild-types (Vremec et al., 
1997), although injection of GM-CSF did not have the same result (Maraskovosky et al., 
1996). However, these methods still do not result in sufficient cell numbers to study the 
effect of schistosome PAMPs on DC maturation and function. 
As an alternative to studying ex vivo DC, a method was developed for the generation of 
DC from murine blood borne precursors cultured in vitro with GM-CSF (Inaba et al., 
1992a). However, the yield from this technique was low, and it was quickly superseded by 
one using murine bone-marrow (13M) precursor cells cultured in vitro with GM-CSF, 
which generated a much higher yield (Inaba et al., 1992b). Since then, this technique has 
undergone numerous adaptations by different groups to produce DC of greater purity and 
higher yield (Lutz et al., 1999; Son et al., 2002). In turn, this has enabled the interaction 
between DC, pathogens, and host factors, to be studied in more detail. Therefore, this 
method was chosen to generate DC with which to study the effect of schistosome PAMPs. 
The literature is inconclusive over a single preferred method for the in vitro culture of BM- 
derived DC due to the many adaptations made by individual groups. Important culture 
factors frequently vary between different reports, including the type of culture vessel, 
length and regime of culture, deletion of erythrocytes before culture, deletion of non- 
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adherent cells during culture, and the cellular, or GM-CSF, concentration. Therefore, a 
number of factors relevant to the in vitro culture of BM-derived DC will be optimised at 
the start of this study. Four criteria were judged to be important in the optimisation 
process: 1) large scale generation of immature DC (IDC), 2) purity of 1DC after six days of 
BM culture with GM-CSF, 3) sensitivity of iDC to stimulation with PAMPs, as Judged by 
the fold increase in activation / maturation markers compared to non-stimulated cells, and 
4) purity of mature DC (mDQ resulting from overnight stimulation of iDC with PAMPs. 
The aim of this chapter is to determine whether schistosome P"Ps stimulate DC to 
mature. In this respect, the phenotype of the resulting mDC will be studied in detail. In 
order to gain perspective on the outcome of DC stimulation with schistosome PAMPs, the 
maturation phenotype of the resulting cells will be compared to that of DC matured using 
classical pathogen PAMPs (LPS & Zymosan A). These PAMPs will be chosen based upon 
their ability to 'instruct' DC to prime for Thl or Th2 polarised responses. In addition, the 
outcome of CD40 ligation during PAMP-induced DC maturation will be studied. 
6.2 MATERIALS AND METHODS 
6.2.1 Animals 
All mice were maintained in open housing at the University of York animal unit. C57131/6 
mice were bred in house, while BALB/c mice were obtained from Harlan UK. C57BI/6 
mice were used in all experiments unless specified. 
6.2.2 Generation of DC from bone marrow 
Two methods for the generation of iDC from bone marrow precursors were compared to 
determine which produced the most suitable cells for screening stimulatory properties of 
PAMPs. For these experiments, the purity of iDC and mDC, and the analysis of mDC 
maturation states, was deten-nined by analysis of myeloid differentiation marker expression 
using flow cytometry. 
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Allethod I. - Culture 'Flask'generation. This method, previously described by Whelan et al. 
(2000) and adapted from Inaba et al. (1992b), was learrit whilst visiting Kevin Rigley's 
laboratory at the Edward Jenner Institute for Vaccine Research. The culture medium 
(DCF) consisted of Iscoves MEM Glutamax 1, containing 200 U/ ml penicillin, 100 ýtg 
ml streptomycin, 50 VtM P-mercaptoethanol (Invitrogen), and 10% heat- inactivated low- 
endotoxin FCS (Harlan Seralab). Bone marrow cells were removed from the femurs and 
tibias of sacrificed C57131/6 mice as previously described (Lutz et al., 1999). Briefly, bones 
were cleaned of muscle and sterilised in 70% alcohol for I min. Bone marrow was then 
flushed-out with DCF using a 23-gauge needle, and cell clusters dissociated by gentle 
pipetting. Cells were cultured in 75 cm 2 tissue-culture flasks (I X 106 cells / ml) in 25 ml 
DCF supplemented with 20 ng / ml GM-CSF (Peprotech, London, UK), at 37 'C, in a 
humidified incubator. On day 4, the spent media (containing the non-adherent cell fraction) 
was carefully removed and discarded, and the flask containing the adherent and semi- 
adherent cells replenished with 25 ml fresh DCF, containing 20 ng / ml GM-CSF. Semi- 
adherent cells were defined as those that would detach from the adherent cell monolayer by 
gentle agitation of the culture medium. Two days later, the non-adherent and semi-adherent 
cell populations were recovered by gentle agitation and used as 1DC. 
Method 2: Culture ýplate'generation. This method, previously described by Son et al. 
(2002) and adapted from Inaba et al. (I 992b), was provided by Melanie Leech (University 
of Manchester). The culture medium (DCP) consisted of RPMI 1640 containing 2mM L- 
glutamine (Invitrogen) and all supplements as added to DCF media. Bone marrow was 
removed as described above. Prior to culture, red blood cells were lysed with ACK buffer 
(Section 4.2.2) and the remaining cells washed three times with DCP. The cells were then 
cultured in 6-well tissue-culture plates (Nalge Nunc) at a concentration of 1.8 x 106 cells 
well in 3 ml of DCP supplemented with 20 ng / ml GM-CSF. On day 4, a further 3 ml of 
DCP, containing 40 ng / ml GM-CSF, was added. Two days later, non-adherent and serm- 
adherent cells were recovered by gentle agitation and used as 1DC. 
6.2.3 DC stimulation and maturation 
For the comparison of DC generation techniques, iDC were seeded into 24-well, or 96-well 
tissue-culture plates (Nalge Nunc), at IX 106 cell / ml, in DCF or DCP containing 20 ng 
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ml GM-CSF. The cells were then cultured for 24 hr alone, or in the presence of LPS (10 ng 
/ ml; see below). 
Subsequently, 1DC generated using the selected method were used to determine the 
outcome of activation with different pathogen, or parasite, PAMPs. Specifically, IDC 
derived from C57131/6, or BALB/c, bone marrow were cultured for 24 hr in DCP 
containing 20 ng / ml GM-CSF as follows: 
* In media alone. 
Or with: 
e 0-3hRP, SCP, 3hSSP, 18hSSP (all 1.1 - 40 ýtg / ml; prepared as described in Section 
2.2.1). 
* Concentrated medium control RPMIc (for 0-3hRP) 
9 Zymosan A (0.2 -5 ýtg / ml; Sigma-Aldnch). 
9 LPS(1-100ng/ml; E. coliscrotypeOlll: B4; Slgma-Aldnch)- 
Assays were carried out in the presence, or absence, of PMB (0.1 - 27 ýtg / ml; Sigma- 
Aldrich) where indicated. Additionally, in some experiments low-endotoxin anti-CD40 
antibody (5 ýtg / ml; clone HM40-3; BID PharMingen) was added to the culture at the time 
of exposure to PAMPs. 
After culture overnight with the different PAMPs, the semi-adherent mDC were harvested 
and analysed for expression of surface markers. Culture supernatants were frozen and 
stored at -20 T to await detection of cytokines by ELISA. 
6.2.4 Phenotypic characterisation of DC populations 
To deten-nine the purity of DC cultures, iDC were analysed for the surface expression of 
myeloid (CD IIc, F4/80, Gr-I) and lymphoid (13220, CD4, CD80c) differentiation markers. 
In addition, mDC resulting from culture with different PAMPs were analysed for surface 
expression of CD IIc and maturation / activation markers (MHC 11, CD40, CD80, CD86 
and OX40L). Cells were stained with specific antibodies, or irrelevant isotype matched 
antibodies using the method previously described (Section 3.2.3.2). Antibodies against 
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various surface markers were as follows (clone; supplier): FITC- or PE-conjugated CD IIc 
(HU; BD PharMingen), CD40 (3/23; BD PharMingen), CD80 (R-MMP-1; Caltag), CD86 
(P, MMP-2; Caltag), Gr-I (RB6-8C5; Caltag), F4/80 (CIA3-1; Caltag), B220 (RA3-6132; 
BD Pharmingen), CD4 (CT-CD4; Caltag), CD8ot (53-6.7; BD PharMingen), or biotin- 
conjugated I-A b, d (28-16-8S; Caltag) and biotin-conjugated OX40L (RM I 34L; 
PharMingen), followed by streptavidin-conjugated Quantum Red TM (QR; Sigma). Where 
specified, two-colour staining was used to analyse co-expression of activation markers and 
CDl Ic on mDC. In this context, the respective antibodies were conjugated to different 
fluorochromes. 
To detennine the number of dead cells, 10 [il of PI (200 mg / ml PI in PBS) was added to 
relevant cell aliquots and incubated for 20 sec before flow-cytometric analysis. Those 
staining positive for PI were considered dead. 
In some experiments, DC were also analysed for expression of intracellular IL- I 2p4O, or 
IL-4, as previously described (Hogg et al., 2003a). Briefly, Golgi Plug TM (I ýig / ml; BD 
PharMlngen) was added to the mDC culture 6 hr before harvesting. DC were first labelled 
with CD II c-FITC as described above. Cells were then fixed and permeabilized with 
Cytofix / Cytoperm TM (131) PharMingen) according to manufacturer's instructions, and 
stained with PE-labelled IL- I 2p4O mAb (clone #C 15.6; BD PharMingen), or IL-4 mAb 
(clone BVD6-24G2; Caltag). 
Cells were analysed by one-colour, or two-colour, flow-cytometry as previously described 
(Section 3.2.3.4 - 3.2.3.5, or Section 4.2.2, respectively). Low expression of I-A and CD86 
is constitutive on some DC but levels of these markers can be up-regulated following 
stimulation. In order to deterimne the percentage of cells expressing high levels of I-A or 
CD86, the cursor was set to exclude all negative and low-level expressing events. 
6.2.5 Cytokine ELISAs 
In addition to the cytokines studied in Chapter 3, DC culture supernatants were tested for 
production of IL-12p7O, IL-4, and IFNy, using ELISA (Section 3.2.6). Supernatants were 
tested neat, or at 1: 2,1: 5,1: 10, or 1: 20 dilutions. Lower limits of detection are shown on 
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figures as dashed lines, or arrows. The IL-12p7O ELISA incorporated the same 
recombinant standard and detecting antibody as the IL-12p4O ELISA (Section 3.2.6), but 
uses an IL- I 2p7O-specific capture antibody (Clone 9A5; BID PharMingen). The antibodies 
for the other additional cytokines were also obtained from BD PharMingen as follows: 
(coating clone; detecting clone): IL-4 (BVD I-ID 11; BVD6-24G2) and LFN7 (R4-6A2 
XMGI. 2). Recombinant standards were as follows: IL-4 (BID PharMingen) and EFN7 
(2A II CHO cell supernatant). 
6.2.6 Statistics 
Data comparisons were tested for significance using the one-tailed Students t-test, 
assuming equal variance if p>0.05 when tested with the Levene's test. Values where p:! ý 
0.05 were considered to be significant, whereas values wherep > 0.05 were considered not 
significant. The following nomenclature was used to denote the value of the significance: 
*p:! A. 05, **p:! ý0.0l, ***p:! ý-0.001. 
6.3 RESULTS 
6.3.1 Generation of maturation-inducible iDC from BM precursor cells. 
'Plate' and 'Flask' methods of generating 1DC from BM precursors were compared. The 
major differences in these techniques are summari sed in Table 6.1. Between the two 
techniques, no difference was observed in the purity of iDC generated from BM after six 
days of culture with GM-CSF, as determined by expression of the DC marker CDI Ic (40% 
versus 39% for 'Plate' and 'Flask' methods respectively; Table 6.1). In contrast, the Yield 
of putative 1DC compared to the starting cell number was twice as high using the 'Plate' 
technique compared to the 'Flask' technique (2.2-fold versus no increase; Table 6.1). 
After transfer to 24-well plates and further overnight culture in the presence of GM-CSF, 
the purity of CD II c+ cells increased in both 'Plate' and 'Flask' generated populations, 
although the former were considerably purer (53% versus 44%, respectively-, Table 6.2a). 
Matured DC (mDQ generated using both techniques showed greatly up-regulated 
expression of high levels of MHC 11 (MHC , high ) after culture with LPS (48% 'Plate'; 32% 
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'Flask') compared to DC cultured alone (27% 'Plate'; 20% 'Flask'; Table 6.2a). Moreover, 
the percentage of mDC expressing CD40, also increased upon stimulation with LPS (58% 
'Plate'; 45% 'Flask') compared to DC cultured alone (34% 'Plate'; 31% 'Flask'-, Table 
6.2a). However, the increase in levels of expression of MHC 11 high and CD40 on LPS- 
stimulated DC compared to DC cultured alone, was slightly greater in the 'Plate'-generated 
population (1.8-fold and 1.7-fold respectively) compared to the 'Flask'- generated 
population (1.6-fold and 1.5-fold respectively; Table 6.2b). Thus, the 'Plate' generation 
technique was used for all subsequent experiments, due to the higher yield of 1DC, the 
higher purity of CD 11 c+ cells after further overnight culture of iDC, and the greater 
sensitivity of iDC to stimulation with LPS. 
Further adaptations to the 'Plate' generation method (e. g. using only BM from femurs) 
increased the purity of CDI lc+ cells in the 6 day old iDC population to 59% (Figure 6.1 a), 
although in many experiments the purity of CD II c+ cells reached 70% (data not shown). 
To ensure reasonable consistency between experiments, iDC were routinely tested for 
CD IIc expression. Analysis of size and granularity of the cells shows that granularity 
increases with size in a continuum, such that there are not any distinct individual cell 
populations (Figure 6.1 b). However, further analysis shows that the CD II c+ population 
comprises the largest and most granular cells, whereas the CD II c- population comprises of 
the smallest and least granular cells (Figure 6.1 c& d). Moreover, the vast majority of the 
large granular population are CD II c+. Indeed, a quadrate placed on the size versus 
granularity scattergram effectively distinguishes the CD 11 c+ and CD II c- populations, with 
85% of CD 11 c+ cells and only II% of CD 11 c- cells in box (11). 
More in-depth phenotypic characterisation of the iDC population demonstrated that nearly 
half (48%) of the cells were MHC II+ (Figure 6.2i. a). Moreover, two distinct groups 
existed within this population, one expressing high levels, and one expressing low levels of 
MHC 11 (Figure 6.2ia). Importantly, the MHC 11 low expressing cells were greater in 
number (27% compared to 21 %), suggesting that the majority were of an immature state, 
and J usti fying their description as iDC. Most of the MHC ll+ cells were located in the large 
granular population (Figure 6.2ib). As most of the large granular cells were CD II c+ 
(Figure 6.1), this suggests that the MHC ll+ cells are also CD1 lc+. Indeed, further 
characterisation using two-colour flow-cytometry, showed that 95% of the MHC ll+ cells 
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were CID II c+ (Figure 6.2na& b). Moreover, 95% of the CD I 1c- cells were MHC IF (data 
derived from Figure 6.211). 
Analysis of other myeloid differentiation markers, demonstrated that 46% of iDC were 
F4/80 + and 24% were Gr-1+ (Figure 6.2ia). The F4/80+ cells were of the large granular 
population, suggesting that they were also CID II c+ (Figure 6.2ib). In contrast, the majority 
of the Gr- I+ cells were of the small / low granular population, and so were distinct from the 
CD II c+ cells (Figure 6.2ib). Analysis with other leukocyte markers showed that there were 
no CD4+, or CD8+, cells (data not shown) and only 2% of cells were B220+ (Figure 6.2i. a). 
6.3.2 Optimisation of PMB concentration for use in iDC stimulation assays. 
In order to deten-nine the effects of schistosome PAMPs upon iDC, PMB was used to 
inhibit the potential stimulatory effects of low levels of contaminating endotoxin. PMB 
concentration had previously been optimised to inhibit endotoxin stimulation of 1Mý 
following culture with parasite PANIPs (Section 3.3.3). However, due to potential 
differences between these accessory cells, the concentration of PMB was optimised for 
culture with iDC using E. coli LPS as a model endotoxin. Both concentrations of LPS (10 
and 100 ng /m 1) stimulated high levels of IL- 12p4O and IL-6 production compared to iDC 
cultured alone (Figure 6.3). However, these stimulatory properties were blocked by PMB 
in a dose-dependent manner, with 1 ýtg / ml PMB completely blocking 10 ng / ml LPS, and 
3 Vg / ml PMB completely blocking 100 ng / ml LPS. Therefore, 3 ýLg / ml PMB was used 
in further assays to ensure sufficient blocking of endotoxin. In addition, this concentration 
of PMB had little effect on the IL-12p4O and IL-6 production produced in response to 
Zymosan A (Figure 6.4), suggesting it would not interfere with the stimulatory properties 
of schistosome PAMPs. Furthermore, PMB (0.1 -9 ýtg / ml; tnpling dilution) had no effect 
on the viability of iDC cultured alone, as determined by PI staining (data not shown). 
6.3.3 0-3hRP but not other schistosome preparations, stimulates cytokine production 
by iDC- 
The stimulatory properties of the different schistosome PAMP preparations were screened 
using iDC cultured in the presence of PMB. 0-3hR_P stimulated a dose-dependent increase 
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in both IL-12p4O and IL-6 production by iDC (Figure 6.5a & b). In contrast, the soluble 
whole larval preparations, SCP, 3hSSP and 18hSSP, and the RPMIc control, did not 
stimulate increased production of either cytokine (Figure 6.5a & b). Similarly, in separate 
experiments the soluble whole larval preparations 3dSSP, 5dSSP, and 8dSSP, did not 
stimulate increased cytokine production (data not shown). No IL-10 was detected in any of 
the supernatants. It is noteworthy that in the absence of PMB, 0-3hRP stimulated 
production of 3- to 7-fold more IL-12p4O, and 9- to 12-fold more IL-6, than in the presence 
of PMB. This demonstrates the sensitivity of iDC to the low levels of endotoxin within 0- 
3hRP and supports the continued use of PMB to analyse the effect of schistosome PAMPs 
on iDC in the absence of endotoxin signalling. 
Since 0-3hRP exhibited greater stimulatory properties compared to other schistosome 
preparations, the study focused upon the response of 1DC to these released molecules. 
Since 40 ýtg / ml of 0-3hRP stimulated the greatest levels of IL-6 and IL- I 2p4O production, 
this concentration was used in all further studies, unless indicated. 
6.3.4 Cytokine response of DC to 0-3hRP compared to other PAMPs. 
There were no significant differences in IL- I 2p4O or IL-6 production by DC cultured with 
PMB, RPMlc + PMB, or LPS + PMB, compared to DC cultured alone (Figure 6.6a & b). 
Conversely, in the presence of PMB, 0-3hRP stimulated a significant increase in the levels 
of IL- I 2p4O (2-fold) and IL-6 (I O-fold) produced compared to all negative controls (Figure 
6.6a & b). However, the increase in IL-12p4O was small compared to that stimulated by 
LPS (198-fold) and Zymosan A (308-fold) (Figure 6.7a). Similarly, 0-3hRP + PMB 
stimulated only a small increase in IL-6 production (10-fold) when compared to LPS (282- 
fold) and Zymosan A (165-fold) (Figure 6.7b). Interestingly, LPS and Zymosan A 
stimulated different profiles of cytokine production, the former stimulating the highest 
level of IL-6, and the latter stimulating the highest levels of IL- I 2p4O. 
6.3.5 CD11c+ cells are the source of IL-12p4O stimulated by PAMPs. 
Two-colour flow-cytometry was used to identify the cellular source of the IL- I 2p4O 
detected in the culture supernatants of the enriched DC population. It is clear that after 
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culture with RPMIc, 0-3hRP, LPS, or Zymosan A, the vast majority of the IL-12p4O' cells 
were CD II c+ (94%, 96%, 87%, and 84%, respectively; Figure 6.8). Moreover, the 
percentage of CDI lc+ IL-12p4O+ cells increased after culture with 0-3hRP (13%), LPS 
(58%) and Zymosan (56%), compared to the RPMlc control (6.6%). In addition, the 
CDI Ic+ IL-12p4O+ cells had higher intensity of cytokine staining (as judged by the median 
fluorescence value) after culture with 0-3hRP (1.5), LPS (6.8) and Zymosan A (5.2) 
compared to the RPMIc control (1.1). This control was chosen as it had the highest 
background percentage of IL- I 2p4O+ cells relative to DC cultured alone, DC cultured with 
PMB, or DC cultured with LPS + PMB (data not shown). However, stimulation with 0- 
3hRP resulted in a lower percentage of CDI lc+ IL-12p4O+ cells and a lower intensity of 
IL- I 2p4O staining than LPS and Zymosan A, as would be expected from the profiles of 
cytokine released into the culture supernatant (Figure 6.7a). 
6.3.6 Phenotype of DC activated with 0-3hRP compared to other PAMPs. 
The up-regulation of MHC 11 complexes and co-stimulatory molecules during maturation 
greatly contributes to the APC function of DC. Therefore, expression of MHC 11, and the 
co-stimulatory molecules CD40, CD80, CD86, and OX40L, on DC stimulated with 0- 
3hRP was compared to DC stimulated with LPS, or Zymosan A. Two-colour flow- 
cytometry was used to compare the expression of CD IIc versus MHC 11 by the DC. 
However, due to limitations on availability of cells for flow-cytometric analysis, it was not 
possible to perforrn similar two-colour staining for co-stimulatory molecules. Therefore, 
analysis of CD40, CD80, CD86, and OX40L expression, was performed on the whole 
population of enriched DC. In the following experiments, expression of MHC II and co- 
stimulatory molecules was also detennined on DC cultured alone, or with PMB, LPS + 
PMB, or RPMIc + PMB. However, there was no significant difference between these 
controls. Therefore, only the data for DC cultured alone, or with RPMIc + PMB, which 
were the controls with the greatest background staining for MHC 11 and all the co- 
stimulatory molecules, are shown in the following figures. 
The CID IIc expression on DC changed after stimulation with different PAMPs (Figure 
6.9a & b). Indeed, LPS and Zymosan A led to an increase in the percentage of CD II c+ 
cells within box A. Most importantly, 0-3hRP (and RPMIc) had little effect on CDI Ic 
expression compared to DC cultured alone. However, any variation in the proportion of 
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CD II c+ cells between stimulation regimes would lead to difficulty in analysing the relative 
expression of co-stimulatory molecules upon the iDC using only one-colour staining. 
Therefore, only the larger most granular cells, previously shown to contain the vast 
majority of CDI Ic+ cells (Figure 6.1), were analysed by gating on box H (Figure 6.9c). 
Consequently, the difference in CDI Ic expression between DC cultured alone and DC 
stimulated with Zymosan A, or LPS, was dramatically reduced (Figure 6.9d). However, 
even gated on box H, there was still a slight increase in CD IIc expression on cells cultured 
with LPS, or Zymosan A, but because the overall levels of CD II c+ expression were very 
high (88% - 92%), this difference is much less relevant. Thus, for the surface expression of 
CD40, CDSO, CD86, and OX40L, only the large granular cells within H were analysed. 
This also increased the sensitivity of the system, as any change in the surface expression of 
co-stimulatory molecules on the CD II c+ cells would become more apparent. 
0-3hRP appeared to stimulate an increase in the percentage of CD II c+ cells expressing 
MHC 11 (Figure 6.10a). Moreover, the proportion of CD II c+ cells expressing MHC 11 high 
appeared to be greater for 0-3hRP-matured DC than for DC cultured alone, or with RPMlc 
(Figure 6.1 Ob). However, in both cases this was not significant and the levels of expression 
were lower than that stimulated by LPS and Zymosan A (Figure 6.1 Oa & b). 
0-3hRP stimulated slight up-regulation of both CD40 and high levels of CD86 (CD86 high 
expression compared to DC cultured alone or with RPMlc, but these levels were not 
significantly different (Figure 6.11 a& b). In contrast, DC stimulated with LPS or Zymosan 
A dramatically up-regulated CD40 (p < 0.05, andp < 0.01, respectively) and CD86 high (P 
< 0.05, and p<0.05, respectively) expression. 0-3hRP did not stimulate an increase in the 
proportion of cells expressing CD80 or OX40L, compared to DC cultured alone or with 
RPMIc (Figure 6.11 c& d). LPS and Zymosan A had differential effects on the expression 
of these co-stimulatory molecules. LPS appeared to up-regulate expression of CD80, but 
did not up-regulate expression of OX40L, whereas Zymosan A up-regulated expression of 
OX40L (p < 0.01) but not CD80. 
6.3.7 The response of BALB/c MC to 0-3hRP compared to other PAMPs. 
In order to detennine if maturation with 0-3hRP effected the capacity of DC to prime and 
polarise T-cells, it was necessary to use DC on a BALB/c background (Chapter 7). 
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Therefore, the maturation phenotypes of BALB/c DC were characterised after stimulation 
with 0-3hR-P, or the control pathogen PAMPs- 
6.3.7.1 Cytokine production. 
0-3hRP stimulated a highly significant increase in both EL-12p4O (P < 0.001) and IL-6 (P < 
0.001) production by BALB/c DC compared to controls (Figure 6.12a & b). This was 
dose-dependent, with a 7-fold and 18-fold increase in IL-6, and a 4-fold and 9-fold 
increase in IL- I 2p4O, after stimulation with 20 ýtg / ml and 40 pg / ml of 0-3hRP 
respectively. However, 0-3hR-P stimulated dramatically lower levels of IL-6 and IL- I 2p4O 
than LPS, or Zymosan A (Figure 6.13a & b). Notably, this was the same when a lower 
dose of LPS (I ng / ml), or a higher dose of Zymosan A (5 ýtg / ml) was used (data not 
shown). 0-3hRP did not stimulate detectable production of IL-12p7O, IL-10, or TNF(X, in 
contrast to LPS and Zymosan A (Figure 6.13c, d, e). Moreover, 0-3hRP did not stimulate 
production of IL-1p, in contrast to LPS (Figure 6.13f). It is worth noting that LPS and 
Zymosan A stimulated different profiles of cytokine production compared to each other. 
LPS stimulated higher levels of IL-6, IL- I P, and IL- 10, whereas Zymosan A stimulated 
higher levels of IL- 12p7O. Notably, IL-4 and IFNy were not detected in any of the 
supernatants. 
Similar to C57BI/6 DC, the percentage of IL-12p4O+ CDI Ic+ cells increased after culture 
with 0-3hRP (I I%), LPS (72%) and Zymosan (30%), compared to the negative control 
(6%) (Table 6.3). Again, similar to C57BI/6 DC, the vast majority of the IL-12p4O+ cells 
were CD II c+ (up to 94%) (Table 6.3). 
In contrast to the absence of detectable levels of IL-4 in DC culture supernatants, an 
increase in the percentage of IL-4 + cells was observed after stimulation with 0-3hRP 
(14%), or LPS (30%), compared to control (10%) (Table 6.3). In contrast, stimulation with 
Zymosan A appeared to decrease the number of IL-4+ cells (7%). Similar to IL- I 2p4O, the 
vast maj ority of the IL-4+ cel Is were CD II c+ (up to 94%). 
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6.3.7.2 MHC H and co-stimulatory molecule expression. 
As in Section 6.3.6, MHC 11 and co-stimulatory molecule expression upon BALB/c DC 
cultured alone, or with PMB, LPS + PMB, or RPMlc + PMB, was deten-nined. However, 
since there was no significant difference between these controls, only the data for DC 
cultured alone and RPMlc + PMB are shown. 
All PAMPs, including 0-3h-RP, stimulated an increase in the percentage of CD II c+ cells 
expressing NIHC II, although this was only significant (p < 0.05) for LPS and Zymosan A 
treatments (Figure 6.14a). However, 0-3h" stimulated a significant (p < 0.05) increase in 
the percentage of CD II c+ cells expressing MHC 11 high (70%) compared to negative 
controls (50%), but this was not as high as stimulated by LPS (76%) and Zymosan A 
(82%) (Figure 6.14b). A lower dose of 0-3hRP (20 ýtg / ml) also up-regulated expression of 
MHC 11 and MHC , high , although to a 
lesser extent than 40 ýLg / ml (data not shown). It is 
noteworthy that similar to iDC, analysis of all MHC II+ cells within the mature DC 
populations revealed that the vast majority (approximately 95 %) were CD II c+ (data not 
shown). 
Similar to the study of C57131/6 DC, analysis of co-stimulatory factor expression upon 
BALB/c DC was focused on the large granular cells (within box H) of the mDC 
population. Again, the vast majority of these cells were CD II c+ (Figure 6.15), with very 
few CD II c+ excluded by this method (< 10%; data not shown). Moreover, the proportion 
of CD II c+ cells within this population did not significantly vary between the differently 
stimulated DC groups (Figure 6.15). 
0-3hRP stimulated significant (p < 0.05) up-regulation of CD40 and CD86 
hh 
expression 
but not to the same extent as LPS or Zymosan A. (Figure 6.16a, & b). Again, a lower dose 
high 
of 0-3hRP (20 Vg / ml) also up-regulated expression of CD40 and CD86 , although to a 
lesser extent than 40 ýtg / ml (data not shown). As observed using C57131/6 DC, 0-3hRP did 
not stimulate up-regulation of CD80 and OX40L, whereas the differential effect of LPS 
and Zymosan A on these co-stimulatory molecules was clear. In this respect, LPS up- 
regulated CD80 (p < 0.05) but not OX40L expression, whereas Zymosan A up-regulated 
OX40L (p < 0.05) but not CD80 expression (Figure 6.16c & d). In addition, the phenotype 
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of DC stimulated with a lower dose of LPS (I ng / ml) was similar to those stimulated with 
100 ng / ml (data not shown). 
6.3.8 Ligation of CD40 effects the profile cytokines produced in response to 0-3hRP. 
Ligation of CD40 can amplify the maturation phenotype of differentially stimulated DC 
(Edwards et al., 2002). In order to detennine if the cytokine profile produced by 
stimulation with 0-3hRP is modified by CD40-signalling, DC were co-cultured with anti- 
CD40 antibody. The presence of the antibody substantially increased IL-12p4O production 
by both non-stimulated DC (10-fold) and by 0-3hRP-stimulated DC (4-fold) (Figure 
6.17a). In contrast, ligation of CD40 had much less of an effect on IL-6 production with 0- 
3hRP-stimulated DC producing just 1.6-fold more cytokine in the presence of the antibody 
(Figure 6.17b). Moreover, anti-CD40 stimulated only a marginal increase (1.3-fold) in 
spontaneous IL-6 production by DC cultured alone. In some experimental repeats IL-6 
production was up to 3-fold greater in the presence of anti-CD40, however, the effect on 
IL- I 2p4O production was always greater (data not shown). No IL- 10 (Figure 6.17c), IL- 
12p7O, IFNy, or IL-4 (data not shown), was detected in any of the supernatants. 
In addition, culture with the anti-CD40 antibody greatly increased the proportion of 
CD II c+ cells staining positive for IL- I 2p4O after culture alone (3.5-fold), or with 0-3hRP 
(2-fold), or Zymosan A (2-fold) (Table 6.4). In contrast, anti-CD40 treatment did not 
increase the percentage of IL-4+ cells after stimulation with 0-3hRP, or Zymosan A (Table 
6.4). Indeed, fewer DC cultured in the absence of PAMPs were IL-4+ in the presence of 
anti-CD40 antibody. Only the DC population stimulated with LPS appeared to contain 
more EL-4+ cells in the presence of the antibody, although this increase was slight (1.2- 
fold). 
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6-well 'Plate' 75 cm' 'Flask' 
Generation Generation 
CD11c' Purity of day 6 40% 39% 
iDC a 
Day 0 Cell Number b 1.8 x 106 / well 25 x 106 / Flask 
Day 6 Cell Number' 4x 106 / well 26 x 106 / Flask 
Cell Yield 2.2 1 
Day O: Day 6 
Cell Number 
Depletion of erythrocytes Yes No 
within fresh BM 
Depletion of non- No Yes 
adherent cell population 
during culture 
GM-CSF 20 ng / ml 20 ng / ml 
Medium RPM11640+10%FCS IscovesMIEM+10% 
FCS 
Culture Regime Day 3: Add 100% more Day 4: Discard 100% 
media, and then GM- of spent culture 
CSF to 20 ng / ml medium, replace with 
concentration new, and add 20 ng 
throughout. ml GM-CSF. 
Table 6.1 Comparison of BM-derived iDC culture techniques. 
'Values represent the percentage of cells staining positive with specific Ab 
compared to matched isotype controls, as determined by flow-cytometry. 
b Values represent the number of BM cells. 
'Values represent the number of non- and semi-adherent cells. 
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a. 
'Plate' Generation 'Flask' Generation 
LPS Treatment 0 10 0 10 
nglml 
CD11c 53% 56% 44% 46% 
MHC 11 high a 27% 48% 20% 32% 
CD40 34% 58% 31% 45% 
b. 
'Plate' Generation 'Flask' Generation 
N4_HC 11 
high a 1.8 1.6 
CD40 1.7 1.5 
Table 6.2 Effect of LPS stimulation on the expression of surface 
markers on iDC generated by different methods. BM precursor cells 
were grown in the presence of GM-CSF for 6 days in culture flasks, or 6- 
well plates. Non- and semi-adherent cells were then recovered and 
cultured overnight alone, or with LPS (10 ng / ml). Values represent the 
percentage of semi-adherent cells staining positive with antibody to 
CD IIc, MHC 11, or CD40 (a). Alternatively, values represent the fold 
increase in the number of positive cells upon stimulation with LPS 
compared to cells cultured alone (b). 
a represents the cells expressing high levels of the surface marker. 
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Figure 6.1 Phenotype of the iDC population generated from RM 
precursors cultured for six days in the presence of GM-CSý'. A distitict 
population of dead cells, shown to be positive lor 111, "its I(Icimlicd aiid 
gated out from all subsequent analysis. Cells were staMcd "Itli aimbodN 
specific for CDI Ic (red line), or with a matched isolype cmitrol (hluc 1111C) 
(a). The value in italics represents the pcrcenUigc ot'cells cx1irc. ssihig 
CD IIc (a). All live cells (b), and those positi vc (c), or iicpat iýc (d). 161' 
CDI Ic were characterised on their size and graiiularitý. IhCCjLK1draICo%cr- 
laid on the size/ granularity scattergrams arhitrarilý doides dic cells mto 4 
populations (i-iv). Data is representative at least ') expermicii1s. 
17 5 
a. CD11c 
.; 2 
Fluorescence 
b. All Live Cells 
2: 1 I- 
C 
59 
(D 
Size 
c. CD11c+ cells 
d. CD1 1 c- cells 
iv) 6% iii) 2% 
Size 
ii) im 
iv) 73% iii) 5% 
11 Size 
i) 7% 'ý ii) 859Wý 
> 
(3 
(3 
(D 
176 
Figure 6.2 Phenotype of the iDC population generated from BM 
precursors cultured for six days in the presence of (; M-('SF. 
i) A distinct population of dead cells, shown to be positive for III, was 
identified and gated out from all subsequent analysis. Cells were stained 
with antibody specific for the markers indicated (red line), or with 
matched isotype controls (blue line). The values in italics represent the 
percentage of cells expressing the marker and the values in red italics 
represent the percentage of cells expressing high / low levels ofthc marker 
(a). For each marker, the population ol'positive (b), or negative (c), cells 
was characterised on size and granularity. The quadrate ovcr-laid oil tile 
size / granularity scattergrams arbitrarily divides the cells Into 4 
populations (1-iv), and is in the same position as on Figure 4.1. Daw is 
representative at least 3 experiments. 
ii) In a separate experiment, cells were double-stained with antibodies 
specific for CD1 Ic and MHC 11 (b) or isotypc matched controls (a). 
Control antibody staining is represented by the quadrant boundaries and 
values represent the percentage of cells staining positive in the particular 
quadrant. The values in italics represent the CDI Ic' MIIC 11 * cells. or the 
CD II c- MHC' cells, as a percentage ofthe total MI IC I I' cel Is. 
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Figure 6.3 PMB effectively blocks the stimulatory properties of LPS. 
iDC were cultured overnight alone (*), or with 10 (0), or 100 (0), ng / 
ml of LPS, in the presence, or absence, of varying concentrations of PMB. 
Supernatants were removed and analysed by ELISA for the production of 
IL- I 2p4O (a), or IL-6 (b). Data is presented as the mean ± SEM of three 
separate wells, and is representative of 2 experiments. 
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0 0.1 0.3 139 27 
PMB ýtg / ml 
0 0.1 0.3 139 27 
PMB gg / mi 
IL-12p4O 
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Figure 6.4 PMB does not effect on the stimulatory properties of 
Zymosan A. iDC were co-cultured with 0 (*), or 3 (M), ýtg / ml PMB and 
the indicated concentrations of Zymosan A. Supernatants from triplicate 
wells were pooled and analysed by ELISA for production of IL- I 2p4O (a) 
or IL-6 (b). Data is representative of two experiments. 
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Figure 6.5 0-3hRP but not soluble whole schistosome preparations, 
stimulates up-regulation of cytokine production by DC. iDC were co- 
cultured overnight with PMB (3 ýtg / ml) and the indicated concentrations 
of different parasite preparations. Supernatants from triplicate wells were 
pooled and analysed by ELISA for the production of IL-12p4O (a) and IL- 
6 (b). t= not done. 
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Figure 6.6 0-3hRP stimulates significant levels of cytokine 
production. iDC were cultured overnight alone, or with PMB (3 ýtg 
ml), LPS (equivalent to EU content of 0-3hRP) + PMB, RPMlc + PMB, 
or 0-3hRP (40 ýtg / ml) + PMB. Supernatants were then removed and 
analysed by ELISA for production of IL- 12p4O (a) and IL-6 (b). Data is 
presented as the mean ± SEM of four individual wells and is 
representative of 3 experiments. Dashed line denotes the lower detection 
limit of ELISA. Levels of significance, as determined by Students t test, 
are indicated as: ** =P:!! ý 0.01 and *** =P:! ý 0.001. 
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Figure 6.7 Stimulation by 0-3hRP is dwarfed by the response to other 
PAMPs. iDC were cultured overnight alone, or with LPS (I ng / ml), 
Zymosan A (5 ýtg / ml), or 0-3hRP (40 ýtg / ml) + PMB (3 [tg / ml). 
Supernatants were then removed and analysed by ELISA for production of 
IL- I 2p4O (a) and IL-6 (b). Data is presented as the mean ± SEM of four 
individual wells and is representative of 3 experiments. Numbers in italics 
represent the fold-increase in cytokine production compared to DC alone. 
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Figure 6.8 CD11c' cells are the major IL-12p4O'population after culture with 
PAMPs, but the number of positive cells varies according to different stimuli. 
Expression of CD IIc versus IL- I 2p4O by iDC cultured overnight with RPMI, 0-3hRP, 
LPS or Zymosan A. Cells were stained with specific antibodies (b), or isotype matched 
controls (a). Control antibody staining is represented by the quadrant boundaries and 
values represent the percentage of cells staining positive in the particular quadrant. The 
values in italics represent the CD II c' IL- I 2p4O' cells as a percentage of the total IL- 
12p4O' cells. The values in red represent the median fluorescent intensity of staining for 
IL- I 2p4O' cells. 
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Figure 6.9 Overall CD11c expression changes after stimulation with different 
PAMPs but does not change on the large / highly granular cells. 1DC were 
cultured overnight alone, or with RPMlc + PMB (3 ýtg / ml), 0-3hR-P (40 [tg / ml) 
+ PMB, LPS (I ng / ml), or Zymosan A (5 ýtg / ml). Histograms display all events 
for DC cultured alone and demonstrate region H (a & c). Cells were stained with 
antibodies specific for CD IIc, or with a matched isotype control, and the percentage 
positive determined in the whole population (b), or within the region H (d). Data is 
presented as the mean +/- SEM of 3 experiments. 
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Figure 6.10 MHC 11 expression on tnDC cultured with different 
PAMPs. Percentage of CD II c' cells expressing MHC 11 (a), or high 
levels of MHC 11 (b) was determined after iDC were cultured alone, or 
with RPMlc + PMB (3 pg / ml), 0-3hRP (40 [tg / ml) + PMB, LPS (I ng 
mi), or Zymosan A (5 [tg / ml). Cells were stained with antibodies specific 
to CD IIc and MHC 11, or with matched isotype controls. Gating on all 
CD II c+ cells, the percentage positive for MHC 11 and high levels of MHC 
11 was determined. Data is presented as the mean ± SEM of 3 experiments. 
Levels of significance, as determined by Students t test, are indicated as: 
=P:! ý 0.05, ** =P:! ý 0.01. 
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Figure 6.11 Phenotype of mDC cultured with different PAM Ps. 
Percentage of cells expressing CD40 (a), CD86`91' (b), CD80 (c), or 
OX40L (d), was determined after iDC were cultured alone, or with RPMlc 
+ PMB (3 ýtg / ml), 0-3hRP (40 ýtg / mi) + PMB, ITS (I ng / ml), or 
Zymosan (5 ýtg / ml). Cells were stained with antibodies specific to CD40, 
CD80, CD86, or OX40L, or with matched isotypc controls. Analysis wýls 
restricted to large granular cells within box 11. Data is presented as the 
mean ± SEM of 3 experiments, except CD80 which is derived from 2 
experiments. Levels of significance, as determined by Students / test. are 
indicated as: *=p:! ý 0.05 and ** = p! ý 0.01. 
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Figure 6.12 0-3hRP stimulates highly significant up-regulation of 
cytokine production by BALB/c DC. iDC derived from BALB/c BM 
were cultured overnight alone, or with PMB (3 ýLg / ml), LPS (equivalent 
to EU content of O-ARP) + PMB, RPMlc + PMB, or O-ARP (20, or 40, 
ýtg / ml) + PMB. Supernatants were analysed for the expression of IL- 
12p4O (a), or IL-6 (b), by ELISA. Data is presented as the mean ± SEM of 
4 wells, and is representative of at least 4 experiments. Levels of 
significance, as determined by Students t test, are indicated as: p 
0.001. 
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Figure 6.13 Different pathogen PAMPs stimulate contrasting profiles 
of DC cytokine production. iDC derived from BALB/c BM, were 
cultured overnight alone, or with RPMlc + PMB (3 ýtg / ml), O-ARP (40 
ýtg / ml) + PMB, LPS (100 ng / ml), or Zymosan A (1.6 ýtg / ml). 
Supernatants were removed and analysed for expression of IL- I 2p4O (a), 
IL-6 (b), IL- 12p7O (c), IL- 10 (d), TNF(x (e), or IL- IP (f)ý by ELISA. Data 
is presented as the mean ± SEM of 4 wells, and is representative of at least 
2 experiments. Dashed lines represent the lower limit of detection of 
ELISA. 
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DC RPMlc+PMB 0.3hRP+ LPS Zy-- A 
PMB 
DC RPM1c - PMS OZhRP - LPS Zy- A 
PMB 
DC RMPIc + PMB 0-3hRP LFS Zym-n A 
PMB 
C5 7BI16 C5 7BI16 BALBIc BALB'c 
IL-12p4O IL-4 IL-12p4O IL-4 
DC 10% (94%) ND 6% (78%) 10% (87%) 
0-3hRP + PMB 22% (96%) 
LPS 85% (87%) 
0a Zymosan A 87/0 (84%) 
ND 11% (94%) 14% (94%) 
ND 72% (89%) 30% (89%) 
ND 30% b (90%) 7% b (82%) 
Table 6.3 Intracellular IL-12p4O and IL-4 staining on DC stimulated 
with different pathogen PAMPs. iDC derived from C57131/6 or BALB/c 
BM, were cultured overnight alone, or with 0-3hRP (40 gg / ml) + PMB 
(3 ýtg / ml), LPS (100 ng / ml), or Zymosan A (1.6 -5 ýtg / ml). Cells were 
stained with antibodies specific for CD IIc, and IL- I 2p4O, or IL-4, or 
with matched isotype controls, and analysed by 2-colour flow-cytometry. 
The values shown in bold represent the percentage of CD II c+ cells that 
were positive for IL- 12p4O, or IL-4. The values in brackets represent the 
CD II c+ cytokine' DC as a percentage of the total cytokine' cells. Data 
presented for C57131/6 DC is derived from the experiment shown in 
Figure 6.8. 
a5 ýtg / ml Zymosan A. 
b 1.6 ýtg / ml Zymosan A. 
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Figure 6.14 0-3hRP stimulates up-regulation of MHC 11 expression on 
DC derived from BALB/c BM. The percentage of CD II c' cells 
expressing MHC 11 (a), or high levels of MHC 11 (b), was determined after 
iDC were cultured alone, or with RPMIc + PMB (3 ýtg / ml), 0-3hRP (40 
ýtg / ml) + PMB, LPS (100 ng / ml) or Zymosan A (1.6 pg / ml). Cells 
were stained with antibodies specific to CD IIc and MHC 11, or with 
matched isotype controls. Gating on CD II c+ cells, the percentage positive 
for MHC 11 (a) and high levels of MHC 11 (b) was determined. Data is 
presented as the mean ± SEM of 3 experiments. Levels of significance, as 
determined by Students t test, are indicated as: p:! ý 0.05 and p 
0.01. 
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Figure 6.15 Percentage of cells expressing CD11c' within the large 
granular population does not differ after culture with different PAMPs. 
iDC derived from BALB/c BM were cultured overnight alone, or with 
RPMlc + PMB (3 ýtg / ml), 0-3hRP (40 pg / ml) + PMB, LPS (100 ng / ml), 
or Zymosan A (1.6 pg / ml). Cells were stained with antibodies specific for 
CD IIc, or with a matched isotype control. Data is presented as the mean 
SEM of three experiments. Analysis was perfon-ned on the large granular 
cell population within box H (see Figure 6.9). 
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Figure 6.16 Expression of co-stimulatory molecules on DC cultured 
with different PAMPs. Percentage of cells expressing CD40 (a), 
CD86 high (b), CD80 (c), or OX40L (d), was determined after BALB/c iDC 
were cultured alone, or with PMB (3 pg / ml), RPMlc + PMB, 0-3hRP (40 
ýtg / ml) + PMB, LPS (100 ng / ml), or Zymosan A (1.6 [tg / ml). Cells 
were stained with antibodies specific to CD40, CD80, CD86, OX40L, or 
with matched isotype controls. Analysis was restricted to large granular 
cells within box H. Data is presented as the mean ± SEM of 3 
experiments. Levels of significance, as determined by Students t test, are 
indicated as: * =p:! ý 0.05 and *** =p: ý 0.001. 
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Figure 6.17 Ligation of CD40 preferentially increases IL-12p4O 
production by unstimulated and 0-3bRP-stimulated DC, compared 
to other cytokines. iDC derived from BALB/c BM, were cultured 
overnight alone, or with 0-3hRP (40 pg / ml) + PMB (3 pg / ml), in the 
presence (hatched bars), or absence (open bars), of anti-CD40 antibody 
(5 pg / ml). Supernatants were removed and analysed for expression of 
IL- I 2p4O (a), IL-6 (b), or IL- 10 (c), by ELISA. Data is presented as the 
mean ± SEM of 3 wells, and is representative of 3 experiments. Dashed 
lines represent the lower limit of detection of ELISA. Levels of 
significance, as determined by Students t test, are indicated as: *** =p < 
0.001. 
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DC 0-3hRP . PMB 
Dc 0-3hRP , PMB 
DC 0-3hRP , PMB 
Anti- 
CD40 
Ab 
BALBIc BALBIc 
IL-12p40 IL-4 
DC Only - 6% (78%) 10% (87%) 
0-3hRP + PMB - 11% (94%) 14% (94%) 
LPS - 72% (89%) 30% (89%) 
Zymosan A - 30% (90%) 7% (82%) 
DC Only + 21% (88%) 7% (86%) 
0-3hP-P + PMB + 23% (92%) 13% (89%) 
LPS + 85% (86%) 37% (88%) 
Zymosan A + 64% (91%) 7% (84%) 
Table 6.4 Intracellular IL-12p4O and IL-4 staining on DC 
stimulated with different pathogen PAMPs. iDC derived from 
BALB/c BM, were cultured overnight alone, or with 0-3hRP (40 ýtg 
ml) + PMB (3 gg / ml), LPS (100 ng / ml), or Zymosan A (1.6 ýLg 
ml), in the presence or absence of anti-CD40 antibody (5 [tg / ml). 
Cells were stained with antibodies specific for CD IIc, and IL- 12p4O, 
or IL-4, or with matched isotype controls, and analysed by 2-colour 
flow-cytometry. The values shown in bold represent the percentage of 
CD II c+ cells that were positive for IL- 12p4O, or IL-4. The values in 
brackets represent the CD II c+ cytokine+ DC as a percentage of the 
total cytokine+ cells. The data presented for cells cultured in the 
absence of anti-CD40 antibody is derived from the same experiment 
but was presented in Table 6.3, and therefore is shown in grey type. 
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6.4 DISCUSSION 
In this chapter, I demonstrate that the PAMP material released by transfon-ning 
schistosomes (0-3hRP) stimulates maturation of iDC with a phenotype commensurate with 
them being potent APC. Indeed, 0-3hRP-induced maturation of iDC corresponds with up- 
regulation of IL- I 2p4O and IL-6 production, and elevated surface expression of MHC 11 
and the co-stimulatory factors CD40 and CD86. However, 0-3hRP stimulated lower levels 
of cytokine production and co-stimulatory factor expression when compared to the classic 
pathogen PAMPs LPS and Zymosan A. 
6.4.1 Generation of immature BM-derived DC 
Initially, I selected and developed a robust technique for bulk in vitro generation of 
enriched iDC based on the culture of BM precursors with GM-CSF. Of two techniques, 
'Plate' generation more fully satisfied the criteria set out in Section 6.2.1, and was used in 
subsequent experiments to generate iDC with which to study the stimulatory potential of 
schistosome PAMPs. Due to the notorious difficulty in establishing iDC culture of high 
purity, this technique was further optimised, resulting in cell populations highly enriched 
(up to 70%) for CD II c+ DC. Indeed, following continuous optimisation, the iDC 
populations used in the latter experiments of this chapter, and in Chapter 7, were routinely 
70% CD II c+ (data not shown). 
CID IIc is one of the most commonly used surface markers to identify DC, and is expressed 
on all subsets including myeloid, lymphoid and plasmacytold DC (Kelsall et al., 2002). 
Further phenotypic characterisation demonstrated that the iDC used in my study were 
negative for the lymphoid DC marker, CD8(x, and only 2% were positive for the 
plasmacytold DC marker, B220. As such, I conclude the CID II c+ DC used in this study 
were myeloid in origin. In addition, most of the CDI lc+ cells expressed low levels of 
F4/80. Although F4/80 is predominantly a Nlý marker, it is expressed on LC (Hume et (/I., 
1983), some ex vivo myeloid DC (Henri et al., 2001), and at low levels on BM-derived DC 
(Lutz el al., 1999; Reid et al., 2000), further supporting the conclusion that the cells 
generated in this study were myeloid DC. 
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A large proportion of the iDC population were also MHC If+ (48%). Two-colour flow- 
cytometry revealed that 95% of the MHC 11+ cells were CD II c+. The expression of MHC 
11 is indicative of the maturation state of the DC. In this context, less than 50% of the cells 
expressed high levels of MHC 11, demonstrating that the majority of DC were immature. 
Therefore, the DC culture technique used in this study is more appropriate than the 
recently described 'higher yield' method, which utilises BM cultured with both IL-4 and 
GM-CSF, and results in DC with a MHC , high mature phenotype (Son et al., 2002). In this 
context, the iDC used in this study more closely resemble DC which schistosome larvae 
would likely encounter in the skin. The spontaneous maturation of a proportion of the iDC 
in my cultures may have been caused by physical trauma during the culture period (i. e. 
through pipetting / changing of media), to which DC are sensitive (Gallucci et al., 1999). 
The minor population of CDI Ic- cells were almost completely MHC IF (95%), and 
partially Gr- I+, corresponding to previous reports that jDC generated after 6 days also 
contain low levels of myeloid precursor cells and granulocytes (Lutz et al., 1999). In this 
respect, the CDI Ic+ and CDI Ic- cells within the iDC, and mDC, populations could be 
divided upon the basis of their size and granularity. This allowed for analysis of surface 
marker expression to focus upon the large highly granular population, confident that this 
contained nearly all the CD II c+ cells, and was almost exclusively CD II c+. 
6.4.2 Schistosome PAMPs stimulate DC maturation: cytokine production 
Having defined the enriched iDC population, these cells were used to analyse the effect of 
schistosome PAMPs on DC maturation. In an initial screen of the schistosome PAMP 
preparations only 0-3hRP had the capacity to induce pro-intlammatory and regulatory 
cytokine production. This work supports the results obtained in Chapter 3 using 1Mý, 
which show that the material released by schistosome larvae upon transformation is highly 
enriched for parasite PAMPs compared to soluble preparations of whole larvae. Therefore, 
the effect of 0-3hRP upon DC was further charactensed; the DC response was also 
compared to that induced by LPS or Zymosan A. In addition to acting as positive controls, 
these well-documented pathogen PAMPs were chosen as examples of molecules that 
instruct DC to mature to a Th I -inducing phenotype (LPS; Whelan et al., 2000; MacDonald 
et al., 2001), or a Th2-inducing phenotype (Zymosan A; Manickasingham et al., 2003). 
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I show for the first time that molecules released by transforming schistosome larvae (0- 
3h") stimulate up-regulation of IL-12p4O production by 1DC. This corresponds with an 
increase in the number and intensity of staining of IL- I 2p4O+ CD II c+ mDC. Importantly, 
staining for intracellular IL- I 2p4O was restricted to the CD II c+ population (94% - 96%), 
demonstrating that the myeloid DC were the source of this cytokine. Although splenic 
myelold DC appear to produce little IL-12p4O upon stimulation in vitro (Edwards et al., 
2002), BM-derived iDC are well known to produce large amounts in response to 
maturation with numerous different pathogens or pathogen PAMPs, such as LPS, CpG 
DNA motifs (Sparwasser et al., 1998), whole live Mycobacterium tuberculosis (Hickman 
et al., 2002), or Propionebacterium acnes (MacDonald et al., 200 1). In addition, myelold 
DC are the source of abundant IL-12p4O produced by in vitro cultured skin biopsies from 
mice vaccinated with y-irradiated S. mansoni cercariae (Hogg et al., 2003a). 
IL- 12 is a pro-inflammatory cytokine (Ma and Trinchien, 200 1). Moreover, IL- 12 
increases blastogenesis of human T-cells (Kubin et al., 1994) and has potent Th I 
polarising activity (Manetti et al., 1994; Macatonia et al., 1995; Trinchien, 2003). 
Although the biologically active heterodimer IL-12p7O, which possesses the pro- 
inflammatory / Thl polarising function, was not detected in the culture supernatant of DC 
stimulated with 0-3hRP (DC/0-3hRP), it is probably released but at lower levels than 
detected by the ELISA assay. In this respect, analysis of the supernatants from DC 
stimulated with LPS (DC/LPS) or Zymosan A (DC/Zymosan A) demonstrated that IL- 
12p7O is released at concentrations approximately 1000-fold less than IL-12p4O. Since IL- 
12p7O is a heterodimer of the p40 and p35 subunits, most of the IL-12p4O detected 
probably represents monomeric p40, or the IL- I 2p7O antagonist p40 homo-dimer 
(Gillessen et al., 1995). However, the p40 sub-unit also complexes with ap 19 sub-unit 
cytokine to forin IL-23, which is known to be produced by DC (Oppmann et al., 2000). IL- 
23 is thought to share many of the properties of IL-12p7O, including driving IFNY 
production by T-cells (Oppmann et al., 2000), although a recent report suggests that it may 
possess greater pro-inflammatory properties (Cua et al., 2003). Therefore, the presence of 
IL-23 in the DC supernatant cannot be excluded. 
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In contrast to IL-12p4O, 0-3hRP did not stimulate production of IL-10, a potent anti- 
inflammatory cytokine, thought to promote Th2 polarisation through the inhibition of Thl 
responses. In addition, IL- 10 is also involved in the development of 'Treg' cells (McGuirk 
et al., 2002). IL- 10 is known to regulate IL- I 2p4O production in the skin and sdLN 
following vaccination with irradiated cercariae (Hogg et al., 2003b). Moreover, IL- 12 (and 
/ or IL-23? ) exerts reciprocal regulation of IL-10 expression in the skin (Hogg et al., 
2003b). Therefore, the control of IL-12p4O and IL-10 production may considerably affect 
the outcome of the innate and acquired responses during normal infection. In this respect, 
the profile of cytokines produced by DC stimulated with 0-3hRP greatly contrasts that of 
iMý, which produced high levels of IL- 10 and low levels / no IL- I 2p4O (section 3.3.3). 
Thus, the balance of IL- 12 versus IL- 10 production in the skin during infection with 
non-nal schistosomes may reflect the relative dominance of DC versus Mý responses. 
In this chapter I also show that 0-3hRP stimulates up-regulation of IL-6 production by 
iDC. Similar to IL-12, iDC are known to produce IL-6 in response to live pathogens, or 
PAMPs (Sparwasser et al., 1998; MacDonald et al., 2001). Therefore, although 
intracellular staining for IL-6 was not perforined, it is most likely that CD II c+ DC were the 
cellular source of this cytokine. Similar to IL-12, IL-6 also acts directly upon T-cells to 
increase proliferation during priming (Vink et al., 1990). Thus, the up-regulated production 
of IL-6 and IL-12p4O by 0-3hRP-matured DC suggests these cells will be more effective at 
priming T-cells. 
The direct effect of IL-6 early in the process of T-cell polarisation remains unclear, 
although it has been linked to Th2 induction (Rincon et al., 1997; LaFlamme et al., 2000; 
Moser, 2001; Diehl et al., 2000; 2002). On the other hand, IL-4 is known to be a potent 
driver of Th2 responses, and therefore production of this cytokine was determined. Using 
intracellular flow-cytometry, an increase in IL-4+ DC was observed after stimulation with 
0-3hRP, although no IL-4 was detected in the culture supernatants. It has been reported 
that DC can be positive for intracellular IL-4 (Kelleher et al., 1999), yet it has only rarely 
been detected in culture supernatants (d'Ostiani et al., 2000). Indeed, my data contrasts 
with that of MacDonald et al. (2001) who found no up-regulation of IL-4 mRNA by BM- 
derived DC stimulated with a variety of PAMPs (including LPS), although it is possible 
that differential regulation of this cytokine occurs at translation rather than transcription. 
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Since IL-4 has potent autocrine effects on DC, including up-regulation of MHC 11 (Son et 
al., 2002), it has been suggested that IL-4 may be released by stimulated DC but 
immediately bound by the surface receptors (Kelleher et al., 1999). Although fL-4 was not 
detected in the DC/0-3hRP supernatants, the intimate localisation of T-cells with DC 
during priming could result with paracrine functions of this cytokine. 
The profile of DC cytokine production stimulated by 0-3hRP differs greatly to that 
stimulated by the classical pathogen PAMPs LPS and Zymosan A. DC/0-3hRP produced 
considerably less IL-12p4O and IL-6 than either DC/Zymosan, or DC/LPS. Moreover, both 
DC/Zymosan and DC/LPS produced detectable quantities of IL- I 2p7O, IL- 10, and TNFU. 
This suggests that 0-3hRP instruct DC in a different manner to these PAMPs, leading to an 
, intennediate' state of maturation. There was also a significant difference in the profile of 
cytokine production stimulated by Thl-associated LPS compared to Th2-associated 
Zymosan A. Therefore, my data supports the hypothesis that DC possess substantial 
plasticity in their cytokine response to different PAMPs (Whelan et al., 2000; MacDonald 
et al., 2001; de Jong et al., 2002; Edwards et al., 2002). Interestingly, Zymosan A 
stimulated more IL- I 2p7O but less IL- 10 and IL-6, compared to LPS, which is more 
suggestive of a Thl profile, contrasting recent findings that all splenic DC subsets produce 
IL- 10 rather than IL- 12 in response to Zymosan A (Edwards et al., 2002). In addition, LPS 
stimulated a large increase in the number IL-4+ DC, which is indicative of Th2 promotion. 
Therefore, from the cytokme profiles it is very difficult to predict whether DC matured 
with 0-3hRP would preferentially prime for a Thl or Th2 response. Indeed, a recent study 
using adoptive transfer of IL-12p4O-, or IL-4-, deficient DC demonstrated that production 
of IL-4 was not necessary to prime a Th2 response, whereas production of IL-12p4O, 
although required for maximal T-cell EFN7 production, was not necessary to prime a Tli I 
response (MacDonald and Pearce, 2002). 
6.4.3 Schistosome PAMPs stimulate DC maturation: MHC 11 expression 
Up-regulation of MHC 11 expression is explicitly important for T-cell priming, and high- 
level expression of MHC 11 is commonly used to define mature DC. In this chapter I 
demonstrate that 0-3hRP stimulates maturation of iDC, corresponding with an increase in 
the number of MHC 11 high + cells, suggesting that DC/0-3hRP xvill have a greater capacity 
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to present antigen to T-cells. However, compared to DULPS, or DC/Zymosan A, fewer 
DC matured with 0-3hRP expressed high levels of MHC 11, concurrent with the hypothesis 
that 0-3hRP matures DC in a different manner to LPS, or Zymosan A, and leads to an 
intermediate state of activation. 
6.4.4 Schistosome PAMPs stimulate DC maturation: co-stimulatory factor expression 
Up-regulation of co-stimulatory factor expression is another way in which DC enhance T- 
cell priming. Indeed, ligation of T-cell CD28 by co-stimulatory CD80, or CD86, augments 
TCR-mediated proliferation, IL-2 production, and T-cell survival (Boise et al., 1995), and 
is essential for normal T-cell cytokine responses (Whelan et al., 2000), while the absence 
of this co-stimulatory pathway promotes T-cell anergy (Van Gool et al., 1999). Expression 
of CD40 on DC also contributes to the survival signal, helping to prevent T-cell anergy by 
CD 154 (CD40L) signalling (Van Gool et al., 1999). In addition, T-cell expansion is 
maintained by anti-apoptotic signals received through OX40 via DC-expressed OX40L 
(Rogers et al., 2001). 
In my studies, 0-3hRP was shown to induce the up-regulation of surface CD40 and CD86 
but not CD80 upon DC. Since the expression of either CD80, or CD86, by DC is sufficient 
for normal T-cell priming through CD28 (Whelan et al., 2000), 0-3hRP-stimulated DC 
should more effectively prime T-cell responses, through greater ligation of CD28 by CD86 
and CD 154 by CD40. Although DC/0-3hRP did not up-regulate surface OX40L compared 
to DC cultured alone (DC/media), the constitutive low level expression of this factor may 
be sufficient to prevent apoptosis of expanding T-cells. However, both LPS and Zymosan 
A stimulated greater up-regulation of CD40 and CD86 high expression than 0-3hRP, again 
suggesting that schistosome PAMPs drive an 'intermediate' state of maturation. There was 
also a considerable difference in expression of CD80 and OX40L between DC/LPS and 
DC/Zymosan A. Therefore, my data agrees with the observations that, in addition to 
cytokine production, DC possess substantial plasticity in their regulation of co-stimulatory 
factor expression in response to stimulation with different PAMPs (Whelan et al., 2000, 
MacDonald et al., 2001; de Jong et al., 2002). 
The role of co-stimulatory factors in T-cell polarisation is the subject of much debate, 
fuelled by observations that they are differentially regulated upon exposure to different 
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PAMPs. Since only LPS stimulated up-regulation of CD80, this could suggest this co- 
stimulatory molecule may have a role in Thl induction. Indeed, polar roles for CD80 and 
CD86 have been reported, with CD80 involved in Thl and CD86 involved in Th2 
commitment (Kuchroo et al., 1995). However, CD86 has been implicated in Th I priming 
by splenic DC (Moser, 2001). Conversely, another group reported that co-stimulation 
through CD28 per. se. promoted Th2 responses (Rulifson et al., 1997), supporting 
observations that CD28-deficient mice generate diminished Th2 but not Thl cytokine 
production, in response to deposition of schistosome eggs (King et al., 1996b). More 
recent data suggests that the role of CD80 / CD86 may chiefly be to promote T-cell 
responses rather than influencing T-cell differentiation (Schweitzer et al., 1997; Whelan et 
al., 2000). 
Co-stimulation via OX40L expression has also been linked to T cell polarisation (Flynn et 
al., 1998; Ohshima et al., 1998; de Jong et al., 2002) but again its role is controversial 
(MacDonald et al., 2001). My results conform with a possible role of OX40L in Th2 
responses, since Th2-associated Zymosan A but not Thl -associated LPS, stimulated an 
increase in the number of DC expressing OX40L. Since 0-3hRP did not stimulate 
increased OX40L expression this suggests that it may not drive Th2 polarisation. 
The effect of CD40 / CD 154 interactions on T-cell priming and polansation is also the 
focus of intense study. There is a strong case for the involvement of CD40 / CD 154 in Th2 
induction. In vitro, human T-cell production of IL-4 induced by anti-CD3 and anti-CD28 
requires co-stimulation through CD 154 (Blotta et al., 1996). Furthermore, adoptive transfer 
of CD40 -/- DC into wild type recipients demonstrated that CD40 expression is essential for 
the Th2 response induced by SEA-matured DC but not for the Th I response driven by DC 
matured with Prop ion ibacterium acnes (MacDonald et al., 2002a). In addition, the Th2 
responses that develop during S. mansoni infection, or after injection with schistosome 
eggs, are impaired in CD 154 -/-mice (MacDonald et al., 2002a, 2002b). However, DC 
expression of CD40 has also been associated with IL-12-dependent induction of Th I 
responses by murine and human DC in vitro (Cella et al., 1996; Reudl et al., 2000). 
In addition to its role as a co-stimulatory molecule for T-cells, CD40 also allows DC to 
receive feedback from T-cells during priming. Since T-cells express surface CD154 
immediately upon activation by APC (Schonbeck and Libby, 2001), the feedback DC 
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receive is restricted to anti gen- specific interactions. There is an increasing body of 
evidence to suggest that CD 154 is expressed on the surface of some accessory cells, 
including certain DC subsets, indicating that accessory cells could provide feedback to 
each other via CD40 to amplify innate responses (Schonbeck and Libby, 2001). A recent 
study suggests that CD40 / CD 154 interactions are essential for maintaining DC activation 
during infections that result in either Thl (T gondii) or Th2 (S. mansoni) responses (Straw 
et al., 2003). It is well established that ligation of CD40 can cause increased / high level 
production of IL-12 by both non-stimulated murine and human DC in vitro (Koch et al., 
1996; Cella et al., 1996; Reudl et al., 2000), and PAMP-stimulated murine DC in i, ivo 
(Schulz et al., 2000). Indeed, in this chapter I showed that signalling via CD40 following 
addition of anti-CD40 antibody increased IL-12p4O production by DC/0-3hP'P I 0-fold, 
corresponding with an increased frequency of IL- I 2p4O+ cells. Increased IL- 12 production 
following CD40 ligation could help amplify developing Thl responses (Cella et al., 1996; 
Schulz et al., 2000), suggesting that 0-3hRP may have Th I -driving capacity. However, it 
has recently been hypothesised that CD40 signalling acts more as an amplification signal 
for DC to increase the cytokine profile already programmed by PAMP recognition. In this 
respect, DC can produce increased IL- 12, or IL- 10, depending on the initial PAMP 
stimulus received (Edwards et al., 2002). Since stimulation of DC/0-3hRP with anti-CD40 
antibody resulted in increased IL-12p4O production but no increase in the frequency of IL- 
4+ cells, no detectable IL- 10 production, and only a marginal increase in IL-6 production, 
suggests that DC matured with 0-3hRP will not display increased Th2-associated cytokines 
during T-cell priming, and will therefore have limited Th2-driving capacity. 
6.4.5 Schistosome PAMPs stimulate DC maturation: an intermediate state? 
A recent report suggests that because of the extensive plasticity of DC responses, 
maturation cannot be defined by a simple set of markers (Huang et al., 2001). In this 
respect, the 'Inten-nediate' DC maturation phenotype induced by 0-3hRP is reminiscent of 
that revealed in studies of the nematode products ES-62 (Whelan et al., 2000) and SEA 
(MacDonald et al., 2001). Specifically, SEA matures BM-derived DC to express 
intermediate levels of MHC Il compared to LPS, yet without any increase in production of 
IL-12p4O, IL-12p7O, IL-6, IL-4, or TNFcc, or any increase in expression of CD40, CD80, 
CD86, or OX40L (MacDonald et al., 2001). Similarly, ES-62 matures BM-derived DC 
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without any increase in co-stimulatory factor expression and with limited up-regulation of 
IL-12p7O, compared to LPS (Whelan et al., 2000). Despite these very limited activation 
states, DC matured with ES-62, or SEA, were both potent drivers of Th2 responses 
(Whelan et al., 2000; MacDonald et al., 2001). However, although the maturation state 
induced by 0-3hRP bears similarity to that reported for SEA and ES-62, DC/0-3hRP do 
appear to have a more highly activated phenotype, evident by their increased IL- I 2p4O and 
IL-6 production, and up-regulated CD40 and CD86 expression. Moreover, in contrast to 0- 
3hRP, both ES-62 and SEA stimulated some up-regulation of IL-10 production. Therefore, 
whilst the limited activation state of DC/0-3hRP might suggest a potential to drive Th2 
responses, the up-regulated pro-inflammatory cytokine production and co-stimulatory 
factor expression suggests otherwise. 
As a point of note, when compared to DC generated ftom C57BI/6 mice, BALB/c 1DC 
appeared to be more sensitive the stimulatory actions of 0-3hRP, demonstrated by a greater 
fold-increase in cytokine production and expression of MHC 11 and co-stimulatory factors. 
One potential explanation for this observation could be the differential expression of PRRs 
upon these cells (Liu et al., 2002). Alternatively, there could be differences in the 
responses to receptor ligation between mouse strains, however, this is an area in which 
further research is awaited. 
6.4.6 Summary 
In summary, soluble schistosome PAMPs released during transforination (0-3hRP) 
stimulate maturation of iDC, corresponding with up-regulation of MHC 11 and co- 
stimulatory factor expression, and increased cytokine production. This suggests that DC 
stimulated with 0-3h" may play a role in developing the innate response, and have an 
increased capacity to prime T-cell responses. However, the maturation state of DC/0-3hRP 
appears limited compared to that induced by Th I -driving LPS and Th2-driving Zymosan 
A, which both stimulated greater overall expression of cytokine, MHC 11, and co- 
stimulatory factors. The specific maturation profiles of these control PAMPs were 
significantly different to each other, but because maturation with 0-3hRP differed from 
both LPS, and Zymosan A, it is difficult to speculate what effect DC/0-3hRP would have 
on T-cell polarisation. In this respect, 0-3hRP stimulated a DC maturation state not unlike 
that reported for the potent helm inth-deri v ed Th2 drivers, ES-62 and SEA. Therefore, 
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further investigation is required into the outcome of T-cell priming by DC matured with ()- 
3hR-P in order to more fully understand how interactions between schistosome PAMPS and 
the innate immune system may effect the polarisation of the acquired immune response. 
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CHAPTER 7 
PRIMING AND POLARISATION OF THE ACQUIRED IMMUNE 
RESPONSE BY DC MATURED WITH RELEASED SCHISTOSOME 
PAMPS 
7.1 INTRODUCTION 
The generation of cell-mediated or humoral acquired immunity can be critical to the 
outcome of infections, and is characterised by selective clonal expansion of Thl or Th2 
effector cells respectively. Generation of the correct type of response can confer protection 
against pathogens or disease, whereas the incorrect response may lead to immune-related, 
or disease-related, pathology. Many factors have been implicated in influencing 
differentiation of naYve T-cells towards committed Thl or Th2 effector lineages, but of 
critical importance is the outcome of the innate immune response during infection (Fearon 
and Locksley, 1996; Medzhitov and Janeway, 1997). 
In this respect, DC form the link between the innate immune system and the acquired 
immune response, initiating naYve Th cell expansion and differentiation by delivering 
antigenic (signal 1) and co-stimulatory (signal 2) messages. Furthermore, recent work has 
demonstrated that DC are highly plastic, with the ability to express a range of differential 
maturation phenotypes upon interpretation of the nature of the pathogen (via PAMPs), or 
the disease state (via tissue factors and cytokines). This flexibility allows the DC to prime 
for either biased Th I -type or Th2-type responses, or mixed Th 1/ Th2 responses (possibly 
representing ThO cells) (Whelan et al., 2000; MacDonald et al., 2001; de Jong et al., 2002; 
Manickasingham et al., 2003), and has led to the concept that DC deliver a third 
4polansing' signal (signal 3) to the expanding T-cell population (Kalinski et al., 1999). 
In Chapter 6,1 have described how 0-3hRP drives DC maturation which is charactensed 
by up-regulated MHC 11 expression, co-stimulatory factor expression, and cytokine 
production. However, whether stimulation with 0-3hRP increases the ability of DC to 
prime naYve T-cells remains to be established. Furthermore, despite analysis of their 
maturation state, it remains difficult to predict whether DC matured with 0-3hRP would 
drive a biased Th I or Th2 T-cell response, or a non-polarised response. 
To determine the outcome of T-cell pnming by 0-3h"-matured DC requires a neutral 
anti gen-presentati on assay from which the T-cell response can be quantified and 
differentiation towards the Thl or Th2 poles established. 
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Both in vitro and in vivo assays of T-cell priming have been described. Since many factors 
can affect the outcome of priming, including the antigen dose (e. g. Reudl et al., 2000; 
Bonnstra et al., 2003), and APC : T-cell ratio (Tanaka et al., 2000; Manickasingham et al., 
2003), in vitro T-cell priming assays, in which DC are cultured directly with T-cells, have 
the benefit that conditions can be much better defined, and are useful for determining how 
effective DC are in driving primary responses. In comparison, in vivo T-cell priming 
assays, in which antigen-loaded DC are injected into recipient mice and effector cells 
subsequently re-stimulated in vitro, offer the distinct advantage that the function of the DC 
can be determined in physiological context. 
Transgenic (Tg) mice are available that contain re-arranged TCR(X and TCRP genes, such 
that their germline DNA encodes a TCR specific for a peptide fragment. Several types of 
TCR Tg mice have been created, such as the D01 1.10 strain which express TCRs specific 
for a chicken ovalburnin peptide (OVA323-339) bound to I-A d MHC 11 (Murphy et al., 1990), 
or a strain which recognise a pigeon cytochrome C peptide bound to I-E k. Using antigen- 
restricted Tg T-cells in both in vitro and in vivo priming assays has the benefit that the 
frequency of antigen- specific responder cells is greatly increased, allowing for greater 
sensitivity in detecting differences between T-cell responses. In addition, this system 
controls for any variation in the antigenicity of different PAMP preparations, such that 
only the effect on DC polarising ability is studied. This antigen-restricted T-cell priming 
system has become widely used, although similar studies have employed various different 
assay regimes (Whelan et al., 2000; Manickasingham et al., 2003; Boonstra et al., 2003). 
Most importantly, in some studies DC are matured with PAMPs prior to in vitro culture 
with T-cells (Whelan et al., 2000), whereas others report co-culture of T-cells and DC in 
the presence of PAMPs (Manickasingham et al., 2003). Since some potential components 
of 0-3hRP may cause T-cell apoptosis and inhibition of proliferation (Vieira et al., 1986; 
Chen et al., 2002), the former system has the distinct advantage that these PAMPs can be 
removed prior to T-cell assay, and will thus be used in this study. 
Thl and Th2 cell populations are predominantly characterised by their differential 
production of EFNy and IL-4, respectively. Therefore many studies deten-nine levels of T- 
cell polarisation by measurement of these 'signature' cytokines. In addition, other 
cytokines can also be used to indicate Th2 polansation, such as IL-5. Since it is generally 
accepted that IL-4 is more potent than IFNy, direct comparisons of cytokine quantities are 
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obsolete, rather it is more relevant to compare cytokine ratios. Therefore, the T-cell 
polarising capacity of DC matured with 0-3hRP will be compared to those matured alone, 
with LPS, or with Zymosan A, as controls for cells priming mixed Thl / Th2, or polarised 
Th I, or Th2 responses respectively (Whelan et al., 2000; Manickasingham et al., 2003). 
Therefore, the effect of 0-3hRP on the ability of DC to prime both T-cell proliferation and 
polarisation will be assessed using an in vitro assay. In addition, the effect of 0-3hRP on 
the T-cell polarising capacity of DC will be determined in vivo. Polarisation will be 
determined by production of 'signature' T-cell cytokines, and will be compared to mixed 
Thl / Th2, and polarised Thl and Th2 control profiles. 
7.2 MATERIALS AND METHODS 
7.2.1 Mice 
A breeding colony of DOI 1.10 (xp TCR Tg mice (on a BALB/c background) were a gift 
from Paul Garside (University of Glasgow), and were maintained in-house at the 
University of York. BALB/c mice were obtained from Harlan UK Ltd, Bicester, UK. Mice 
were age and / or sex matched in individual experiments. 
7.2.2 Generation of differentially-matu red DC 
Bone marrow from BALB/c mice (Harlan UK Ltd) was used to generate iDC by the 
'Plate' method, as previously described (Section 6.2.1). The iDC were stimulated 
overnight in 24-well plates with the various pathogen PAMPs, as previously described 
(Section 6.2.3). Briefly, cells were cultured overnight alone, or with 0-3hRP (20 - 40 Vg 
ml) and PMB (3 [ig / ml), LPS (100 ng / ml), or Zymosan A (1.6 ýtg / ml). In some 
experiments, additional controls of iDC cultured with PMB, or PMB and a concentration 
of LPS equivalent to the low levels of endotoxin contained within 0-3hRP, were included. 
For assays in which the resulting PAMP-matured DC (mDQ were to be used for in vivo 
T-cell priming (Section 7.2.4), OVA323-339 (323-ISQAVHAAHA-EMAGR-339) peptide 
(100 nM; Albachem, University of Edinburgh, UK) was also added the DC cultures. 
Culture of iDC with OVA323-339 alone did not result in increased cytokine production, 
providing confirmation that the peptide was free of endotoxin. Additionally, in some 
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experiments low-endotoxin anti-CD40 antibody (5 ýtg / ml; clone HN140-3; BD 
PharMingen) was added to the culture at the time of DC exposure to PAMPs. After 
overnight maturation, mDC were collected and washed 3 times in 5 ml RPMI 1640 prior 
to use in either in vitro (Section 7.2.3), or in vivo (Section 7.2.4), T-cell priming assays. 
7.2.3 In vitro T-cell priming assay 
7.2.3.1 Purification of splenic CD4+ cells 
CD4+ cells were purified from spleens of DOI 1.10 Tg mice, using Magnetic-Activated 
Cell Sorting (MACS), following the manufacturer's instructions. Throughout this process 
the cells were kept sterile. Briefly, spleens were removed and placed in DCP media, 
consisting of R_PM1 1640 supplemented with 10% heat-inactivated FCS, penicillin (200 U 
ml), streptomycin (100 ýtg / ml), L-glutamine (2 mM), and P -mercapto ethanol (50 ýtM). 
Single cell suspensions were created using 40 [im cell strainers (Falcon, Becton- 
Dickenson, Oxford, LTK). Cells were centrifuged at 350 g, for 5 min, and the supernatant 
discarded. The cells were then incubated with ACK buffer (10 ml; Section 4.2.2) for 5 min 
at RT to lyse red blood cells. ACK buffer was then quenched with DCP (10 ml) and the 
cells washed once in DCP (10 ml). Splenocytes were counted using a haernocytometer and 
re-suspended in chilled de-gassed MACS buffer (MACSB; pH 7.2; PBS containing 2mM 
EDTA and 0.5% BSA; 90 ýd / 107 cells). Anti-CD4 microbeads (Miltenyi Biotec, Bisley, 
UK; 10 [t, / 107 cells) were incubated with the cell suspension for 15 min at 4 T. The 
splenocytes were then washed and resuspended in MACSB, and CD4+ cells positively 
selected by passing the suspension through a MACS MS+ column (Miltenyi Biotec). Flow- 
cytometric analysis determined the purified cells to be > 90% CD4+ (data not shown). 
7.2.3.2 Priming ofD01 1.10 CD4+ splenocytes by dififerentially matured DC 
T-cell proliferation assays were performed in 96-well plates (200 [d), whereas cytokine 
assays were performed in 96-well (200 [d), or 24-well (1 ml), plates. Purified CD4+ 
splenocytes (2-5 x 105 cells / ml) were cultured with y-irradiated (1500 krads) mDC (2.5 x 
104 cell / ml; Section 7.2.2) for 72 hr in DCP media with, or without, various 
concentrations of 
OVA323-339 (1 
- 100 nM). 
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For the proliferation assay, cells were then pulsed with [3 H]-Thymidine (0.5 ýtCi / well; 
Amersham Pharmacia), and harvested 18 hr later using a Packard Cell Harvester (Packard, 
Pangbourne, UK). Cell proliferation was detennined according to the incorporation of 3 H- 
thymidine into DNA using a TopCountTM scintillation counter (Packard). 
Alternatively, to deten-nine T-cell cytokine production, phorbol myristate acetate (50 ng / 
ml) and ionomycin (500 ng / ml; Sigma-Aldrich) were added to the cells after the first 72 
hr of culture. The culture supernatants were then removed 24 hr later and frozen at -20 T. 
7.2.4 In vivo T-cell priming assay 
For in vivo T-cell priming, mDC (3 - 4.5 x 105 cells in 100 [d) were administered to 
recipient nalve DO 11.10 Tg mice by subcutaneous injection over the sternum. After 7 
days, the spleens and axillary lymph nodes (sdLN) were removed aseptically into RPMI 
1640 and single cell suspensions created using 40 l_tm cell strainers. Cells were then 
washed, transferred to 96-well plates (sdLN cells, 2x 10' cells / well; splenocytes, 4x 105 
cell / well), and cultured with OVA323-339 peptide (100 - 1000 nM), or plate-bound anti- 
CD3E; mAb (0.25 pg / well; Clone 145-2CI 1; BD PharMingen). To prepare plate-bound 
anti-CD36 mAb, wells were coated with antibody in PBS (30 pl), incubated for 2 hr at 37 
'C, and then washed 3 times with PBS (150 ltl). Cells were cultured in R_PMI 1640 
supplemented with 3% heat-inactivated normal mouse serum (instead of FCS; produced in 
house), penicillin (200 U/ ml), streptomycin (100 [tg / ml), L-glutamine (2 mM), and P- 
mercaptoethanol (50 ýtm). After 3 days, culture supernatants were removed and frozen at - 
20 OC to await detection of cytokines by ELISA. 
7.2.5 Cytokine ELISAs 
Culture supernatants were tested neat, or at a 1: 2 dilution, for the presence of IL-4, IL-5 
and IFN7, using ELISA (Section 3.2.6 & 6.2.5). Lower limits of detection are shown on 
figures as dashed lines or arrows. The coating and detecting antibody clones for EL-5 
(TRFK5 and TRFK4, respectively) were obtained from BD PharMingen, whereas the 
recombinant standard was from R&D Systems. 
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7.2.6 Statistics 
Comparisons of data within an individual experiment were tested for significance using the 
two-tailed Students Mest, assuming equal variance ifp > 0.05 when tested with the 
Levene's test. Alternatively, data was expressed as the log value of the fold-increase in 
cytokine production when compared to the mean value produced by cells primed with 
DC/media. These values were then pooled from multiple individual experiments. The 
mean log data from pooled experiments was then tested for significance difference from a 
theoretic value of 0 (equivalent to a1 -fold increase, which represents cells primed with 
DC/media) using the two-tailed one-sample Students Mest. Values where p:! ý 0.05 were 
considered to be significant, whereas values where p ý! 0.05 were considered not 
significant. The following nomenclature was used to denote the value of significance: *p 
:! ý 0.05, ** p:! ý 0.01, *** p:! ý- 0.001. 
7.3 RESULTS 
7.3.1 DC matured with 0-3hRP have increased capacity to prime T-cells 
An in vitro 'anti gen-restri cted' assay was used to determine whether DC matured with 0- 
3hRP, or other control PAMPs, acquired a phenotype exhibiting increased capacity to 
prime T-cells. In this assay, differentially-matured DC were cultured with purified CD4+ T- 
cells from DOI 1.10 Tg mice, in the presence of varying concentrations of the model 
antigen (OVA). Subsequent proliferation was assessed by measurement of DNA synthesis, 
via the incorporation of 3 H-Thymidine. 
Compared to DC matured with media alone (DC/media), or with LPS and PMB (DC/LPS 
+ PMB), DC matured with 0-3hRP and PMB (DC/0-3hRP) primed for a significant 
increase in anti gen-specific T-cell proliferation in the presence of I and 10 nM OVA 
(Figure 7.1 a). Moreover, this heightened capacity to prime T-cell proliferation was 
enhanced by maturing DC with a greater concentration of 0-3hRP (Figure 7.1 a). 
Background proliferation of punfied CD4+ splenocytes was minimal (up to 16-fold less 
than DC-media; Figure 7.1 a). As expected, y-irradiated DC cultured without T-cells did not 
proliferate at all, demonstrating that they did not contribute to the proliferation observed in 
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the mixed T-cell cultures (data not shown). DC matured with LPS (DC/LPS) or Zymosan 
A (DC/Zymosan A) also exhibited an increased capacity to drive T-cell proliferation 
compared to DC-media (Figure 7.1 b). 
7.3.2 0-3hRP instructs DC to prime for Th2 polarisation in vitro 
To determine if DC/0-3hRP polarised the expanding T-cell population, the profile of Th I- 
signature (EFNy) and Th2-signature (IL-4) cytokine production was compared to that of T- 
cells cultured with the neutral DC/media control. A DC to T-cell ratio of 1: 10 was used as 
previous studies demonstrated this to result in a mixed Th response, characterised by both 
JFNy and IL-4 production (Whelan et al., 2000; Manickasingham et al., 2003). DC 
matured with either Th I -associated LPS (Whelan et al., 2000), or Th2-associated, 
Zymosan A (Manickasingham et al., 2003), were assayed as positive controls. The data 
from two individual experiments are presented (Figure 7.2). 
DC matured with PMB (DC/PMB) and DC/LPS + PMB primed T-cells for slightly 
increased EFNy production compared to DC/media (Figure 7.2a). DC/0-3hRP also primed 
for increase IFNy production compared to DC/media, but this was not more than that 
primed by the DC/PMB and DC/LPS + PMB negative controls (Figure 7.2a). Conversely, 
priming with DC/LPS led to a much greater increase in IFNy production than priming with 
any other mDC. In contrast to IFNy, DC/0-3hRP drove increased production of the 
reciprocal cytokine IL-4 compared to controls, whereas DC/LPS did not (Figure 7.2b). A 
similar pattern was observed in a repeat experiment, in which DC/0-3hRP primed T-cells 
for increased IL-4 but with little increase in EFNy production compared to DC/media, 
whereas DC/LPS primed for increase EFNy but not EL-4 production (Figure 7.2c & d). 
Additionally, DC/Zymosan A were also analysed in the second experiment, and primed for 
a similar cytokine profile to DC/0-3hRP, with increased IL-4 production but little increase 
in IFNy (Figure 2.2c & d). DC or CD4+ cells cultured alone did not produce detectable 
cytokine (data not shown). Taken together, the data from these experiments suggests that 
DC/0-3hRP promotes Th2 polansation. Indeed, increasing the dose of 0-3hRP appeared to 
enhance the DC capacity to drive Th2 polansation (Figure 7.3a & b). It is noteworthy that 
in these experiments increased production of one polar cytokine (i. e. IFNy or IL-4) did not 
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necessarily result in inhibition of the reciprocal polar cytokine when compared to 
DC/media. 
7.3.3 0-3hRP instructs DC to prime for Th2 responses in vivo 
During percutaneous infection with sch'stosomes, initial T-cell priming occurs In the sdLN 
(Constant et al., 1990; Pemberton et al., 1991). Therefore, I wanted to examine whether 
MC matured in vitro with 0-3hRP could prime for Th2 responses in vivo, after delivery via 
the skin. Consequently, DOI 1.10 mice were injected subcutaneously with differentially 
matured DC previously pulsed with OVA antigen; the outcome of T-cell priming was 
determined after 7 days by in vitro re-stimulation of sdLN cells with OVA. As with the in 
vitro assays, Th I- and Th2-associated, or neutral DC, were included as markers of 
polarisation. In addition to JL-4, production of another Th2 signature cytokine, IL-5, was 
also analysed. 
Re-stimulation with limiting dilutions of OVA (100 - 1000 nM) revealed that sdLN cells 
from mice injected with LPS-matured DC produced approximately 5-fold greater 
IFNy than sdLN cells from mice injected with DC/media (Figure 7.4a). In contrast, sdLN 
cells from mice injected with DC/0-3hRP, or DC/Zymosan A, produced no detectable 
IFNy upon re-stimulation with 100 nM OVA and only two-fold more than DC/media 
control, when re-stimulated with 1000 nM OVA. Analysis of Th2 signature cytokines 
revealed that sdLN cells from DC/0-3hRP recipients produced dramatically increased 
levels of IL-4 and IL-5 upon re-stimulation compared to cells from DC/media recipients 
(Figure 7.4b & c). Moreover, DC/LPS stimulated no significant increase in fL-4 
production and only a little increase in IL-5 production. Similarly to DC/LPS, 
DC/Zymosan A did not prime for increased IL-4 production, and only a limited increase in 
IL-5 production. However, in experimental repeats, DC/0-3hRP and DC/LPS appeared to 
drive little increase in IFNy production, whereas DC/Zymosan A stimulated increased 
IFN7, IL-4, and IL-5 production. Therefore, the data from three experiments (representing 
3 individual mice) was collated and analysed. Due to variations in overall cytokine 
production between the experiments, the data was expressed as the log fold-increase in 
cytokine production compared to the DC/media control. Therefore, in this analysis the 
DC/media control assumes the value of zero. In one experiment, sdLN cells from mice 
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injected with DC/LPS appeared to produce little cytokine, and so this data was 
disregarded. 
Analysis of the pooled data demonstrated that sdLN cells from DC/0-3hRP recipients 
appear to produce an overall decreased level of IFNy production upon re-stimulation with 
either concentration of OVA, compared DC/media (Figure 7.5a). In contrast, DC/0-3hRP 
primed for increased IL-4 and IL-5 production at both concentrations of OVA, compared 
to DC/media (Figure 7.5b & c). It is noteworthy that DC/0-3hRP-primed sdLN cells 
produced significantly more IL-4 and IL-5 than DC/media-primed cells in two of the three 
individual experimental repeats when re-stimulated with 100 nM OVA, and in all repeats 
when re-stimulated with 1000 nM OVA (data not shown). Overall, DC/LPS appeared to 
drive increased EFNy production, although the variation between experiments was 
considerable (Figure 7.5a). In addition, DC/LPS primed for little, or no, increase in IL-4 
and IL-5 production compared to that primed by DC/0-3hRP (Figure 7.5b & c). 
Surprisingly, DC/Zymosan A primed sdLN cells for increased EFNy and IL-5 production 
but with little increase in IL-4, apart from a small elevation upon re-stimulation with 1000 
nM OVA, and therefore appear to be less potent drivers of Th2 polarisation than DC/0- 
3hRP. 
Interestingly, the log fold-increases in IFN7 production primed by DC/LPS and 
DC/Zymosan A were quite low when compared to the log-fold increases in EL-4 and IL-5 
production primed by DC/0-3hRP. This is probably due to the relatively high levels of 
EFN7 but low levels / undetectable levels of IL-4 or IL-5 produced by DC/media (Figure 
7.4). 
To determine if subcutaneous injection of the differentially matured DC also affected the 
systemic polarisation of the T-cell population, splenocytes ftorn recipient mice were re- 
stimulated in vitro, in the same manner as for sdLN cells. Splenocytes ftorn mice injected 
with DC/0-3hRP produced higher levels of IFNy when re-stimulated with 100, or 1000, 
nM OVA compared to those from DC/media recipients but lower levels than splenocytes 
from mice injected with DC/LPS (Figure 7.6a). Splenocytes from mice injected with 
DC/Zymosan A also produced high levels of IFNy similar to, or less than, that produced by 
DULPS recipients upon re-stimulation with 1000, or 100, nM OVA respectively. Analysis 
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of 'Th2 signature' cytokines demonstrated that both splenocytes from mice injected with 
DC/0-3hR-P and those injected with DC/Zymosan A, produced dramatically increased 
levels of IL-4 compared to DC/media, whereas splenocytes primed with DC/LPS produced 
little (1000 nM OVA), or no (100 nM OVA), increase (Figure 7.6b). In addition, 
splenocytes from DC/0-3hRP recipients appeared to produce relatively high levels of IL-5 
compared to those from DC/media recipients (Figure 7.6c). In contrast, DC/LPS and 
DC/Zymosan A primed for less, or no, increase in IL-5 production. 
The data from three individual experiments were pooled, as for sdLN, allowing greater 
confidence in the trends observed in cytokine production. All PAMP-stimulated DC 
appeared to drive increased IFNy production compared to DC/media (Figure 7.7a). 
Moreover, this increase in IFNy production was similar between DC/0-3hRP, DC/LPS, and 
DC/Zymosan A. In contrast, splenocytes from mice injected with DC/0-3hRP and 
DC/Zymosan A but not DC/LPS produced increased IL-4 and IL-5 compared to cells from 
DC/media recipients (Figure 7.7b & c). Indeed, when splenocytes were re-stimulated with 
100 nM OVA, DC/0-3hR-P appeared to be a more potent promoter of IL-4 and IL-5 
production than DC/Zymosan A. Moreover, cells from DC/LPS recipients appeared to 
produce an overall decreased level of IL-5 production compared to splenocytes primed 
with DC/media, when re-stimulated with 1000 nM OVA. 
It is noteworthy that splenocytes cultured with anti-CD3 antibody (which non-specifically 
stimulates all T-cells) produced similar cytokine profiles to that of their OVA-re- 
stimulated counter-parts. In this respect, splenocytes from mice injected with DC/0-3hRP, 
DC/LPS and DC/Zymosan A, all produced similarly increased levels of IFNy compared to 
DC/media primed splenocytes, but only splenocytes from DC/0-3hRP and DC/Zymosan A 
recipients produced increased IL-4 and EL-5 (Figure 7.8a, b, c). Moreover, when the CD3- 
stimulated cytokine production was averaged for 3 separate experiments, the profiles were 
also very similar (Figure 7.9a, b, c). Considerable variation in EFNy production was 
observed between experiments due to high-level production by cells from DC/media 
treated mice in one experiment (data not shown). Although a large variation in the log fold- 
increase of IL-5 production compared to DC/media was apparent (Figure 7.9c), it is 
noteworthy that in each individual experiment, both DC/0-3h" and DC/Zymosan A 
primed for significant increases compared to DC/media. In contrast, in only one 
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experiment did DC/LPS prime for a significant increase in IL-5 production, with 
significantly reduced levels apparent in one of the repeats. 
7.3.4 Culture of DC with anti-CD40 antibody leads to a heighten ability to drive 
antigen-specific responses but impairs the generation of Th2 polarised responses 
One of the factors thought to play a pivotal role in the activation and function of DC is the 
interaction between CD40 and CD 154. In this respect, co-culture of DC with 0-3hRP and 
anti-CD40 antibody increased their production of IL- 12, a cytokine known to contribute to 
Thl development, whilst having limited effects on Th2-associated cytokines (Section 
6.3.8). However, the role of CD40-signalling in T-cell polarisation is controversial 
(discussed in Section 6.4). Therefore, the in vivo priming assay was used to deterimne 
whether stimulation through CD40 affects the ability of DC/0-3hRP to drive Th2 polarised 
responses. 
Upon re-stimulation, sdLN cells from mice injected with anti-CD40-treated DC/media 
produced 3-fold more EFNy, compared to cells from mice injected with untreated 
DC/media (Figure 7.1 Oa). Similarly, DC/0-3hRP treated with anti-CD40 antibody primed 
for 2-fold greater IFN7 production compared to the levels produced by sdLN cells from 
DC/0-3hRP recipients. In addition, analysis of Th2 cytokines revealed that sdLN cells from 
anti -CD40-treated DC/media recipients also produced increased levels of IL-4 and IL-5 (3- 
to 4-fold, respectively) compared to the low levels produced by DC/media-primed cells 
(Figure 7.1 Ob & c). In contrast, compared to the high levels of EL-4 and IL-5 primed for by 
DC/0-3hRP, sdLN cells from anti-CD40-treated DC/0-3hRP recipients produced 
significantly less Th2 cytokines (2- to 3-fold, respectively). 
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Figure 7.1 DC/0-3hRP promote T-cell proliferation. Splenic CD4' 
cells from DOI 1.10 mice were cultured alone (X), or with mDC 
previously matured alone (0), with '20' ýtg / ml (* ) or '40' ýtg / ml (0) 
0-3hRP in the presence of PMB, or with LPS and PMB (0) (a). In the 
same experiment, CD4' cells were also cultured with mDC previously 
matured with LPS (100 ng / ml; *), or Zymosan A (1.6 ýtg / ml; 0) (b). 
Cells were then cultured in the presence of OVA peptide (0 - 100 nM) for 
72 hr, before measuring DNA synthesis by uptake of IH-Thymidine. Data 
is presented as the mean ± SEM of 6 wells. Data is representative of 2 
experiments. 
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Figure 7.2 DC/0-3hRP polarise nalive CD4' T-cells towards a Th2 
phenotype in vitro. iDC matured alone, with 0-3hRP (20 ýtg / ml) + PMB, 
with LPS (100 ng / ml), with LPS + PMB, or with Zymosan A (1.6 ýtg 
ml), were co-cultured with purified splenic CD4+ cells from DOI 1.10 
mice in the presence of OVA peptide (10 nM). After 3 days, cells were 
pulsed overnight with phorbol myristate acetate and ionomycin. The 
supernatants were analysed by ELISA for production of IFNy (a & c) and 
IL-4 (b & d). Data from two different experiments is presented (note that 
low levels of IL-4 in Data Set I were probably due to omission of P- 
mercaptoethanol from the culture medium). Data Set I represents values 
from pooled wells (a & b). Data Set 2 is presented as the mean ± SEM of 
3 wells (c & d). Arrows denote the lower detection limit of ELISA. Levels 
of significance are between DC/media control and test groups. 
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Figure 7.3 Th2-polarising function of DC is dependent on 0-3hRP 
dose. iDC matured alone, with 0-3hRP (20 - 40 ýLg / ml) + PMB, or with 
Zymosan A (1.6 [tg / ml), were co-cultured with purified splenic CD4+ 
cells from DO 11.10 mice, in the presence of OVA peptide (10 nM). After 
3 days, cells were pulsed overnight with PMA and ionomycin. The 
supernatants were analysed by ELISA for production of IFNy (a) and IL-4 
(b). Data is presented as the mean ± SEM of 5 wells. Arrows denote the 
lower detection limit of ELISA. Levels of significance are between 
DC/media control and test groups. 
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Figure 7.4 DC/0-3hRP drives polarisation towards a Th2 phenotype 
in vivo. DOI 1.10 mice were injected subcutaneously with OVA-pulsed 
DC previously matured alone, with 0-3hRP (40 ýtg / ml) + PMB, with 
LPS (100 ng / mi), or with Zymosan A (1.6 pg / ml). After 7 days, sdLN 
cells were re-stimulated in vitro with OVA (0 - 1000 nM) for 72 hr. 
Supernatants were analysed by ELISA for production of IFNy (a), IL-4 
(b), and IL-5 (c). Data is presented as the mean ± SEM of 3 wells. Arrows 
denote the lower detection limit of ELISA. Levels of significance are 
between DC/media control and test groups. 
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Figure 7.5 DC/0-3hRP drives polarisation towards a Th2 phenotype 
in vivo. In three separate experiments DO 11.10 mice were injected 
subcutaneously with OVA-pulsed DC previously matured alone, with 0- 
3hRP (40 ýtg / ml) + PMB, with LPS (100 ng / ml), or with Zymosan A 
(1.6 ýtg / ml). After 7 days, sdLN cells were re-stimulated in vitro with 
OVA (0 - 1000 nM) for 72 hr. Supernatants were analysed by ELISA for 
production of IFNy (a), IL-4 (b), and IL-5 (c). Data is expressed as log 
fold-increase in cytokine production compared to DC matured with 
media. Data is presented as the mean ± SEM of 3 individual experiments, 
except LPS for which n=2. Levels of significance are between 
DC/media control and test groups. 
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Figure 7.6 DC/0-3hRP drives systemic Th2 polarisation. DOI 1.10 
mice were injected subcutaneously with OVA-pulsed DC previously 
matured alone, with 0-3hRP (40 pg / ml) + PMB, with LPS (100 ng / ml), 
or with Zymosan A (1.6 ýtg / ml). After 7 days, splenocytes were re- 
stimulated in vitro with OVA (0 - 1000 nM) for 72 hr. Supernatants were 
analysed by ELISA for production of IFNy (a), IL-4 (b), and IL-5 (c). 
Data is presented as the mean ± SEM of 3 wells. Arrows denote the lower 
detection limit of ELISA. Levels of significance are between DC/media 
control and test groups. 
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Figure 7.7 DC/0-3hRP drives systemic Th2 polarisation. In three 
separate experiments DOI 1.10 mice were injected subcutaneously with 
OVA-pulsed DC previously matured alone, with 0-3hRP (40 ýtg / ml) + 
PMB, with LPS (100 ng / ml), or with Zymosan A (1.6 ýtg / ml). After 7 
days, splenocytes cells were re-stimulated in vitro with OVA (0 - 1000 
nM) for 72 hr. Supernatants were analysed by ELISA for production of 
IFN7 (a), IL-4 (b), and IL-5 (c). Data is expressed as log fold-increase in 
cytokine production compared to DC matured with media. Data is 
presented as the mean ± SEM of 3 individual experiments. Levels of 
significance are between DC/media control and test groups. 
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FiLyure 7.8 DC/0-3hRP drives systemic Th2 polarisation. DOI 1.10 mice 
were injected subcutaneously with OVA-pulsed DC previously matured 
alone, with 0-3hRP (40 ýtg / ml) + PMB, with LPS (100 ng / ml), or with 
Zymosan A (1.6 ýtg / ml). After 7 days, splenocytes were re-stimulated in 
vitro with anti-CD3 antibody for 72 hr. Supernatants were analysed by 
ELISA for production of IFNy (a), IL-4 (b), and IL-5 (c). Data is presented 
as the mean ± SEM of 3 wells. Arrows denote the lower detection limit of 
ELISA. Levels of significance are between DC/media control and test 
groups. 
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Figure 7.9 DC/0-3hRP drives systemic Th2 polarisation. In three 
separate experiments DOI 1.10 mice were injected subcutaneously with 
OVA-pulsed DC previously matured alone, with 0-3hRP (40 gg / ml) + 
PMB, with LPS (100 ng / ml), or with Zymosan A (1.6 ýtg / ml). After 7 
days, splenocytes were re-stimulated in vitro with anti-CD3 antibody for 
72 hr. Supernatants were analysed by ELISA for production of IFNy (a), 
IL-4 (b), and IL-5 (c). Data is expressed as log fold-increase in cytokine 
production compared to DC matured with media. Data is presented as 
mean ± SEM of 3 individual experiments. Levels of significance are 
between DC/media control and test groups. 
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Figure 7.10 Ligation of CD40 inhibits the ability of DC/0-3hRP to 
drive Th2 polarisation. DOI 1.10 mice were injected subcutaneously with 
OVA-pulsed DC previously matured alone, or with 0-3hRP (40 [tg / ml) + 
PMB, in the presence (hatched bars), or absence (open bars), of anti-CD40 
antibody (5 ýtg / ml). After 7 days, sdLN cells were re-stimulated in vitro 
with 1000 nM OVA for 72 hr. Supernatants were analysed by ELISA for 
production of IFNy (a), IL-4 (b), and IL-5 (c). Data is presented as mean ± 
SEM of 3 wells, and was obtained from the same experiment presented in 
Figure 7.4. Data is representative of 2 experiments. Arrows denote the 
lower detection limit of ELISA. Levels of significance are between cells 
cultured with, or without, anti-CD40 antibody. 
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7.4 DISCUSSION 
hi this chapter, a series of experiments were performed using an antigen-restricted TCR Tg 
system to determine if exposure to released schistosome PAMPs affects the capacity of DC 
to prime and polarise T-cells. I demonstrate that maturation with 0-3hRP increases the 
ability of DC to stimulate clonal expansion of T-cells. Furthermore, exposure to 0-3hRP 
instructs DC to drive differentiation of the proliferating T-cells towards the Th2 pole in 
vitro. The capacity of DC/0-3hRP to drive Th2 polarisation was further demonstrated using 
a more physiologically relevant in vivo priming assay. 
7.4.1 T-cell proliferation in vitro 
A well-characterised in vitro T-cell priming assay, in which DC were co-cultured with 
purified TCR Tg T-cells in the presence of model antigen, was used to show that DC 
matured with 0-3hRP activate T-cells to undergo greater clonal expansion than DC 
matured alone. Clonal expansion of naYve T-cells requires signalling through both the TCR 
(signal 1), and co-stimulatory receptors (signal 2). This occurs following ligation of these 
receptors by specific antigen-MHC 11 complexes and co-stimulatory factors expressed 
upon APC. Importantly, the strength of signalling, determined by the amount of receptor 
ligation, is proportional to subsequent T-cell proliferation (Murtaza et al., 1999). 
Moreover, cytokines such as IL-12 and IL-6 are also co-stimulatory factors, increasing T- 
cell expansion during priming (Vink et al., 1990; Kubin et al., 1994). Therefore, the 
increased T-cell proliferation stimulated by DC/0-3h" probably directly relates to their 
up-regulated surface expression of MHC H and the co-stimulatory factors CD86 and 
CD40, and their up-regulated production of IL-6 and IL-12p4O (Section 6.3.7). This 
confirms that released schistosome PAMPs stimulate maturation of DC and highlights the 
relevance of this to the functional phenotype of these cells. Moreover, this study indicates 
that APC exposed to released schistosome PAMPs at the onset of infection may have an 
increased capacity to prime schistosome-specific T-cell responses in the host. 
Both LPS and Zymosan A stimulated greater expression of MHC 11 and co-stimulatory 
factor expression upon DC compared to that stimulated with 0-3hRP, yet this did not 
confer greater levels of T-cell proliferation. This suggests that other factors also affect the 
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rate of clonal expansion. Indeed, IL- 10 produced by both DC/Zymosan A and DC/LPS 
(Section 6.3.7) could act in an autocrine manner to regulate the APC function of these 
cells. In addition, Th cells could limit their own proliferation, through mechanisms such as 
IL- 10 production. Alternatively, incorporation of 3 H-thymidine into DNA only measures 
proliferation between two time points, thus representing a 'snapshot' of cell proliferation. 
Therefore, it is possible that peak proliferation could have occurred earlier in cultures 
containing DC/Zymosan A, or DC/LPS. Assessment of actual T-cell numbers may more 
accurately address this issue. 
7.4.2 T-cell polarisation in vitro 
The same 'antigen-restricted' in vitro T-cell priming assay was also used to detennine the 
T-cell polarising capacity of DC/0-3hRP compared to the control DC. As a point of note, 
the cytokine production measured in these experiments also represents a 'snapshot' of 
polarisation at one point post-priming. Although this is sufficient for the purpose of my 
study, further analysis of the kinetics of cytokine production may produce a more detailed 
account of T-cell differentiation following priming with the differentially-matured DC. 
DC/media primed for production of the Thl cytokine IFNy and the Th2 cytokine IL-4. In 
contrast to this mixed or ThO profile, DC/LPS primed for increased production of EFNy but 
not IL-4, whereas DC/Zymosan A primed for increased production of IL-4 but not IFNy. 
Therefore, as expected DULPS promoted a more Th I -biased response, whereas 
DC/Zymosan A promoted a more Th2-biased response, agreeing with previous reports 
(Whelan et al., 2000; MacDonald et al., 2001; Manickasingham et al., 2003). In 
comparison to DC/media, and other negative control DC, DC matured with 0-3hRP primed 
for increased production of IL-4, but little or no increase in IFNy production. Therefore, I 
conclude that DC/0-3hRP promote Th2 polarisation in vitro. It is noteworthy that DC 
matured with 0-3hRP appeared equally as potent as those matured with Zymosan A in 
driving towards Th2 polarisation. 
The responder T-cell population used in these assays may have contained low levels of 
memory T-cells, thought to exist by expressing an additional endogenously rearranged 
TCR, which allows them to respond to cross-reactive environmental antigens (Lee et al., 
1996). Although originally linked to IL-4 production (Macatonia et al., 1995), the presence 
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of these memory cells is now thought to preferentially skew the T-cell population towards 
EFN7 rather than IL-4 production when stimulated with similar levels of OVA to those 
used in my study (Hosken et al., 1995; Lee et al., 1996; Manickasingharn et al., 2003). 
Thus, the possible presence of Thl -promoting memory cells in the responder T-cell 
population emphasises the potency of DC/0-3hRP and DC/Zymosan A to drive Th2 
responses, and DC/LPS to enhance Thl responses. Differences in the number of these cells 
in responder T-cell populations could explain the variation in overall cytokine production 
between individual experiments. Many studies have used naYve T-cells selected for 
expression of CD62L high as responder cells. However, this requires access to a flow- 
assisted cell sorter, which unfortunately was not possible during the course of my studies. 
Furthermore, recent studies demonstrate that memory T-cells can be CD62L high (London et 
al., 1999; Ben-Sasson et al., 2000), thus questioning the validity of using this marker to 
purify naYve cells. 
7.4.3 T-cell polarisation in vivo 
The same 'antigen-restricted' system was used to determine the in vivo T-cell priming 
capability of DC/0-3hRP. This assay required adoptive transfer of 'antigen-loaded' mature 
DC into nalve recipient Tg mice, and subsequent re-stimulation of sdLN, or splenic, 
effector cells in vitro. Due to restrictions on available mice, one mouse per DC-type were 
compared in individual experiments but the results from three experiments were pooled to 
give greater confidence in the data. However, due to variations in the overall levels of 
cytokine production between experiments, the data was first expressed as the log of the 
fold-increase in cytokine production over the DC/media control. The cytokine profiles 
generated in repeat experiments did vary, as is evident by the standard error of the pooled 
data, although this was more notable in the profile of IFN7 production, than EL-4 or IL-5, 
possibly reflecting differences in antigen-responsive memory populations within the 
individual mice. Further experimental repeats should reduce the error within this data. 
Moreover, repeating this study with a greater number of mice per experimental group 
would be an advantage, removing inherent errors incurred by the direct comparison of data 
from different experiments. However, in all experiments DC/0-3hRP primed for a dramatic 
increase in IL-4 and IL-5 production by sdLN cells compared to DC/media and DC/LPS. 
This is reflected by the significance of the pooled experimental data. Although in one 
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experiment, priming with DC/0-3hRP also resulted in a limited increase in EFNy 
production, analysis of the pooled data demonstrated that there was an overall decrease in 
production of this cytokine compared to priming with the DC/media control. This leads to 
the conclusion that DC matured with 0-3hRP promote Th2 polarisation in the sdLN, 
reinforcing the observations from the in vitro assays. Furthermore, DC/0-3hRP were more 
potent than DC/Zymosan A at driving Th2 polarisation. Indeed, DC/Zymosan A appeared 
to prime for a more mixed Thl/Th2 response, with overall greater levels of IFNy and IL-5 
produced compared to DC/media primed sdLN cells. Similarly, DC/LPS appeared to prime 
for both increased IFN7 and IL-5. The overall increase rather than qualitative difference in 
the cytokine responses induced by DC/Zymosan A and DULPS compared to DC/media 
could reflect a greater overall level of in vivo T-cell priming by these DC, as might be 
expected from their increased capability to drive T-cell expansion in vitro. 
Injection of differentially primed DC also led to the polansation of responder T-cells in the 
spleen. This may have occurred through the immigration of effector T-cells ansing in the 
sdLN. Alternatively, the transferred DC may have immigrated from the sdLN to spleen. 
However, it is possible that following injection some DC bypassed the sdLN, and primed 
naYve T-cells upon their arrival in the spleen. Indeed, since the APC to T-cell ratio is 
known to affect polarisation (Tanaka et al., 2000; Manickasingham et al., 2003), 
differences in the number of DC reaching the LN or spleen between experiments could 
account for the variation observed in the resulting cytokine profiles. 
Similar to cytokine profiles produced by sdLN cells, splenocytes primed in vivo with 
DC/0-3hRP produced dramatically increased levels of IL-4 and IL-5. However, DC/0- 
3hRP also primed splenocytes for increased LFNy production. Indeed, both DC/Zymosan A 
and DC/LPS also primed for similar increases in IFNy production compared to DC/media 
(significant in 2 of the 3 individual experiments). However, only DC/Zymosan and not 
DC/LPS also primed for increased production of Th2 cytokines. Again, the increase in 
both Th I and Th2 cytokine production primed for by PAMP-matured DC suggests a 
greater level of in vivo T-cell priming in the spleen, compared to that by DC/media. One 
interpretation of this data is that DC/0-3hRP and DC/Zymosan A prime more for a mixed 
Thl / Th2, or ThO response in the spleen, and that DULPS drive only weak Thl 
polarisation. Alternatively, polarisation of T-cell responses represents a continuum 
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between highly differentiated Thl and Th2 poles, and thus, it could be interpreted that 
DC/0-3hRP and DC/Zymosan A prime more towards a Th2 response simply because they 
drive co-production of IL-4 and EL-5, in addition to EFNy. In this respect, DC/LPS may be 
described as Th I -polansing simply by not driving Th2 cytokine production. However, it is 
noteworthy that the log mean fold-increase in IFN7 production driven by DC/LPS and 
DC/Zymosan A in both the spleen and sdLN was low compared to the high log mean fold- 
increases in IL-4 or EL-5 production primed by DC/0-3h" and DC/Zymosan A (especially 
at the highest concentration of OVA). This suggests that the assay system could be biased 
towards Thl cytokine production, making it difficult to detect further Thl polarisation. 
It is interesting that in vivo DC/0-3hRP appeared to prime for a greater increase in IFN7 
production by spleen cells than by sdLN cells, possibly reflecting a difference in function, 
or in a biased potential for T-cell polarisation, of these organs. However, since priming in 
the sdLN might be expected to precede that in the spleen, these observations may reflect 
differences in the kinetics of priming in these organs. In this respect, developing Th2 
responses may first go through transient ThO phases in vivo (Vella and Pearce, 1992), and 
EFN7 production is thought to precede IL-4 by expanding T-cells (Bird et al., 1998). 
7.4.4 DC function in T-cell priming 
Although the DC populations used in these experiments contain a number of myeloid 
precursor cells / granulocytes, the vast majority of the MHC II+, co-stimulatory factor+ and 
cytokine+ cells were CD II c+ (Section 6.4). Thus, it is reasonable to conclude that enriched 
CD II c+ DC are responsible for the in vitro polansation of the T-cell population. This 
conclusion is supported by a similar study in which the outcome of priming was the same 
whether purified CD 11 c+, or non- fractionated whole BM-derived DC populations were 
used (Whelan et al., 2000). Furthen-nore, although DC can exchange antigen / MHC H 
complexes with each other (Bedford et al., 1999), it seems most that likely that in vivo 
polansation was primed directly by the PAMP-matured DC. 
The data presented in this chapter confirins the growing evidence that DC can distinguish 
between the nature of different pathogens, or their products, subsequently allowing them to 
drive either Th 1, or Th2, responses (Whelan et al. 2000; MacDonald et al, 200 1; de Jong et 
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al., 2002). This directly contrasts the view that DC subsets are pre-programmed to prime 
either Th I, or Th2 responses (Rissoan et al., 1999; Maldonado-Lopez et al., 1999; Moser 
2001). Moreover, recent work shows the plasticity of DC to drive either Thl or Th2 
polarisation is universal between DC subsets, and not just an aberrant trait of myeloid BM- 
derived DC (Manickasingham et al., 2003; Boonstra et al., 2003), suggesting that 0-3hRP 
could stimulate many DC subsets to prime Th2 responses. Interestingly, a bias in the 
potential of human and munne DC subsets to polarise T-cells could be explained by their 
selective expression of PRRs, which effectively restricts the class of PAMPs to which they 
can respond (Kadowaki et al., 2001; Kelsall et al., 2002; Boonstra et al., 2003). Since there 
have been no studies on the repertoire of PRR expressed on LC or dermal DC, it is difficult 
to know if they would be limited in the range of PAMPs to which they could respond. 
However, in vivo evidence of APC activation and accumulation at the site of schistosome 
infection / vaccination (Reingrojpitak et al., 1998; Angell et al., 2001 a; Hogg et al., 2003a; 
Kumkate et al., 2003) would indicate that these cells do respond to molecules released by 
penetrating schistosomes. 
The data presented in this chapter and Chapter 6 suggests that DC/0-3hRP prime for Th2 
responses in the absence of high levels of polarising cytokines and co-stimulatory factors. 
Similarly, the Th2 responses driven by DC matured with nematode ES-62, or schistosome 
SEA, occur in the absence of increased co-stimulatory factor expression or cytokine 
production (Whelan et al., 2000; MacDonald et al., 2001). Together with these studies, my 
work supports the view that Th2 differentiation represents a default pathway in the absence 
of strong polarising signals. This is consistent with observations that T-cells can be rescued 
from ES-62-driven Th2 polansation by addition of EL- 12 to cultures (Whelan et al., 2000), 
whereas Th I responses do not develop, or are impaired, using DC from IL-12 -/- mice, or 
can be ablated by addition of anti-IL-12 antibody to cultures (Whelan et al., 2000; Moser, 
2001; MacDonald and Pearce, 2002; Jankovic et al., 2002). Moreover, simultaneous 
blocking of a number of pro-inflammatory cytokines (EL- 12, EL- 18 and EFNU) in human 
DC / T-cell co-cultures switched Thl -dominated responses to Th2-dominated responses 
(de Jong et al., 2002). In addition, mice deficient for MyD88 develop Th2 instead of Thl 
responses to mycobacterial PAMPs, or T gondii infection, corresponding with a decrease 
in the activation state of their DC (Schnare et al., 2001; Jankovic et al., 2002). 
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Another way in which priming with DC/0-3hRP could result in increased IL-4 and IL-5 
production is through the expression of low levels of MHC H-peptide complexes, which 
has been linked to Th2 induction (Ruedl et al., 2000). Although 0-3hRP did stimulate 
increased expression of MHC 11 compared to DC/media, this was lower than on DC/LPS. 
This intermediate up-regulation of MHC 11 could allow increased T-cell priming, but result 
in Th2 rather than Thl polarisation. 
My data also suggests that Th2 polarisation need not require IL-10 production, since DC/0- 
3hRP did not produce this cytokine (Section 6.3.7). Similarly, Th2 polarisation driven by 
ES-62 is independent of IL-10 (Whelan et al., 2000). It is possible that DC/0-3hRP-derived 
IL-4 and IL-6 production may be involved in Th2 polarisation, although DC can drive Th2 
responses in the absence of IL-4 (MacDonald and Pearce, 2002). Furthermore, I 
demonstrate that Thl polansation can occur in the presence of considerable amounts of IL- 
10, IL-6, and IL-4, since DOLPS produced high levels of these cytokine in addition to 
high levels of pro-inflammatory cytokines, emphasising that the balance between these 
different signals is probably important to the outcome of T-cell polarisation. 
In contrast to DC/0-3hRP, DC/Zymosan A also appear to 'instruct' Th2 differentiation yet 
have a 'highly' activated maturation state, characterised by production of considerable 
quantities of polarising cytokines, such as IL-12p7O, and high level expression of co- 
stimulatory factors and MHC 11. It is noteworthy that at the doses used in this study 
DC/Zymosan A did not appear to be as potent as DC/0-3hRP in driving Th2 polansation in 
vivo, since they also primed for increased EFN7 by sdLN cells. It is quite possible that this 
is a result of the high levels the pro-inflammatory cytokines produced by DC/Zymosan A. 
In this respect, although Manickasingham et al. (2003) reported that DC stimulated with 
Zymosan A drive Th2 polarisation, their study focused upon splenic DC which have 
previously been shown to preferentially produce IL- 10 rather than IL- 12 upon exposure to 
this PAMP (Edwards et al., 2002). 
This data further highlights the complexity of the DC / T-cell interactions that result in the 
polarisation of the effector population, and demonstrate that there might be several 
independent mechanisms that lead to Th2 induction. Indeed, DC/Zymosan A but not DC/0- 
3hR_P up-regulated expression of OX40L, which has been implicated in Th2 polansation 
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(discussed in Section 6.4). One similarity between DC/0-3hRP and DC/Zymosan A is that, 
in contrast to DC/LPS, neither up-regulated expression of CD80, suggesting this factor 
could be involved in promoting Thl. polarisation, although this is highly debatable 
(discussed in Section 6.4). However, it possible that there is an essential factor for PAMP- 
driven Th2 polarisation, common to both DC/0-3hRP and DC/Zymosan A, which has not 
yet been identified, or was not analysed in Chapter 6. 
One factor thought to play a critical role in DC activation and function is the interaction of 
CD40 and CD 154. In this chapter, I demonstrate that simultaneous culture of DC with anti- 
CD40 antibody dramatically increases their ability to drive anti gen-specific acquired 
responses. This concurs with similar findings that CD40-activation of human DC results in 
increased T-cell proliferation and cytokine production in vitro (Cella et al., 1997). 
Furthermore, I demonstrate that anti-CD40 treatment of DC/0-3hRP reverses their capacity 
to prime Th2 responses, instead causing the induction of Th I responses. Indeed, in vivo 
administration of anti-CD40 antibody can reverse the Th2 response resulting from 
injection of schistosome eggs, in favour of a Thl response (Martin et al., 2000). One way 
anti-CD40 treatment may exert this pro-Th I effect is by stimulating increased IL-12p4O 
but not Th2-associated cytokine production (Section 6.3.8). Indeed, CD40 ligation on DC 
can lead directly to Th 1 polarisation through the increased production of IL- 12 (Cella et 
al., 1996; Ruedl et al., 2000). Concurrent with this, the inhibition of Th2 cytokine 
production observed in response to co-injection of schistosome eggs with anti-CD40 
antibody was dependent upon IL- 12 (and IL-23? ) production (Martin et al., 2000). 
Alternatively, the anti-CD40 antibody used in my experiments, and that of Martin et al. 
(2000) may act to mask CD40, thus blocking signals received, or given, through CD 15 4, 
since these are important for Th2 development (Poudrier et al., 1998). Indeed, DC 
generated from CD40 -/- mice have an impaired ability to drive Th2 but not Thl responses, 
and CD 154 -/- mice do not mount Th2 responses to schistosome eggs or schistosome 
infection (MacDonald et al., 2002a; 2002b). This work suggests that exposure of DC to 
released schistosome material during infection will lead to an increased ability to prime 
Th2 responses, but that feedback from CD 154' cells would potentially aid the development 
of Thl responses. 
It has been shown that T-cells from mice on BALB/c backgrounds default to a ThO / Th2 
phenotype upon priming in neutral conditions (Hsieh et al., 1995). These mice also 
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preferentially mount Th2 responses in experimental leishmanial infection, compared to the 
protective Thl response seen in C57BI/6 mice (Heinzel et al., 1989; Scott, 1991). 
Moreover, they develop Th2-dependent mechanisms of protection following schistosome 
vaccination (Mountford et al., 2001), compared to more protective highly Th I -polansed 
response mounted by seen in C57BI/6 mice. Together, these observations have lead to the 
suggestion that BALB/c are naturally 'Th2' mice. This bias may lie intrinsically with the 
T-cell (Hsieh et al., 1995), however, recent work shows that differences in DC responses 
also play a role (Kuroda et al., 2000; Liu et al., 2002). In this respect, BALB/c DC were 
more responsive to 'Th2 inducing' 0-3hRP, than their C57BI/6 counterparts (Chapter 6), 
suggesting that part of the 'Th2' phenotype of BALB/c may be due to their ability to 
respond to Th2 driving PAMPs. However, SEA can stimulate DC to drive Th2 responses 
in C57BI/6 mice (MacDonald et al., 2001). Repeats of these experiments using TCR Tg 
mice on a C57131/6 background would determine if 0-3hRP retains its 'Th2' properties in 
this Thl-associated strain. 
7.4.5 Summary 
In summary, PAMPs released during the transformation of schistosomes instruct immature 
DC to mature to a phenotype promoting T-cell proliferation. Moreover, these DC drive 
Th2 polarisation of antigen- sp eci fic responses. The differentiation towards the Th2 pole 
may occur due to a default mechanism of T-cells in the absence of polansing cytokines. h-1 
this respect, early ligation of CD40 on DC leads to increased IL- I 2p4O production and a 
switch from Th2 to Thl priming. However, it is possible that other factors may be involved 
in active polarisation of Th2 responses by 0-3hRP-stimulated DC. 
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CHAPTER 8 
GENERAL DISCUSSION 
The overall goal of this thesis was to determine if host accessory cells recognise molecules 
derived from schistosome larvae. The secondary objective was to establish what effect 
innate schistosome recognition may have upon the development of the acquired response. I 
have shown that molecules released from schistosome larvae in the first 3 hours following 
transformation are potent stimulators of innate accessory cells. Furthen-nore, APC exposed 
to these molecules acquire the capacity to drive Th. 2 responses. 
8.1 Innate recognition of schistosome larval molecules 
My studies appear to show that schistosomes directly activate the innate immune system 
through the expression of molecules with PANW-like activity. In this respect, larval 
components are capable of stimulating IL-6 and IL- 10 production by inflammatory MO 
(Chapter 3), and IL-6 and IL- I 2p4O production by IFNy-activated MO (Chapter 3) and 
BM-derived DC (Chapter 6). Furthermore, I show that these stimulatory larval components 
are highly concentrated within the secretory material released by the parasite (0-3hRP) 
(chapters 3& 6). This would appear logical since released larval components have the 
greatest potential to be encountered by the hosts' immune system. In addition, it is possible 
that larval surface components may also have stimulatory properties since iMO become 
activated following culture with live larvae. In the in vivo context, skin accessory cells are 
likely to be exposed to both secreted material and surface molecules. 
In contrast to 0-3hRP, soluble somatic preparations from whole larvae had little 
stimulatory capacity, suggesting either the absence or dilution of stimulatory components, 
and / or the presence of potentially inhibitory molecules. Although this thesis has focused 
entirely upon the identification of stimulatory schistosome material, analysis of the 
inhibitory properties of the larval preparations may further reveal important biological 
interactions that occur between parasite and host at the onset of infection. In this respect, 
eicosanoids produced by larvae upon contact with host precursor material (e. g. linoleic 
acid) may exert such an inhibitory effect in vivo, but are unlikely to be a factor in my 
preparations. 
One major concern throughout my studies has been the possible effects of low-level 
endotoxin contained within the larval preparations. In Chapter 3, several lines of 
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experimentation, including co-culture with polymixin B, were used to conclude that 
schistosome molecules (representing putative schistosome PAMPs) stimulate accessory 
cells independently of contaminating endotoxin. Further strengthening this conclusion, 
data presented in chapters 6 and 7 demonstrate that the schistosome PAMPs have a quite 
different effect on iDC compared to other classical microbial PAMPs, including the major 
endotoxin constituent LPS. This implies that iDC matured with 0-3hRP have not been 
stimulated in a manner suggestive of endotoxin contamination. Therefore, under conditions 
where endotoxin contamination is eliminated, my studies show that 0-3hR-P contains 
stimulatory molecules that represent novel innate ligands of larval origin. 
I have termed the stimulatory larval components as schistosome PAMPs, supported by 
evidence of their interaction with PRRs, such as the TLR4 and the MR (chapters 3& 4). 
However, they could instead represent virulence factors, which Medzhitof (200 1) states are 
not PAMPs due to their restriction to a limited number of pathogens. In this respect, the 
skin inflammatory response to cercarial secretions is known to aid parasite penetration 
(Fallon et al., 1996). Although coverall terms, such as 'Modulins' have been used more 
recently to describe pathogen molecules that exert effects upon the innate and acquired 
immune systems (Whelan et al., 2000), the general title of putative PAMPs will suffice for 
this thesis. 
Activation of innate accessory cells occurs following ligation of their PRRs. The 
stimulatory effects of 0-3hRP upon IL- 10 and IL- I 2p4O production was partly dependent 
upon the TLR4, since Mý and IFNy-Mý from C3H/HeJ mice, which lack a functional 
form of this receptor, produced considerably reduced levels of these cytokines compared to 
cells from C3HJHeN mice. The TLR4 is known to be a promiscuous PRR and my data 
suggests the existence of TLR4-ligands of schistosome origin, although another 
interpretation is that there was an intrinsic difference in the activation state of Mý from 
these mice. The availability of cell-lines expressing individual TLRs, additional TLR-gene 
deficient mice, and antibodies that block TLR signalling should enable us to more fully 
assess the roles of these receptors in schistosome PAMP recognition. An interesting issue 
raised by my results was that high-level IL-6 production stimulated by 0-3hRP appeared to 
be largely independent of TLR4 recognition. Further work upon the signal transduction 
events downstream of PRRs that lead to IL-6 production may help to explain these 
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observations. With a complex mixture of PAMPs, as represented by 0-3hRP, it is quite 
possible that simultaneous recognition occurs through several receptors. Indeed, although 
FcR 7-chain signalling appeared to have little role in IL- 10 production stimulated by 0- 
3hRP (Chapter 5), the released material did contain molecules recognised by carbohydrate- 
recognition domains of the MR (Chapter 4). However, MR ligands were much more 
abundant in the relatively non-stimulatory preparations of whole larvae, and represented 
molecular species distinct from those within 0-3hRP. Studies using MR -/- mice will allow 
further dissection of the role of this receptor in the innate responses to schistosomes. 
Fractionation of 0-3hRP would also allow identification of the individual schistosome 
PAMPs responsible for these stimulatory (or possibly inhibitory) properties, and the 
identification of the receptors through which they signal. 
8.2 Innate recognition of schistosomes: APC and the development of acquired 
immune responses 
The successful priming of an acquired immune response first requires activation of the 
local APC population, and there is clear evidence that this occurs in the skin following 
exposure to schistosome larvae (Hogg et al., 2003a). Consequently, immature BM-derived 
DC were used to study the effects of schistosome PAMPs on professional APCs (Chapter 
6). O-ARP stimulated the maturation of BM-derived DC corresponding with an increased 
number expressing MHC , high, CD40, CD86 high , and 
increased production of IL- I 2p4O and 
IL-6. However, when compared with the 'high-level' of maturation induced by the classic 
pathogen PAMPs LPS and Zymosan A, DC activated with 0-3hRP were shown to be of an 
'intermediate' maturation state, reminiscent (yet potentially distinct) of that stimulated by 
other helminth products (Whelan et al., 2000; MacDonald et al., 200 1). 
An in vitro antigen-restricted priming assay was used to show that DC matured with 0- 
3hRP had an increased capacity to prime for proliferation of CD4+ cells from DOI 1.10 (XP 
TCR mice in the presence of the model antigen (OVA peptide) (Chapter 7). This 
demonstrates that schistosome PAMPs have adjuvant-like qualities and that DC exposed to 
these molecules during the onset of infection would gain the capacity to prime acquired 
responses. 
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Comparison of the results from chapters 3 and 6 demonstrates clear differences between 
the responses of iM0 and DC to 0-3hRP. In terms of the amount of cytokine production, 0- 
3hRP had broadly similar effects on iM0 compared to LPS and Zymosan A. However, 0- 
3hRP caused only minimal increases in cytokine production by iDC compared to the high 
levels stimulated by LPS and Zymosan A. One interpretation of this is that there are 
differences in the responses of DC and iM0 to ligation of the PRRs responsible for 
recognition of 0-3hRP. In this context, signalling via the MR has been implicated in the 
inhibition of IL-12 production by human dendritic cells (Nigou et al., 2001) but has 
cytokine promoting effects upon Mo (Yamamoto et al., 1997). Alternatively, there may be 
differential expression of PRRs upon these cells, such that each is restricted in the 
repertoire of PAMPs to which they can respond. Analysis of the differences in the 
expression of PRRs between accessory cells remains to be fully investigated, and could 
lead to a greater understanding of the roles of individual accessory cells in responses to 
different pathogens. In this respect, differences in responsiveness of iDC and iM0 to larval 
PAMPs could reflect the relative contribution of these cells to the inflammatory response 
that occurs in the skin following infection. Furthermore, iM0 produced a regulatory 
repertoire of cytokines (IL- 10, IL-6, low IL- I 2p4O) upon stimulation with 0-3hRP, 
whereas the cytokine profile produced by DC was much more pro-inflammatory (IL-12p4O 
and IL-6), mimicking that produced by IFN7-primed Mo. In this respect, DC could 
indirectly enhance IL- 12 production by Mo during infection, through IL- I 2-mediated IFN7 
production from NK cells. Identifying exactly how the schistosome interacts with the range 
of other accessory cells in the skin, and how these cells co-operate to orchestrate the 
inflammatory response in vivo are major questions for ftirther research. 
8.3 Innate recognition of schistosomes: polarisation of the acquired immune response 
Innate responses appear to exert control over the selection of acquired effector responses, 
via the polarisation of the Th cell population. As the bridge between these two immune 
systems, DC are in a unique position to directly effect the outcome of Th cell priming, and 
further work in Chapter 7 focused upon the ability of DC exposed to released schistosome 
PAMPs to polarise acquired responses. Controls that were expected to prime for 'neutral', 
'Th I' and 'ThT polar responses were used to provide reference points, allowing the 
outcome of priming to be gauged. Using the in vitro antigen-restricted priming assay, DC 
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activated with 0-3hRP primed CD4+ cells from DO 11.10 (xp TCR Tg mice to secrete 
increased IL-4 but little IFNy similar to DC activated with Zymosan A. In contrast, CD4+ 
cells primed by LPS-matured DC only produced abundant IFNy. Furthermore, inoculation 
of DO 11.10 mice with DC matured by 0-3hRP in the presence of OVA, also led to in vivo 
development of polarised Th2-type responses in both the sdLN and spleen. 
A major area of research on T-cell regulation is identification of factors controlling the 
development of Th I and Th2 responses, since these represent potential targets for immuno- 
therapies that either promote protective, or interfere with deleterious immune responses. In 
this respect, the PRRs that are involved in the induction of Th2 responses are not well 
defined compared to the relative wealth of knowledge on TLR- and MyD88-dependent 
Th I responses. Much work has focused on the hunt for factors expressed by DC, or other 
APC which contribute to polarisation. A clear role for certain cytokines, most obviously 
IL-12, has been defined in the promotion of Thl responses but factors involved in Th2 
polarisation are less well understood. One current theory suggests that Th2 responses 
develop as a default of T-cell-priming by activated DC that do not produce known 
polarising cytokines (Kelsall et al., 2002). My data tends to support this view, since DC/0- 
3hRP are defined by a state of 'intermediate' maturation, and low-level cytokine 
production. 
Several studies have highlighted a critical involvement of individual co-stimulatory signals 
in the development of Th2 but not Thl responses. However, since many cytokines also act 
as co-stimulatory factors, it may be that high-level cytokine production by Th I -inducing 
DC compensates for the loss of any one co-stimulatory survival signal. Indeed, the absence 
of certain co-stimulatory signals results with the loss of Th2 responses without the 
development of compensatory Thl responses (MacDonald et al., 2002a; 2002b). However, 
the Th2-driving capacity of highly-activated DC/Zymosan A (Chapter 7) which produce 
high levels of cytokines and express high levels of co-stimulatory molecules supports the 
alternative theory that certain factors (possibly cytokines or co-stimulatory molecules) may 
actively drive Th2 polarisation, rather than by a passive default mechanism. One co- 
stimulatory partnership that clearly affects the differentiation of acquired responses is 
CD40 / CD 154.1 show that ligation of CD40 following anti-CD40 antibody treatment of 
DC matured with 0-3 hRP increased their production of IL- 12 and reversed their capacity to 
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prime Th. 2 responses, instead causing the induction of a more Th I -type response. CD40 
ligation could exert its effects by further activating DC to produce increased IL- I 2p4O, 
although the antibody used in this study could also mask CD40 and potentially block Th2- 
dependent signals between CD40 and CD 154. The use of CD I 54-expressing fibroblasts to 
ligate CD40 rather than anti-CD40 antibody would allow the dissection of the individual 
roles of CD40 and CD 154 signalling in the switch from Th2 to Th I induction by DC. 
Furthermore, gene-array, or proteomic, analysis of differentially-matured DC could 
identify new markers to better define DC maturation and highlight novel factors 
differentially expressed by Th I- or Th2-driving DC that could be involved in polarisation. 
8.4 Relevance to infection 
This is the first study to demonstrate that DC activated by released products from 
schistosome larvae acquire the capacity to drive Th2 acquired immune responses. A 
fundamental question is whether Th2 responses are important to host protection. In the 
context of schistosome infection, the widely accepted view is that exposure to normal 
cercariae results in a mixed Th I/ Th2 response compared to the more Th I polarised 
response induced by vaccination. My data suggests that DC activated during natural 
infection should skew the acquired response towards the Th2 pole. However, the response 
of local APCs in the skin and sdLN to released schistosome PAMPs may be only one of 
many factors involved in polarisation during infection. In this respect, it is possible that the 
presence of live larvae in situ-in the skin and sdLN might contribute to the induction of 
Th I rather than Th2 responses through the release of Th I -inducing PAMPs by later-stage 
parasites, or the surface expression of such molecules. Alternatively, endogenous danger 
signals released in the skin / sdLN due to tissue damage following parasite penetration and 
migration, could be involved in Thl induction. 
What about the development of immune responses following repeated exposure of the host 
to cercariae? In this respect, mice that are multiply-infected with either S mansoni, or T 
regenti, exhibit Th-2-associated immediate hypersensitivity reactions and cercarial 
dermatitis upon re-infection (Section 1.3.4). Indeed, single infection with T. regenti 
appears to result in a mixed Th I/ Th2 response in the sdLN, but in multiply-infected mice 
re-infection results in extreme Type-2 polarisation (Kourilova et al., 2003). Therefore, 
exposure of DC to released schistosome PAMPs may contribute to the development of 
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immediate hypersensitivity within the host, and repeat infection could enhance this by 
further polarising the Th2 response. Production of anti-schistosome antibody may also 
contribute to Th2 polarisation upon exposure to 0-3hRP, via the augmentation of IL- 10 
production via FcR y-chain signalling (Chapter 5). 
How come many individuals in endemic areas are repeatedly exposed to high levels of 
infectious cercariae yet do not develop correspondingly massive worm burdens? Very little 
is known about the dermal responses of humans whom are repeatedly exposed to cercariae. 
However, it is possible that Th2 responses induced by exposure to released larval material 
contribute to anti-schistosome immunity, potentially operating at the level of immediate 
hypersensitivity responses in the skin and lungs. Indeed, the natural parasite attrition that 
occurs following single infection is significantly decreased in IgE -1- mice (King et al., 
1996b). In addition, parasite death is more rapid during irnmediate-hypersensitivity 
reactions following the re-infection of mice multiply-infected with T regenti, compared to 
death following primary infection. 
The early induction of Th. 2 responses by parasite larvae may also predispose the host to 
develop Th. 2 responses upon egg deposition. Whether the schistosome molecules that drive 
Th2 responses to eggs are the same as the immunologically active components in 0-3hRP, 
or whether they act through the same PRRs, remains to be determined but these biological 
compartments share similar glycosylated molecules. 
Manipulation of the innate immune system could provide an important avenue to potentiate 
the development of protective immunity to infection. However, the results presented in this 
thesis raise important questions for the development of an effective schistosome vaccine. 
Although PAMPs within 0-3hRP have adjuvant properties, they may be of only limited use 
within a Th I -inducing vaccine due to their promotion of Th2 responses. Whilst these 
responses may provide protection, the development of vaccines that induce Type-2 
response have the potential hazardous side-effects of inducing allergies to bystander 
antigens. Moreover, although strong Th I responses can provide protection to infection 
(Wynn et al., 1995; 1996), repeated exposure to the Th2-inducing PANIPs released by 
cercariae (which would presumably occur in areas of endemic infection) could potentially 
revert vaccine-induced Th I responses towards mixed Th I/ Th2, or Th2 responses. 
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8.5 Summary 
In conclusion, it is fundamentally important that we understand the early innate events that 
follow exposure to schistosome cercariae and lead to the development of inflammatory 
responses in the skin and acquired responses in the sdLN. The work contained in this thesis 
furthers our knowledge of how accessory cells are stimulated during infection and the 
effect this has on promotion of Th2-type acquired immune responses. These events could 
be key to the development of immediate hypersensitivity to schistosomes, and may present 
a considerable obstacle to ftirther infection. Indeed, the role of Th-2 responses in host 
protection represents an exciting area for further study. A more precise understanding of 
the events that lead to the inflammatory response and polarisation of the acquired immune 
response will better enable intervention, or induction of protection against disease. 
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ABBREVIATIONS 
Gene deficient 
0-3hRM 0-3 hr released material 
0-3hRP Soluble 0-3 hr released preparation 
0-3hSN 0-3 hr released material 
3hSom 3 hr schistosormilae 
3dSSP 3 day SSP 
5dSSP 5 day SSP 
8dSSP 8 day SSP 
3hSSP 3 hr SSP 
18hSSP 18 hr SSP 
I-D I -dimension 
2-D 2-dimension 
ACK Ammonium chloride buffer 
APC Antigen presenting cells 
BAL Broncho-alveolar lavage 
BBGC Brilliant Blue G-Colloidal Concentrate 
BLAST Basic local alignment search tool 
BM Bone marrow 
BSA Bovine serum albumin 
CCR Chemokine receptor 
CercN Normal cercariae 
CercT Transformed cercariae 
CPM Counts per minute 
CR Complement receptor 
CRD Carbohydrate recognition domains 
Cox Cyclo-oygenase 
DC Dendritic cells 
DNA Deoxyribonucleic acid 
dsRNA Double-stranded RNA 
EDTA Ethylene diamine tetra-acetic acid 
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ELISA Enzyme-linked immunosorbant assay 
EU Endotoxin units 
Fc Antibody constant region 
FcyR Fey receptor 
FcR y Fc receptor y chain 
FCS Foetal calf serum 
FITC Fluorescein isothiocyanate 
GM-CSF Granulocyte-macrophage colony stimulation factor 
GPI Glycophosphoinsitol 
GST Glutathione-s-transferase 
HRP Horseradish peroxidase 
HSP Heat shock protein 
IFN Interferon 
Ig Immunoglobulin 
IL Interleukin 
IL-XR IL-X receptor 
IL- I Ra IL- I receptor antagonist 
iDC Irnmature dendritic cells 
imý Inflammatory peritoneal macrophages 
IFNy-Mý IFNy-activated peritoneal macrophages 
IRS 0-3hRM immunised rabbit serum 
IRAK IL- I receptor associated kinase 
LAL Limulus Amoebocye Lysate 
LBP LPS-binding protein 
LC Langerhans cells 
Le' Lewis X 
LNFP Lacto-N-fucopentose 
LPS Lipopolysaccharide 
Mý Macrophages 
MACS Magnetic activated cell sorting 
MACSB Magnetic activated cell sorting buffer 
MAL MyD88 adaptor-like 
mDC Mature dendritic cells 
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MHC Major histocompatibiltiy complex 
MIP Macrophage inflammatory protein 
mLN Mediastinal lymph node 
MR Mannose receptor 
MR-Cys Mannose receptor N-ten-ninal cysteine-rich domain 
mRNA Messenger RNA 
NF Nuclear factor 
NK Natural killer 
NKT Natural killer T-cell 
NRS Normal rabbit serum 
OVA Chicken ovalbumin peptide 
PAGE Poly-acrylamide gel electrophoresis 
PAMP Pathogen- associated molecular pattern 
PB Phenobuffer 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate buffer saline 
PBS-T Phosphate buffered saline tween 
PCR Polymerase chain reaction 
PE Phycoerythrin 
PEC Peritoneal exudate cells 
PG Prostaglandin 
PI Propidium. iodide 
PMB Polymyxin B 
PRR Pattern recognition receptor 
PVDF Polyvinylidene difluoride 
QR Quantum red 
rIL Recombinant Interleukin 
RANTES Regulated on activation, normally T-cell expressed and secreted 
RNA Ribonucleic acid 
RPMlc Concentrated RPMI preparation 
RT Room temperature 
RT-PCR Reverse-transcription polymerase chain reaction 
SCP Soluble cercarial preparation 
sdLN Skin-draining lymph node 
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SEA Soluble egg antigen 
SEM Standard error of the mean 
SDS Sodium dodecyl sulphate 
Sm S. mansoni protein 
SMAF S. mansoni-derived apoptosis inducing factor 
SN Supernatant 
SOCS Suppressor of cytokine signalling 
SSP Soluble schistosomulae preparation 
STAT Signal transducer and activation of transcription 
SWAP Soluble adult worm preparation 
TBS-T Tris buffered saline tween 
TCR T-cell receptor 
TCTP Translationally controlled tumour protein 
T9 Transgenic 
TGF Transforming growth factor 
Th T-helper 
TIR Toll / IL- IR domain 
TER-AP Toll-IL- IR domain containing adapter protein 
TLR Toll-like receptor 
TMB Tetra-methylbenzidine 
TNF Turnour necrosis factor 
TNFR TNF receptor 
Tr Regulatory T-cell 
Treg Regulatory T-cell 
T 1/2 Time taken for half the event to occur 
U Units 
WHO World health organisation 
WT Wild-type 
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